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Abstract  
 
During infection with Neisseria meningitidis, an important causative agent of bacterial 
meningitis and septicaemia, the host innate immune system clears bacteria by 
complement-mediated lysis and phagocytosis. In order to evade phagocytosis, the 
bacterium expresses a number of surface components, including a polysaccharide 
capsule and sialylated lipopolysaccharide (LPS). The aim of this project was to 
investigate the influence of bacterial metabolism and DNA repair on the interaction with 
polymorphonuclear leukocytes (PMNs). Results demonstrated reduced expression of 
the polysaccharide capsule and lowered LPS sialylation in a strain (∆lctP) unable to 
acquire exogenous lactate, but no effect in a strain unable to utilise glutamate (∆perM). 
These changes were associated with increased phagocytosis of fixed bacteria by the 
human PMN cell line, HL60. Further investigations showed that capsule expression in 
the ∆lctP strain was restored to wild-type levels following exposure of live bacteria to 
PMNs. Next, assays were established using primary human PMNs to investigate post-
phagocytic events. The wild-type meningococcus survives within PMNs and is able to 
delay host cell apoptosis. Furthermore, the ∆lctP and ∆perM strains were significantly 
killed by PMNs, indicating a role for acquisition of both lactate and glutamate for 
survival in PMNs. Killing was dependent on actin polymerisation and the PMN oxidative 
burst. The role of the meningococcal Base Excision Repair (BER) DNA repair pathway 
was also investigated through characterisation of two Apurinic / Apyrimidinic (AP) 
endonuclease paralogues, NExo and NApe. Both exhibit distinct biochemical functions 
and are required for resistance against oxidative stress. A strain lacking both these 
enzymes, which is attenuated in vivo, was significantly killed by human PMNs as a 
result of the oxidative burst. 
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Chapter 1 Introduction  
 
1.1 N. meningitidis and meningitis 
 
1.1.1 History and background 
Bacterial meningitis was first described in 1805 following an epidemic that resulted in 33 
deaths in the vicinity of Geneva (Vieusseux, 1805). In 1884, Italian pathologists Marchiafava 
and Celli observed intracellular micrococci in samples of cerebrospinal fluid (CSF), but it was 
Weischelbaum in 1887 who first confirmed that the bacterium was responsible for meningitis 
(Weichselbaum, 1887; Marchiafava, 1884). Originally named Diplococcus intracellularis meningitidis, 
the microorganism was renamed Neisseria meningitidis by Albert Neisser following the 
characterisation of the related bacterium Neisseria gonorrhoeae in 1879 (Kampmeier, 1978).  
 
N. meningitidis is an aerobic Gram-negative diplococcal β-proteobacterium, and a member 
of the family Neisseriaecae. It is an obligate human bacterial pathogen, and an important 
agent of bacterial meningitis and septicaemia. The bacterium is also a commensal of the 
human nasopharynx. Between 10-40% of the population is colonised by the meningococcus, 
which is transmitted between hosts by aerosol spread (Taha and Alonso, 2008). The incidence 
rate of meningococcal disease is 0.39 – 7.41 per 100,000 per annum in Europe, and as high 
as 25 per 100,000 in developing countries (Pace and Pollard, 2007). Over 2,000 people are 
affected annually in the UK, where the mortality rate is approximately 10% (Health Protection 
Agency, 2007). Patients who recover may suffer permanent damage from meningococcal 
infection, including partial paralysis or deafness. The disease manifests primarily as a 
bloodstream and/or meningeal infection although it can also cause metastatic infections 
such as arthritis, pericarditis or cellulitis, endophthalmitis, conjunctivitis, pneumonia, 
sialadenitis (inflammation of the salivary glands), adnexitis (inflammation of ovaries and 
oviducts) and pelvic inflammatory disease (Wells et al., 2001; Blaser et al., 1984; Odegaard, 1983).  
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1.1.2 Symptoms and treatment of meningococcal disease 
The onset of meningococcal disease can be extremely rapid. In the absence of appropriate 
medical care, patients can quickly lapse into septic shock. Coma, organ failure and death 
can follow within less than 24 hours of the onset of disease (Branco, 2007). Initial symptoms 
are largely non-specific, making the diagnosis problematic. Patients experience flu-like 
symptoms such as headache, fever, nausea and vomiting, and may display early signs of 
sepsis such as abnormal skin colouring and/or coldness of the extremities (Branco, 2007). 
These early symptoms are frequently misdiagnosed and often it is not until the patient 
begins to show more specific symptoms that meningococcal disease is suspected. These 
advanced symptoms include neck stiffness, aversion to bright light and the purpuric skin 
rash that is a classical manifestation of septicaemia. Meningitis refers to inflammation of the 
meninges of the surrounding central nervous system. If untreated, this condition can lead to 
coma and eventually death, usually as a result of multiple organ failure.  
 
The diagnosis of meningitis and septicaemia relies on testing blood or cerebrospinal fluid 
(CSF), although the collection of CSF may not be possible if the patient is in a critical 
condition. Detection of bacteraemia may be by Gram stain, antigen detection or culture, and 
the use of polymerase chain reaction (PCR) is increasingly common. Rapid diagnosis and 
early treatment are key for the successful management of meningococcal disease. Prior to 
the 1920’s, bacterial meningitis was fatal in up to 70% of cases. Early treatments included 
the administration of serum from immunised horses, which reduced death rates to 30% 
(Flexner, 1913). The discovery of antibiotics further diminished mortality, and case fatality rates 
are now at 10%. The recommended antimicrobial treatment for meningococcal disease is 
with cephalosporin antibiotic such as ceftriaxone. Administration of antibiotics may be 
influenced by local antibiotic resistance patterns, although there is little clinically significant 
resistance to β-lactams. Patients often require from fluid replacement and resuscitation early 
on in disease (Branco, 2007). 
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1.1.3 Classification 
The classification of the meningococcus was originally based on the antigens expressed on 
the surface of the bacterium. The polysaccharide capsule determines serogroup, the outer 
membrane-bound porin proteins, PorA and PorB, define sero-subtype and sero-subtype 
respectively, and the lipopolysaccharide (LPS) relates to the immunotype (Feavers and Maiden, 
1998; Frasch et al., 1985). More recently additional classifications have been identified according 
to genetic differences. 
 
There are thirteen known serogroups of N. meningitidis (A, B, C, E-29, H, I, K, L, M, W-135, 
X, Y and Z), of which six represent the majority of disease-causing strains (A, B, C, W-135, 
X, Y) (Stephens et al., 2007; Jodar et al., 2002; Pollard and Levin, 2000a). Serogroups B, C, W and Y all 
express polysialic acid-containing capsules. The sialic acid in the capsules of serogroups X 
and Y, which is O-acetylated, are α1-4 linked. The capsule of serogroup C strains is α2-9 
linked, while serogroup B capsule is α2-8 linked, mimicking a modification of the human 
neural cell adhesion molecule (N-CAM) (Liu et al., 1971b; Liu et al., 1971a; Slaterus, 1961). The 
serogroup A capsule is composed of α1-6-linked N-acetyl-D-mannosamine-1-phosphate 
polymers (Swartley et al., 1998). 
 
There are five classes of outer membrane proteins (OMPs). Class 1, designated P1, are 
represented by PorB, which determines sero-subtype, whilst Class 2/3, or PorA, establish 
the serotype. To date, over 20 serotypes and 10 sero-subtypes have been identified, 
although many isolates cannot be classified with this system (van Deuren et al., 2000). 
Immunotype according to LPS structure is determined by the groups on the α and β chains 
added to the inner core region (Mandrell and Zollinger, 1977; Zollinger and Mandrell, 1977). When 
combined, these independent methods of classification provide reference numbers 
describing the characteristics of a strain. For example, a serogroup B strain, of serotype 3 
and subtype P1.2, with an immunotype of L3 would be designated B:3:P1.2:L3 (van Deuren et 
22 
 
Chapter 1 Introduction  
 
al., 2000). Further classification according to the immunoglobulin A1 (IgA1) protease and pilin 
is also possible (Stephens et al., 1985). 
 
Classification of the meningococcus according to the surface structures can be problematic 
due to antigenic variation. The capsule, porins and LPS antigens are subject to selective 
pressure, and thus the genes encoding them are highly variable. In addition, many carriage 
isolates are unencapsulated and thus cannot be serogrouped (Vogel et al., 2004). Therefore, 
following the advent of molecular biology techniques, strains are now classified according 
variations in enzymes with metabolic functions, and by characteristics of their genomes. This 
is performed by Multilocus Enzyme Electrophoresis (MLEE) and Multilocus Sequence 
Typing (MLST). MLEE relies on separation of bacterial intracellular enzymes according to 
their electrophoretic mobility. The position of each enzyme following electrophoresis is 
compiled to give the electrophoretic type (ET) of a strain (Caugant et al., 1986). Meanwhile, 
MLST involves the determination of the sequence of 400-500 bp of seven housekeeping 
genes. Differences in the nucleotide sequence between strains allow their classification into 
different sequence types (ST) (Maiden et al., 1998). Both MLEE and MLST are powerful tools 
since they allow the typing of ambiguous and previously unclassifiable strains. MLST is 
generally regarded as the more useful of the two since data generated by independent 
laboratories can be directly compared. Disease-causing isolates from different serogroups 
can be grouped according to their ET or ST into clonal complexes. Data has shown that a 
small number of clonal complexes account for the majority of meningococcal disease 
(Brehony et al., 2007). For example, strains classified in clonal complex ET-37/ST-11 have been 
responsible for outbreaks in Canada, Europe, Australia and Israel (Jelfs et al., 2000). 
 
1.1.4 Epidemiology 
Meningococcal disease occurs worldwide as endemic disease, with the incidence varying 
between 1-1,000 per 100,000 people depending on location (Rosenstein et al., 2001; Tzeng and 
Stephens, 2000). It most frequently affects infants, due to their waning maternal passive 
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immunity, and young adults, although all age groups are susceptible, particularly during an 
epidemic (Cartwright et al., 2001; Pollard and Levin, 2000a; Goldschneider et al., 1969). 
Immunocompromised individuals are at a heightened risk, especially those individuals with 
deficiencies in the complement system (Rosa et al., 2004; Cunliffe et al., 1995; Mitchell et al., 1990; 
Ross and Densen, 1984). Due to the mode of transmission of the bacterium, outbreaks are more 
common when people live in overcrowded conditions, including military barracks and student 
accommodation (Yazdankhah and Caugant, 2004; Cartwright et al., 1987). In these situations, carriage 
of the bacterium by asymptomatic individuals is frequently as high as 40% of the population, 
and carriage frequencies have reached 70% in military recruits (Yazdankhah and Caugant, 2004). 
Bacteria are present in the nasopharynx of carriers, often residing deep within the tissue 
layer where detection by swabbing can be problematic (Sim et al., 2000). Carriage is affected 
by age and risk is associated with recent respiratory infections such as influenza, but the 
highest correlation is linked with social behaviour such as smoking and levels of intimate 
contact (MacLennan et al., 2006; Moore et al., 1990). 
 
Of the serogroups that cause the majority of meningococcal disease, serogroups A and C 
are most common in Africa and Asia, whilst serogroups B and C are responsible for most 
cases in Europe and the US (Rosenstein et al., 1999; Caugant, 1998; Schwartz et al., 1989). The sub-
Saharan Meningitis Belt in Africa, which spans ten countries from Ethiopia in the east to 
Senegal in the west, represents the region with the highest incidence of meningococcal 
disease in the world. Outbreaks of serogroup A disease are frequent, with the most severe 
epidemic to date occurring in 1996 when the total number of reported cases reached 
152,000 with almost 16,000 deaths, although many more cases went unreported or were 
misdiagnosed (Mohammed et al., 2000; Ahmed et al., 1996). A number of outbreaks have also 
arisen in Asia, the most severe of which were caused by two serogroup A clones that 
originated in northern China, and eventually spread around the world (Wang et al., 1992; Cochi et 
al., 1987). Serogroup W-135 strains were responsible for causing outbreaks amongst pilgrims 
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during the Hajj Mecca, including a large-scale epidemic in Burkhina Faso (Raghunathan et al., 
2006; Aguilera et al., 2002). 
 
Meningococcal disease in the UK is now predominantly the result of infection by serogroup B 
strains following the introduction of routine vaccination against serogroup C (Zimmer and 
Stephens, 2006; Ramsay et al., 2003; Maiden and Stuart, 2002). The disease affects over 2000 people 
in the UK each year, with a marked increase in cases during winter months (Health Protection 
Agency 2007). Despite available medical treatment, meningococcal disease still causes 150 
deaths in the UK each year (Health Protection Agency, 2007).  
 
1.1.5 Vaccines 
The first vaccines against serogroup A and C meningococcal disease were introduced in the 
1960’s (Pollard and Levin, 2000a). Raised purely against the polysaccharide capsular antigen, 
the vaccines were designed to elicit B-cell responses resulting in the production of 
antibodies against the polysaccharide (Pace and Pollard, 2007). These polysaccharide vaccines 
induced high levels of protection in clinical trials and were effective in controlling outbreaks 
within communities (van Deuren et al., 2000). However, the resulting antibody production is 
short-lived and varies greatly with age and serogroup (De Wals et al., 2001; Gold et al., 1978). The 
protective effect of the serogroup C vaccine does not extend to infants and young children, 
the most high-risk group (Lepow et al., 1977). This is because an effective immune response is 
dependent on a mature T-cell response, which is lacking in young children (Morley et al., 2001). 
Since the vaccines do not elicit immunologic memory, repeated immunisation is required to 
maintain protection. This is true of the monovalent, bivalent (A/C) and tetravalent (A/C/W/Y) 
polysaccharide vaccines (Pollard and Levin, 2000b). Both the serogroup A and C vaccines 
appear to influence mucosal carriage of these serogroups, indicating a possible effect on 
herd immunity and transmission of the meningococcus (Zhang et al., 2001; Zhang et al., 2000).  
Monovalent, bivalent and tetravalent conjugate meningococcal vaccines have now been 
developed using the same technology employed for the Haemophilus influenzae type B 
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glycoconjugate vaccine (Rennels et al., 2002; Booy et al., 1994; Costantino et al., 1992; Beuvery et al., 
1983a; Beuvery et al., 1983b). Combining the polysaccharide capsular antigen by conjugation 
with a protein enhances T-cell responses against the polysaccharide, producing high-affinity 
antibodies and B-cell-dependent immunologic memory, and thus long-lasting protective 
immunity (Lesinski and Westerink, 2001). These vaccines also provide effective protection of 
young children. The conjugate vaccine against serogroup C N. meningitidis was introduced 
to the UK in 1999 in response to an epidemic caused by an ST-11 clone (Lakshman and Finn, 
2002). Subsequent surveillance showed an 81% decrease in cases of meningococcal disease 
caused by serogroup C strains in the period between 1998-1999 and 2000-2001 (Miller et al., 
2001). The protective effect of the serogroup C conjugate vaccine appears to wane after a 
period of four years but herd immunity also prevents disease in unvaccinated individuals and 
may reduce transmission rates (Trotter et al., 2004; Ramsay et al., 2003). Furthermore, despite 
potentially eliciting a selective pressure for capsule switching from serogroup C to B, this 
phenomenon does not appear to have been an issue since the incidence of serogroup B 
meningococcal disease has not risen following the introduction of the vaccine (Balmer et al., 
2002) (Health Protection Agency 2004). 
  
A bivalent conjugate vaccine against serogroups A and C is also available and has been 
widely administered in sub-Saharan Africa following successful trials in Niger, the Gambia 
and the UK (Chippaux et al., 2004; Fairley et al., 1996; Twumasi et al., 1995). A tetravalent A/C/W/Y 
conjugate vaccine that employs diphtheria toxin as the carrier protein has been successfully 
introduced into the United States and Canada (Bilukha and Rosenstein, 2005). The challenge for 
manufacturers of these vaccines is to ensure protection is higher than offered by the 
vaccines raised against individual serogroups. Recently, encouraging data has been 
released on trials performed with a H. influenzae type B–N. meningitidis serogroup C–
tetanus toxoid glycoconjugate vaccine (Tejedor et al., 2008). 
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As a result of the mimicry by the serogroup B polysaccharide capsule of a modification of a 
human N-CAM, the design of vaccines against this serogroup is problematic since 
immunisation with the polysaccharide antigen does not elicit an IgG response and may lead 
to auto-immunity (Stephens et al., 2007). Vaccine development is focussed on alternative 
bacterial antigens. These include outer membrane proteins (OMPs), outer-membrane 
vesicles (OMVs) and LPS (Stephens et al., 2007). The challenge is to find a conserved antigen 
present in all serogroup B strains. Many meningococcal antigens are highly variable and 
thus are unsuitable as vaccine targets. Recent trials have shown success with a vaccine 
raised against a combination of OMV targets, including the Factor H binding protein 
expressed by the meningococcus, which is known to help subvert the host immune response 
(Beernink and Granoff, 2008; Beernink et al., 2006; Schneider et al., 2006). Further work is also 
investigating the possibility of using antigens expressed by the commensal Neisseria 
lactamica to produce a vaccine against the serogroup B meningococcus (Finney et al., 2008; Liu 
et al., 2008).  
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1.2 Virulence determinants 
 
1.2.1 Capsule 
An important feature that distinguishes the meningococcus from the gonococcus is 
expression of a polysaccharide capsule (Nassif and So, 1995). There are six distinct 
meningococcal capsule serogroups with differing chemical compositions. The serogroup B 
capsule is similar in structure to the Escherichia coli K1 capsule (Echarti et al., 1983; Hirschel et 
al., 1983). It is composed of chains of N-acetyl neuraminic acid (NeuNAc or NANA) of varying 
length. These monomers are linked at carbons two and eight, to form polysialic acid. At the 
reducing terminus of the sialic acid polymers is a diacylglycerophosphate group (Frosch and 
Muller, 1993).  
 
Capsule expression is controlled by the cps locus, a 24 kb region with homology to the E. 
coli kps locus. The cps locus comprises three distinct regions that control synthesis 
(siaABCD) and transport (ctrABCD and lipAB) (Tzeng et al., 2001; Swartley et al., 1996; Frosch et al., 
1989). The molecular basis of capsule expression was first characterised by Frosch et al. 
Expression of the cps locus in E. coli, followed by deletion of individual regions, enabled 
characterisation of the separate regions responsible for transport of capsule polysaccharide 
from the cytoplasm to periplasm, and thence to the cell surface (Frosch et al., 1989). The first 
stage of capsule biosynthesis involves sialic acid synthesis in the bacterial cytoplasm. D-
glucosamine is modified to produce N-acetyl mannosamine, the open chain form of which 
combines with phosphoenolpyruvate (PEP) via the action of NANA synthetase (SiaC) and 
cytidine monophosphate N-acetyl neuraminic acid (CMP-NANA) synthetase (SiaB) to 
produce sialic acid, or NeuNAc (Gunawan et al., 2005; Edwards et al., 1994).  
 
Polymerisation of sialic acid also occurs in the cytoplasm. The biochemistry of the initiation 
of this process is not yet fully understood as the initial acceptor molecule has not been 
identified. Following initiation, polymerisation is mediated by the glycosyltransferase 
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encoded by siaD, which transfers a Neu5Ac group from the donor CMP-Neu5Ac to the 
reducing terminus of the sialic acid glycan, thus elongating the oligosialyl polymer (Edwards et 
al., 1994). The mechanism of termination of this process is also not known. However, E. coli 
K1 chain termination occurs between 160-230 units, indicating that there is active 
determination of chain length (Pelkonen et al., 1988). It has been suggested that this may be 
caused by a loss of affinity once the chain reaches this length, or that abortive translocation 
within the catalytic site prevents further elongation. Termination may also be caused by an 
unknown allosteric effect. 
 
Capsule expression is modified in response to the immediate environment within the host. 
Expression of capsule is phase-variable as a result of on-off switching and slipped-strand 
mispairing or reversible frameshift mutation in the siaD gene (de Vries et al., 1996; Hammerschmidt 
et al., 1996). Capsule expression appears to be up-regulated during bloodstream infection, 
where the capsule is known to protect the bacterium from complement-mediated killing and 
phagocytosis (Vogel et al., 1997; Read et al., 1996; Hammerschmidt et al., 1994). Down-regulation 
occurs during colonisation to allow intimate binding of the bacterium to the epithelial 
monolayer (Stephens et al., 1993; Virji et al., 1993). Down-regulation of capsule, and also pili, was 
detected by Western blotting. Reverse transcriptase PCR (RT-PCR), DNA binding and 
footprinting analysis confirmed the regulatory role of CrgA, a transcriptional regulator 
belonging to the LysR family (Deghmane et al., 2002). However, more recently, work using 
transfected cell lines expressing the carcinoembryonic antigen-related cell adhesion 
molecule (CEACAM) has demonstrated invasion of cells by capsulate meningococci (Bradley 
et al., 2005). CEACAM expression is upregulated on host epithelial cells by chemokine 
signalling orchestrated by cytokines Interferon-gamma (IFNγ), Tumour necrosis factor alpha 
(TNFα) and Interleukin-6 (IL-6). It has been suggested that the increase in receptor density 
allows for adhesion and invasion of capsulate bacteria, mediated by the surface-expressed 
Opacity proteins and, to a lesser extent, by pili (Rowe et al., 2007). 
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1.2.2 LPS 
Meningococcal LPS, also called lipooligosaccharide (LOS) is an important endotoxin and a 
major factor contributing to the pro-inflammatory response during  disease. LPS is an 
amphipathic glycolipid of approximately 4.8 kDa (Jones et al., 2003), which comprises 
oligosaccharide chains added to the inner core, anchored to the lipid A moiety embedded in 
the bacterial outer membrane. Immunotypes are distinguished by differences in the 
modification of the oligosaccharide chains such as by acetylation and addition of 
phosphoethanolamine groups (Tsai et al., 1987). There are twelve distinct Neisserial 
immunotypes. Serogoup B strains tend to express L3,7,9 immunotype LPS (Figure 1.1) (Tsai 
et al., 1987). These strains are also able to add sialic acid onto the lacto-N-neotetraose (LNnt) 
moeity. Sialylation is achieved either from endogenously synthesised sources of sialic acid, 
or from exogenous CMP-NANA in the surrounding environment (Exley et al., 2005b; Smith et al., 
1992).  
 
Unlike E. coli, where the LPS biosynthesis genes are organised as large operons, the 
meningococcus possesses a number of small operons that are distributed throughout the 
genome (van der Ley et al., 2001; van der Ley et al., 1997). Localised chromosomal rearrangements 
at these individual loci are responsible for some of the variation seen in LPS structure, an 
important feature in meningococcal pathogenesis (Kahler et al., 1998; Kahler and Stephens, 1998). 
The first step of LPS biosynthesis is governed by the lpx locus, which synthesises the lipid A 
portion of the molecule (van der Ley et al., 2001). The UDP-GlcNAc acetyltransferases encoded 
by lpxA and lpxD acetylate UDP-GlcNAc, which is then dimerised by LpxB (Steeghs et al., 
1997). Following addition of a 3-deoxy-D-manno-octulosonic acid (Kdo) group to the lipid A 
molecule, a secondary acetylation step is achieved by lpx1 and lpx2 (van der Ley et al., 2001).    
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Figure 1.1 Structure of Neisserial immunotype L3,7,9 LPS 
Schematic representation of Neisserial LPS immunotype L3,7,9 comprising the inner Kdo 
and Lipid A core (black), heptose moieties (Hep; red), phosphoethanolamine (PEA, yellow 
on black), Glucose (Glc; green), Galactose (Gal, dark blue), N-acetylglucosamine (GlcNAc, 
light blue) and sialic acid (NeuAc, magenta). Linkages are shown for each bond (Plested et 
al., 1999).  
 
 
 
 
 
 
Glycosylation of the moiety is performed by the Kdo transferase encoded by kdtA (Tzeng et al., 
2002). Extension of the LPS molecule from lipid A is achieved by enzymes encoded by two 
main loci, rfa and lgt. The α-1,5 heptosyltransferase encoded by rfaC adds the first heptose 
group (HepI), followed by the action of rfaF, which attaches the second heptose (HepII) and 
is required for elongation of the LPS inner core (Stojiljkovic et al., 1997; Jennings et al., 1995). rfaK 
encodes the α-1,2-N-acetylglucosamine (GlcNAc) transferase which adds the GlcNAc group 
to HepII (Kahler et al., 1996). Glycosyltransferases encoded by the lgt locus catalyse the 
elongation reactions of the different LPS chains (Wakarchuk et al., 1996). The products of  lgtF, 
lgtE, lgtA and lgtB result in the addition of galactose, glucose, GlcNAc and galactose 
respectively to form the terminal LNnt. The UDP-glucose-4-epimerase encoded by galE is 
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important for the addition of the first glucose molecule in the oligosaccharide (Jennings et al., 
1993). Sialylation of the LNnt terminus is achieved by the alpha-2,3-sialyltransferase encoded 
by lst (Vogel et al., 1997).  
 
Meningococcal LPS is heterogeneous and highly variable, with individual strains able to 
display more than one LPS immunotype (Tsai et al., 1983). Variation is achieved by sequence 
changes within encoding regions and alterations in transcriptional regulation of the enzymes 
involved. In particular, the terminal structures are subject to high-frequency switching of 
expression, leading to variation in immunotype. High mutation rates in the lgtA gene of 
immunotype L3,7,9 strains as a result of slipped-strand mispairing in a homopolymeric tract 
of guanine residues, leads to variation in the terminal lacto-N-neotetraose (Jennings et al., 
1995). Such modulation of immunotype may impact further upon the LPS structure. For 
example, serogroup B strain MC58 switches between immunotypes L3 and L8. Of these two 
immunotypes, only L3 can be sialylated, an effect that is important for adhesion and invasion 
of host cells, and avoidance of host killing mechanisms (Jennings et al., 1999).   
 
1.2.3 Variable antigens 
 
1.2.3.1 Type IV pilus  
Type IV pili (Tfp) are dynamic, hair-like protein filaments that extend from the bacterial 
surface. In addition to mediating bacterial attachment to various host cell types, Tfp are 
involved in the generation of twitching motility that allows bacterial aggregation, and are also 
required for DNA transformation (Koomey, 1998; Goodman and Scocca, 1991). The pilus fibre is 
composed mainly of pilin, an 18-22 kDa polypeptide that is synthesised as precursor 
subunits with signal sequences. Processing of pilin by the PilD prepilin peptidase / 
transmethylase in the periplasm produces the mature pilin (Freitag et al., 1995; Strom and Lory, 
1993), which undergoes further post-translational modification by O-glycosylation and 
phosphorylation at external sites on the fibre (Forest et al., 1999; Jennings et al., 1998). Further 
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modification of the Tfp may include addition of phosphocholine or phosphoetholamine, which 
has been characterised in the gonococcus (Hegge et al., 2004). Recent work has identified an 
alternative method of pilin glycosylation via the addition of a glyceramido-acetamido-
trideoxyhexose residue (Chamot-Rooke et al., 2007). The structure of the neisserial pilus has 
been elucidated via a range of techniques including cryoelectron microscopy, fibre diffraction 
and antigenic mapping, revealing a helical cylindrical structure (Parge et al., 1995). The 
hydrophobic tail units form the cylinder core, providing tensile strength, while the globular 
head units form the helix surface (Merz and So, 2000). Within the globular domain is a surface-
exposed loop structure that represents the hypervariable region of the pilus (Seifert, 1996). 
 
Pilin biosynthesis occurs in the periplasm, and is controlled by proteins encoded by pil 
genes. The pilin polypeptide is composed of subunits of PilE, and assembled into the mature 
pilin in the periplasm by three further pilus proteins, PilD, PilF and PilG (Tonjum and Koomey, 
1997). The full-length fibre is thought to emerge through pores in the cell membrane 
composed of twelve units of PilQ, which form rings in the outer membrane that are proposed 
to allow passage of the pilus (Collins et al., 2005; Collins et al., 2001). The filament is then stabilised 
by the membrane protein PilW, which is also involved in maintaining pilus functionality, and 
by PilC, which works antagonistically with PilT, which acts to retract the pilus from the 
bacterial surface (Yasukawa et al., 2006; Carbonnelle et al., 2005; Rahman et al., 1997). 
 
Variation in Tfp occurs primarily within the regions of the PilE subunit that are exposed on 
the surface and occur at a rate of approximately 10-4 per cell division, effecting changes in 
post-transcriptional modification, immunoreactivity and adhesive capacity (Nassif et al., 1993; 
Virji et al., 1993). Recombination events occur within multiple small sequence regions within 
conserved elements in the pilE / pilS locus. The locus consists of one expressed gene (pilE) 
and eight homologous silent regions, including pilS. These non-expressed alleles recombine 
with the active pilE gene through gene conversion, leading to mutation within pilE (Haas et al., 
1992; Aho and Cannon, 1988; Haas and Meyer, 1986). Positive selection acting on these regions 
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results in the emergence of novel antigenic variants (Andrews and Gojobori, 2004). In addition, 
pilC2 is subject to phase variation as a result of frameshift mutations in a poly-G tract within 
the region encoding the signal peptide (Rytkonen et al., 2004; Jonsson et al., 1991).  
 
2.2.2 Opacity proteins 
The opacity proteins comprise two families of neisserial outer membrane proteins, Opa and 
Opc. Opa proteins are more abundant than Opc, which were so named due to their 
homology to Opa (Merz and So, 2000). The Opa proteins were originally identified due to the 
effect of their expression on colony opacity and colour, which is attributed to bacterial 
aggregation (Swanson, 1982; Swanson, 1978). Opas are important neisserial adhesins, mediating 
intimate adhesion to epithelial cells via heparin sulphate proteoglycan (HSPG) receptors, 
and interact with the CEACAM, or CD66, receptors expressed by phagocytic host cells (Virji 
et al., 1996a; Lambden et al., 1979; King and Swanson, 1978).  
 
Meningococcal strains possess up to five opa loci, with differences in sequence that occur 
within one semi-variable and two hyper-variable regions. Variation arises as a result of 
translocations, deletions and point mutations within these regions (Hobbs et al., 1998; Hobbs et 
al., 1994). Opas possess eight trans-membrane strands and four surface-exposed loops, three 
of which correspond to the variable regions in the corresponding gene (Malorny et al., 1998). 
The variable nature of opa gene expression may result in expression of more than one Opa 
per strain, allowing for a spectrum of proteins expressed at the cell surface.  
 
2.2.3 Porins 
Neisserial porins are the most abundant outer membrane proteins displayed on the bacterial 
cell surface. They fall into two discrete groups, PorA (45 kDa) and PorB (33 kDa) (Frasch et al., 
1985), and contribute greatly to the antigenic variability of the meningococcus. Porins 
possess a β-pleated barrel structure which is embedded in the lipid membrane (Derrick et al., 
1999), and mediate interactions both within the bacterial membrane and with host cells (Weel 
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et al., 1991). Porins act as ion channels across the plasma membrane and are modulated by 
adenosine triphosphate (ATP) and guanosine triphosphate (GTP) (Rudel et al., 1996). 
 
Work with gonococcal porins has revealed a role for PorB1A in invasion of host epithelial 
cells (Bauer et al., 1999). As yet the role of porins in entry of the meningococcus into epithelial 
cells has not been elucidated. However, meningococcal porins are known to induce actin 
reorganisation in host cells, indicating a role in invasion (Merz and So, 2000).  Gonococcal 
porins also play a role in interactions with phagocytic cells. PorB modulates phagosome 
maturation and the oxidative burst of neutrophils (Lorenzen et al., 2000; Mosleh et al., 1998), and is 
responsible for redistribution of late-endosomal marker LAMP1 to the plasma membrane 
(Ayala et al., 2002). 
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1.3 Pathogenesis 
 
1.3.1 Colonisation of the nasopharynx 
Colonisation of the human nasopharyngeal epithelium by N. meningitidis is dependent on 
adhesins expressed on the surface of the bacterium. Adhesion, which is limited to non-
ciliated secretory epithelial cells, follows two distinct steps (Stephens and McGee, 1981). The first, 
initial attachment, is characterised by dispersed microcolonies of 10 – 100 meningococci on 
the surface of epithelial cells. This is followed by extension of microvilli, or filopodia, from the 
surface of the epithelial cells (Stephens et al., 1983). The second stage, intimate attachment, 
develops eight to sixteen hours after infection. The bacteria disperse from the microcolonies 
and individual diplococci become intimately attached to the cell surface. This process has 
been investigated using an organ culture model to mimic conditions in the human host and 
enable dissection of the colonisation process (Stephens et al., 1983). Adhesion to epithelial cells 
has also been investigated in the closely related pathogen, N. gonorrhoeae. However, 
extrapolation from work with the gonococcus may be unreliable due to significant differences 
in the species’ gene content. Crucially, the gonococcus does not express a polysaccharide 
capsule, which is likely to be of particular importance when considering adhesion to host 
cells since it might affect accessibility of bacterial adhesins to host receptors (Fox et al., 1991). 
 
Initial attachment is mediated primarily by the Tfp, and is proposed to occur through 
interaction with the CD46 receptor, a complement regulatory protein expressed on nearly all 
human cells. This interaction has been demonstrated by Western blotting with purified pili, 
and can also be blocked with an anti-CD46 antibody (Kallstrom et al., 1997).  Doubt has been 
cast on CD46 as the cognate receptor for Tfp since meningococcal adhesion to CD46 
expressed in cell lines is very weak, and further work with N. gonorrhoeae indicates that a 
CD46-independent occurs (Kirchner et al., 2005; Tobiason and Seifert, 2001). However, pilus binding 
mediates the transient release of calcium within the host cell that occurs immediately after 
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initial contact. This response is dependent on CD46 expression and the pilus protein PilC1, 
and is thought to aid bacterial adhesion by triggering lysozyme exocytosis (Ayala et al., 2001). 
Furthermore, initial attachment of gonococci to host epithelial cells results in phosphorylation 
of tyrosine 354 on the intracellular domain of CD46 by Src-family kinases. Inhibition of these 
tyrosine kinases results in a significant reduction in adhesion of the gonococcus to the 
epithelium (Lee et al., 2002). Despite the lack of evidence for a direct interaction between Tfp 
and CD46, these data support the hypothesis that the CD46 receptor is involved in adhesion 
to host epithelial cells.  
 
Four hours post-infection, the bacteria proliferate and begin to form microcolonies on the 
epithelial surface. This is accompanied by the formation of actin-, ezrin- and moesin-rich 
microvilli-like extrusions from the host cell, which eventually engulf and internalise the 
bacteria (Edwards et al., 2000). These membrane rearrangements rely on PilT, which mediates 
pilus retraction (Forest et al., 2004). The mechanical force exerted upon the cell membrane by 
pilus retraction is equivalent to that required to induce microvilli elongation (Merz and So, 2000). 
Cortical plaques, rich in the integral membrane proteins CD44 and intracellular cell-adhesion 
molecule 1 (ICAM-1; CD54), also form beneath the adherent bacteria (Merz and So, 1997). 
Actin polymerisation and rearrangement is mediated by activation of GTPases Rho and 
Cdc42 (Eugene et al., 2002). Recruitment of ezrin, moesin and transmembrane proteins, 
however, is independent of GTPase activation. There is also evidence for a role for 
transmembrane receptor tyrosine kinase ErbB2 in internalisation of meningococci (Hoffmann et 
al., 2001). Infection induces clustering and phosphorylation of this receptor, which in turn 
activates the tyrosine kinase Src, which then phosphorylates cortactin, an actin-binding 
protein that is present in cortical plaques, and regulates actin assembly (Weed and Parsons, 
2001). Little else is known about this process but it is clear that the resulting cytoskeletal 
reorganisation is essential for internalisation of meningococci into epithelial cells. 
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Eight to sixteen hours post-infection, host cell membrane protrusions retract, and bacteria 
disperse across the epithelial surface. Dispersal is mediated by PilT and down-regulation of 
pilus expression (Yasukawa et al., 2006; Pujol et al., 1999). A simultaneous up-regulation in the 
pilus component PilC and reduction in capsule expression results in intimate attachment of 
bacteria to the epithelial layer (Deghmane et al., 2002). Capsule down-regulation is thought to aid 
this process by permitting Opacity proteins to interact with CD66 receptors and HSPGs, 
binding bacteria to the apical epithelial surface (de Vries et al., 1998). This process is under 
genetic control within the meningococcus, coordinated by the negative transcriptional 
regulator CrgA, named for its binding affinity for the CREN (Contact Regulatory Element of 
Neisseria) region identified in the pilC, pilE and capsule biosynthetic sia loci, and twelve 
other genes of unknown function (Deghmane et al., 2004; Morelle et al., 2003). crgA itself possesses 
a CREN region and so is up-regulated on contact with host cells to suppress capsule 
expression, but is transcriptionally controlled by a negative feedback loop (Deghmane et al., 
2002). 
 
1.3.2 Invasion and traversal of the nasopharyngeal epithelium  
The nasopharyngeal epithelium comprises 60–90% squamous epithelium, interspersed by 
120 µm thick ciliated pseudostratified columnar cells with secretory simple columnar goblet 
cells (Ali, 1965). The distribution of these cell types varies according to the location in the 
nasopharynx, with a higher density of goblet cells in the lateral wall, and a higher proportion 
of squamous epithelium in the posterior wall (Ali, 1965). Networks of capillaries underlie 
patches of these epithelial layers, and a high density of mast cells and secretory cells are 
present in the tunica propria, a framework of collagenous fibres and bundles of blood and 
lymphatic vessels (Ali, 1965). The nasopharyngeal epithelium has barrier functions, mediated 
by tight junctions between cells (Pujol et al., 1997). Traversal of the epithelial layer by the 
meningococcus is not well understood. Transmission electron microscopy and gentamicin 
protection assays demonstrate that meningococci are internalised by and reside within 
vacuoles inside epithelial cells, and are thus protected from host clearance mechanisms 
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(Plant et al., 2006; Capecchi et al., 2005; Pujol et al., 1997). Successful invasion of the epithelial cell 
layer relies on a number of bacterial factors including Tfp, Opa, Opc and LPS (Plant et al., 2006; 
Muenzner et al., 2000; Pujol et al., 1997; de Vries et al., 1996). Truncated LPS mutants lacking the 
sialic acid decoration or one heptose group in the inner core show reduced invasion of 
epithelial cell lines, whilst a strain lacking both heptose moieties is unable to invade (Plant et 
al., 2006). Expression of the polysialic acid capsule hinders invasion and is down-regulated 
during this stage of infection (de Vries et al., 1996). Work with the gonococcus has implicated 
PorB in the invasion process (Rechner et al., 2007). More recently, additional invasins have 
been identified in the meningococcus, including NadA, a surface antigen that, when 
expressed in E. coli, is sufficient to induce adhesion and invasion of epithelial cell lines. A 
meningococcal mutant lacking the nadA gene also shows significantly reduced invasion in a 
capsule-negative background (Capecchi et al., 2005). 
 
It is as yet unclear as to whether bacteria traverse the epithelial layer by a transcellular 
route. It has been hypothesised that the meningococcus migrates para-cellularly via the tight 
junctions but evidence to support this is conflicting. One study reported that the integrity of 
the epithelial barrier is lost during traversal of bacteria (Stephens and Farley, 1991). However, 
more recent work has also described bacterial traversal of the epithelial layer whilst electrical 
resistance across the monolayer remained intact, indicating that tight junction integrity was 
not affected by infection (Pujol et al., 1997; Merz et al., 1996). 
 
 
1.3.3 Invasion of the Blood-Brain Barrier (BBB) and Blood-CSF (B-CSF) Barrier 
Following dissemination of N. meningitidis in the bloodstream, the development of meningitis 
occurs as a result of invasion and colonisation of the CSF. The leptomeningeal layers 
consist of the pia mater, a delicate membrane composed of fibrous tissue that is closely 
associated with the surface of the brain and spinal cord, and the arachnoid mater, a looser 
membranous layer that surrounds the central nervous system. The outermost layer is the 
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dura mater, a thicker membranous layer that is attached to the skull itself. The mechanism 
by which N. meningitidis invades the subarachnoid space is unknown but is thought to be 
facilitated by high levels of bacteraemia (Bergman et al., 2006). There are two distinct barriers 
through which bacteria reach the CSF. They can cross the endothelium of capillaries in the 
BBB and enter the subarachnoid space between the leptomeninges. Alternatively, the 
bacteria may traverse the B-CSFB via the endothelium of the choroid plexus, the capillary 
network within the ventricles where CSF is produced by specialised cuboidal cells (Levine, 
1987). Both of these routes present a barrier of a monolayer of polarised endothelial cells 
which, unlike capillary endothelia throughout the rest of the body, possess tight junctions 
which confer high electrical resistance (Rubin et al., 1991). Thus the BBB is very similar in 
nature to the nasopharyngeal epithelium and much of the research performed with the 
meningococcus on polarised monolayers of epithelial cells is thought to be directly relevant 
to the invasion into CSF (Pujol et al., 1997).  More recently, work has been performed using the 
human brain microvascular endothelial cell line (HBMEC). Invasion of these cells relies on 
Opc engaging fibronectin, which anchors the bacterium to integrins on the surface of the 
endothelial cells (Unkmeir et al., 2002b). In addition to mediating the internalisation of bacteria, 
this contact also activates MAP- and tyrosine kinase signalling cascades that result in the 
release of inflammatory cytokines (Sokolova et al., 2004). Microscopy confirmed the presence of 
bacteria residing within Neisseria-containing vacuoles (NCV) inside HBMECs (Nikulin et al., 
2006). Expression of the polysialic acid capsule is necessary for survival and replication of the 
meningococcus within the NCV (Nikulin et al., 2006). 
 
 
 
 
 
 
 
40 
 
Chapter 1 Introduction  
 
1.4 N. meningitidis and the immune response 
 
1.4.1 Humoral immunity 
 
 1.4.1.1 Antibody-mediated immunity 
The humoral immune response against N. meningitidis relies on the production of antibodies 
by B cells. Opsonisation of bacteria by antigen-specific antibodies leads to phagocytosis 
and/or complement-mediated lysis. Antibody-mediated immunity against N. meningitidis 
develops over time and is age-dependent, detectable in approximately 20% of individuals 
aged 12 months, rising to 50–80% at 12 years of age, and reaching up to 85% in adulthood 
(Matsunami, 1918). Trans-placental transfer of immunoglobulins provides newborn infants with 
anti-meningococcal antibodies, and serum from 50% of newborns show bactericidal activity, 
which explains the low incidence of disease in this group (Goldschneider et al., 1969) (Health 
Protection Agency 2007). However, maternal immunity wanes rapidly, and susceptibility to 
infection is highest in children aged between 6 to 12 months (Goldschneider et al., 1969). The 
levels and specificity of bactericidal activity as a result of natural immunity vary between 
individuals, determining susceptibility to disease (Heist, 1922).  
 
Immunity to meningococcal infection acquired following repeated transient colonisation with 
different strains confers a degree of cross-protection (Reller et al., 1973). Some protective 
immunity may also be afforded following infection by other bacterial species which express 
antigens related to the meningococcal outer surface antigens (Hoff and Hoiby, 1978). 
Colonisation by the commensal N. lactamica occurs frequently in childhood, and has been 
linked to production of antibodies against pathogenic meningococcal strains (Gold et al., 1978; 
Goldschneider et al., 1969). It is now thought that the close relatedness of N. lactamica could be 
exploited to design cross-protective vaccines. Work has shown that live bacteria or outer-
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membrane preparations of the commensal species induce protective responses in mice (Li et 
al., 2006; Gorringe et al., 2005). 
 
 1.4.1.2 Complement-mediated killing 
Humoral immunity also relies on antibacterial components of the blood, most importantly the 
complement system, which is the primary killing mechanism of N. meningitidis. Complement-
mediated killing is particularly effective against Gram-negative bacteria, and is closely linked 
to the inflammatory response (Schneider et al., 2007). The complement system comprises a 
proteolytic cascade of a series of membrane-bound and fluid-phase components that 
culminates in the production of a C3 convertase, which cleaves complement component C3 
to produce C3b (Walport, 2001b; Walport, 2001a). Binding of C3b to the bacterial surface results in 
phagocytosis by cells of the innate immune response, or lysis by formation of the membrane 
attack complex (MAC) (Walport, 2001b; Walport, 2001a). The complement cascade is initiated by 
the classical (CP) and lectin (LP) pathways, and amplified by the alternative pathway (AP) 
(Schneider et al., 2007). The CP is initiated by binding of the C1 complex to bacterial surface 
components such as lipid A, or to pathogen-specific IgG or IgA bound to the bacterium, 
whilst the LP is initiated by binding of mannose-binding lectins or ficolins to microbial 
carbohydrates (Fujita et al., 2004). The importance of the complement system in the prevention 
of meningococcal disease is highlighted by the increased susceptibility of individuals who 
lack complement components such as C3, C4, and most strikingly, elements of the MAC 
(Rosa et al., 2004; Figueroa et al., 1993; Fine et al., 1983).  
 
 
1.4.2 Cell-mediated immunity 
During disease N. meningitidis encounters a range of phagocytic cells, or leukocytes, that 
represent the cellular arm of the innate immune response. Granular leukocytes include 
neutrophils, basophils and eosinophils, which are characterised by the presence of granules 
in the cytoplasm, whilst agranular leukocytes include monocytes, macrophages and 
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lymphocytes. Opsonisation results in targeting of the bacterium for phagocytosis. Cells 
expressing the Fcγ receptor recognise particles opsonised by IgG, whilst the complement 
receptor 3 (CR3) binds bacteria opsonised by the complement component C3b (Mantovani et 
al., 1972; Messner and Jelinek, 1970; Lay and Nussenzweig, 1968). Non-opsonic phagocytosis of 
bacteria also occurs following engagement of phagocytic receptors by bacterial surface 
antigens. Phagocytosis of bacteria follows receptor engagement, and is initiated by 
conformational changes in the cytoplasmic part of the target receptor, often as a result of 
tyrosine phosphorylation (Greenberg et al., 1996; Greenberg et al., 1993). This process triggers the 
phagocytic signalling cascade which culminates in actin polymerisation beneath the site of 
receptor engagement, and mediates subsequent internalisation of the bacterium.  
 
Phagocytosis triggers the release of proteolytic and additional degredative enzymes from 
cytoplasmic granules that facilitate the intracellular degradation of the bacterial cell. Certain 
phagocytic cells, including neutrophils and macrophages also employ an oxidative burst, 
characterised by the production and release of highly reactive oxygen species (ROS). The 
oxidative burst is mediated by a cellular NADPH oxidase (Babior et al., 1976; McPhail et al., 1976). 
The dormant oxidase comprises four components that reside in the cytosolic compartment 
and a membrane-bound b-type cytochrome component (Dewald et al., 1979). Cell activation, as 
a response to bacterial LPS for example, results in translocation of the cytosolic components 
to the membrane to form a functional electron-transfer system. NADPH is exploited to 
catalyse reduction of molecular oxygen, the products of which are then transported via the 
cytochrome domain of the enzyme to the phagosomal compartment (Babior, 1999). Within the 
phagosome these antimicrobial oxidising agents, including ROS such as hydrogen peroxide 
(H2O2), superoxide anion and hydroxyl radicals, and nitrogen species such as nitric oxide 
and peroxynitrite kill pathogens by damaging lipids, proteins and DNA (Dyet and Moir, 2006; 
Hampton et al., 1998). 
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Degradation of bacterial antigens by antigen-presenting cells (APC) such as dendritic cells 
(DC) and macrophages results in presentation of bacterial peptides by the multi-
histocompatibility complex (MHC) on the APC cell surface. This process triggers maturation 
of DCs, leading to a characteristic change in receptor expression profile (Roake, 1995; Inaba, 
1994; Schuler et al., 1985). Mature DCs and macrophages migrate to the lymph nodes and 
present the MHC bearing antigens, in combination with co-stimulatory molecules on the cell 
surface, to T- and B-cells. T-cells express the T-cell receptor (TCR) and are divided into 
subsets of helper, cytotoxic, regulatory and memory T-cells (Gatenby et al., 1984). They provide 
the host with an efficient repertoire of phagocytic cells specific to individual antigens, which 
are closely regulated by cytokines released by other phagocytic cells. B-cells are 
lymphocytes, which produce specific antibodies against different antigens. Immature B cells 
are activated by detection of the antigen that they are specific for, combined with the activity 
of helper T-cells, resulting in rapid production of specific antibodies (Kipps, 1997). This arm of 
the cell-mediated immune response represents an important link to humoral immunity. 
 
1.4.2.1 Interaction between N. meningitidis and polymorphonuclear leukocytes 
Polymorphonuclear leukocytes (PMN), or neutrophils, infiltrate nasopharyngeal tissue at the 
site of infection in response to chemoattractant cytokines, or chemokines, such as IL-8, 
released by infected epithelial and endothelial cells (Moller et al., 2005; Lee et al., 2003). PMNs are 
usually the first cell type to be recruited to the site of bacterial infection, and thus it is likely 
that N. meningitidis encounters PMNs during both colonisation and development of disease. 
Following opsonisation by C3b or IgG, meningococci are internalised by PMNs via CR3 and 
Fcγ receptors, respectively (Fijen et al., 2000). Non-opsonic phagocytosis of the meningococcus 
by PMNs also occurs but at a lower level, and would be a particularly important mechanism 
for individuals with complement defects (Estabrook et al., 1998). This non-opsonic interaction 
appears to be mediated primarily by direct interaction between Opa and CD66 (or CEACAM) 
receptors expressed by PMNs (Hauck et al., 1998; Virji et al., 1996a). Members of the CD66 
receptor family are expressed by epithelial and endothelial cells as well as phagocytic cells 
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such as PMNs. They function in cell-cell adhesion, cell cycle control and cellular 
differentiation. Their frequency of expression on cancer cells indicate a regulatory and 
sensory aspect to their adhesive role (Bos et al., 1999). In addition to this primary function, 
CD66a, CD66c, and CD66e also recognise neisserial Opa proteins (Virji et al., 1996b). A range 
of techniques have been employed to identify the residues involved in this interaction. Opas 
target a sequence within the centre of the N-terminal domain of the receptor that is likely to 
have functional importance to the host and thus is conserved (Chen et al., 1997; Virji et al., 1996b). 
The conserved amino acids Tyr34 and Ile91 are critical for Opa-binding although specificity is 
conferred by additional residues that are not shared by all CD66 family members (Bos et al., 
1999). Since Opas are subject to phase variation there are distinct requirements for CD66 
binding within the antigen which have not been characterised (Billker et al., 2000; Popp et al., 
1999). Regulation of capsule expression may be imperative for the meningococcus to control 
the Opa-CD66 interaction (Dehio et al., 2000). Opa-CD66 binding enables adherence to the 
epithelium and thus the capsule is down-regulated to maximise contact between antigen and 
receptor. However capsule expression is thought to be up-regulated to evade phagocytosis. 
As postulated above, this response may occur in order to mask Opas on the bacterial 
surface, either sterically or by charge, thus preventing CD66-mediated phagocytosis. 
 
Phagocytosis by PMNs initiates the oxidative burst signalling cascade within the cell. The 
fate of N. meningitidis within PMNs has not been fully established. Studies have shown 
some killing of internalised opsonised meningococci by the endo-lysosomal degradation 
pathway and the oxidative burst (Peters et al., 1999; Estabrook et al., 1992). However, Neisseria 
gonorrhoeae is able to survive and replicate within PMNs (Simons et al., 2005; Parsons et al., 1982) 
and it has been suggested that N. meningitidis is also capable of intracellular survival 
(Estabrook et al., 1998; Estabrook et al., 1992). N. meningitidis expresses a number of enzymes to 
combat the oxidative burst, such as catalase and superoxide dismutase, which neutralise 
hydrogen peroxide (Soler-Garcia and Jerse, 2004; Dunn et al., 2003). Glutathione peroxidise 
expression is required for resistance to killing by paraquat (Moore and Sparling, 1996). More 
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recently, it has been shown that the gonococcus is able to downregulate the oxidative burst 
elicited by PMNs. Infections of PMN with live and dead bacteria revealed that live gonococci 
inhibit the oxidative burst in a contact-dependent manner. Dead gonococci elicited an 
oxidative burst but PMNs challenged with both live and dead bacteria produced significantly 
less ROS, indicating that the live gonococci were actively inhibiting the oxidative burst (Criss 
et al., 2008). In addition, it has been shown that expression of porins reduces phagocytosis 
and modifies the oxidative burst of PMNs (Lorenzen et al., 2000).  
 
 1.4.2.2 Interaction between N. meningitidis and macrophages 
The interaction of pathogenic Neisseria with macrophages has been studied with the 
gonococcus using Transmission Electron Microscopy (TEM) and quantitative measurement 
of association to show that the bacterium is internalised by macrophages, although 
expression of the Tfp reduces phagocytosis (Jones and Buchanan, 1978; Blake and Swanson, 1975; 
Ota et al., 1975). In the presence of opsonins, macrophages preferentially phagocytose 
opsonised gonococci via the Fcγ receptor (Jones et al., 1980). Following phagocytosis, 
gonococci are efficiently killed (Cooper and Floyd, 1982) although more recent work has shown 
that expression of porins by the gonococcus results in a delay in the maturation of the 
phagolysosome (Mosleh et al., 1998). Work with the meningococcus has also demonstrated that 
phagocytosis of N. meningitidis occurs, and revealed a crucial role for the polysialic acid 
capsule in modifying a number of steps in the interaction with macrophages. Capsulate 
bacteria associate significantly less than unencapsulated strains, and once internalised, 
expression of the capsule delays the initial recruitment of late endosomal and lysosomal 
markers to the phagolysosome (Read et al., 1996). Opsonisation of bacteria with mannose-
binding lectin (MBL) enhances both association and killing (Jack et al., 2005). Interestingly, 
capsulate bacteria are killed more effectively than unencapsulated strains, indicating that a 
non-lysosomal killing mechanism may be responsible (Read et al., 1996). More recent work has 
revealed that the meningococcal superoxide dismutase reduces phagocytosis by 
macrophages and nitric oxide detoxification systems enhance intracellular survival (Stevanin et 
46 
 
Chapter 1 Introduction  
 
al., 2005; Dunn et al., 2003). Furthermore, the meningococcus has been shown to delay 
apoptosis of macrophages following phagocytosis. This process is dependent on a functional 
nitric oxide detoxification system, and on the PorB porin (Tunbridge et al., 2006). 
 
The inflammatory response that characterises meningococcal disease is mediated largely by 
cytokine production by phagocytic cells. There is evidence that the bacterium manipulates 
this process during interaction with macrophages to effect changes in the release of pro-
inflammatory mediators. LPS is a well-characterised molecule that induces pro-inflammatory 
cytokine secretion by macrophages. This process relies on the Kdo2 moiety linked to the 
lipid A core (Zughaier et al., 2004). N. meningitidis also expresses other non-LPS components 
that induce this response since LPS-deficient mutants are still able to induce IL-8 production 
(Pridmore et al., 2001). Non-LPS surface components are also responsible for the induction of 
TNFα, IL-1β and IFN-γ production (Sprong et al., 2001). Expression of Neisserial adhesin NadA 
results in increased release of TNF-α and IL-8 by macrophages, indicating a stimulatory 
function that would in turn augment the resulting inflammation and recruitment of further 
inflammatory cells to the site of infection (Franzoso et al., 2008). Opa expression also affects the 
outcome of the interaction, with different Opa variants eliciting varying levels of pro-
inflammatory cytokine release (Makepeace et al., 2001). Furthermore, meningococcal 
metabolism of nitric oxide produced by macrophages during the oxidative burst modifies the 
release of nitric oxide-regulated cytokines and chemokines resulting in decreased production 
of TNF-α, IL-12 and CXCL8, and an increase in secretion of IL-10 and CCL5 (Stevanin et al., 
2007).  
 
 1.4.2.3 Interaction between N. meningitidis and dendritic cells 
In the presence of N. meningitidis, DCs undergo maturation and release cytokines including 
TNF-α, IL-1α, IL-6 and IL-12. This is mediated partly via engagement of encapsulated 
meningococci by the class A scavenger receptor, although unencapsulated bacteria also 
elicit cytokine release (Villwock et al., 2008). The pro-inflammatory DC response also relies 
47 
 
Chapter 1 Introduction  
 
partly on non-LPS outer membrane components including PorA, although LPS is required to 
induce high-level release of cytokines, particularly IL-12 (Al-Bader et al., 2004; Uronen-Hansson et 
al., 2004; Dixon et al., 2001). Expression of the polysialic acid capsule, sialylation of the LPS and 
elongation of the LPS α-chain inhibit association and phagocytosis of the meningococcus by 
DCs (Kurzai et al., 2005; Unkmeir et al., 2002a; Kolb-Maurer et al., 2001). Unencapsulated strains are 
also significantly more susceptible to intracellular killing (Kolb-Maurer et al., 2001). However, 
neither expression of capsule nor LPS sialylation by intracellular bacteria affect DC cytokine 
release (Unkmeir et al., 2002a; Kolb-Maurer et al., 2001). Work has also compared the effect of live 
and dead meningococci on DC maturation and cytokine release. Phagocytosis of live 
meningococci elicits cytokine release but results in significantly reduced maturation of DCs. 
This manipulation of DC receptor expression profile may affect DC interaction with T-cells, 
and thus influence the resulting inflammatory response (Jones et al., 2007). 
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1.5      Neisserial carbon metabolism 
 
1.5.1 Nutritional requirements 
Iron metabolism and its role in pathogenesis has been extensively studied in the 
meningococcus.  Bacteria grown in the absence of iron show reduced rates of growth and 
replication (Perkins-Balding et al., 2004). The role of iron in meningococcal virulence was 
demonstrated during in vivo experiments performed by injecting host mice with supplemental 
iron compounds followed by inoculation with N. meningitidis. Mice receiving supplemental 
iron developed a lethal infection while control animals suffered only transient bacteraemia 
(Holbein et al., 1979). The meningococcus acquires iron from a range of sources within the host 
by removing the metal ion from host carrier proteins such as haemoglobin, transferrin and 
lactoferrin (Price et al., 2004; Lewis and Dyer, 1995; Mickelsen et al., 1982). Acquisition of iron from 
these sources is mediated by a number of OMPs, the expression of which is regulated by 
iron availability (Pettersson et al., 1993). Despite being unable to produce siderophores, the 
meningococcus is, however, able to utilise siderophores produced by other bacteria (Rutz et 
al., 1991). One major iron transporter is FrpB, an OMP that works with energy-coupling protein 
TonB to import enterobactin, a siderophore produced by E. coli (Carson et al., 1999; Pettersson et 
al., 1995). Transferrin-binding proteins (TBPs) TbpA and TbpB are expressed at the bacterial 
surface and work antagonistically to bind human transferrin (Renauld-Mongenie et al., 1997; Irwin et 
al., 1993). The role of both proteins in virulence has been assessed in the murine model of 
bacteraemia. Mutant strains lacking either both TBPs or TbpA were significantly attenuated, 
whereas a strain deficient in TbpB was not (Renauld-Mongenie et al., 2004). The meningococcus 
also expresses lactoferrin binding proteins (LBPs) LbpA and LbpB and haemoglobin-specific 
receptors such as HmbR (Quinn et al., 1994; Lee and Hill, 1992; Schryvers and Morris, 1988). 
 
With the exception of iron, little is known about the role of metabolism in meningococcal 
pathogenesis. N. meningitidis is a fastidious micro-organism that is able to utilise only a 
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limited range of carbon sources, including glucose, lactate and pyruvate (Cartwright et al., 1987). 
These compounds are available throughout the upper airway, bloodstream and CSF (Smith 
and Forman, 1994; Horwitt et al., 1949).  
 
1.5.2 Lactate 
Lactate is taken up by N. meningitidis via an inner membrane permease encoded by lctP 
(Exley et al., 2005a). When grown in liquid media, both the meningococcus and gonococcus 
emerge from lag phase earlier and grow faster when lactate is added to media containing 
glucose (Exley et al., 2005b; Smith et al., 2001). Addition of lactate to gonococcal cultures results in 
a two-fold increase in oxygen consumption and general stimulation of metabolism 
culminating in up to 20% greater LPS production and enhanced protein synthesis (10 to 
20%) and pentose content (30 to 60%), indicating stimulation of ribosome production (Smith et 
al., 2007; Gao et al., 1998; Parsons et al., 1996; Britigan et al., 1988). The underlying mechanism of this 
metabolic stimulation was revealed by NMR studies that showed that in the presence of 
glucose, lactate was diverted away from gluconeogenesis and used purely as an energy 
source (Leighton et al., 2001). In vivo, analysis of gonococcal metabolism following sub-
cutaneous infection of guinea-pigs showed a preferential use of the lactate generated by the 
leukocyte inflammatory response over glucose (Goldner et al., 1979).  
 
Similarly, in the CSF, lactate is utilised preferentially by the meningococcus. As lactate levels 
in the CSF rise during bacterial meningitis whilst glucose levels drop, this preference for 
lactate may enable the bacteria to grow more rapidly during disease and therefore enhance 
its virulence. A mutant lacking the lactate permease showed a significant growth defect 
during growth in CSF (Exley et al., 2005a). Following import, lactate is converted to pyruvate by 
one of three lactate dehydrogenases (Fischer et al., 1994; Erwin and Gotschlich, 1993). The reason 
for this potential redundancy has not been elucidated, although work suggests that each 
enzyme is independently regulated (Erwin and Gotschlich, 1996). Pyruvate is converted to PEP 
via PEP synthase, and combined with N-acetyl mannosamine to produce NANA or sialic 
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acid (Gunawan et al., 2005). The activated form of this compound, CMP-NANA, is used by the 
bacterium to produce the polysialic acid capsule via enzymes encoded by the capsule 
biosynthetic and assembly locus, cps. CMP-NANA can also be incorporated into LPS via the 
LPS-specific sialyltransferase encoded by lst (Gilbert et al., 1996) (Figure 1.1). As a result of its 
direct link with sialic acid production, mutants lacking lctP shows a marked reduction in 
sialylation of the LPS. Furthermore, this strain is significantly attenuated during bloodstream 
infection of infant rats, but not in complement-deficient animals. Thus, unlike in the CSF, 
lactate is required during bloodstream infection not for growth but for production of sialic acid 
to avoid complement-mediated lysis (Exley et al., 2005a). 
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Figure 1.2 Neisserial carbon metabolism and sialic acid production 
(A) Schematic of central carbon metabolism in N. meningitidis. Sialic acid is manufactured 
from lactate via PEP. (B) Sialic acid polymer. The α(2,8)-linked polymer is bound to the 
outer membrane via a diglyceride moiety to form the α(2,8)-linked polysialic capsule.  
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1.5.3 Glutamate 
Glutamate metabolism provides a crucial link between carbohydrate and nitrogen 
metabolism (Smith, 1975). NADP-specific glutamate dehydrogenases (GDHs) are primarily 
involved in assimilation of ammonia and production of glutamate, catalysing the reaction that 
converts 2-oxoglutarate and ammonia to L-glutamate. Meanwhile, NAD-specific GDHs 
catalyse glutamate catabolism (Merrick, 1988). Many bacteria also employ an alternative 
glutamine synthesis pathway that relies on glutamine synthase (GS) and glutamate synthase 
(GOGAT). This GS/GOGAT pathway operates during nitrogen-limiting conditions, whilst the 
NADP-GDH is only active in high nitrogen concentrations (Reitzer, 1996). 
 
 N. meningitidis possesses two NADP- and NAD-GDH but no glutamate synthase, and thus 
does not possess a functional GS/GOGAT pathway, indicating that the NADP-GDH plays a 
major role in ammonia assimilation (Parkhill et al., 2000; Tettelin et al., 2000; Holten and Jyssum, 1973). 
Regulation of GDH expression is poorly understood, although work has shown that addition 
of glucose to media results in a decrease in NAD-GDH and an increase in NADP-GDH, 
indicating an increase in glutamate production (Holten and Jyssum, 1973). Screening of a library 
of signature-tagged meningococcal mutants revealed that a strain lacking a gene encoding a 
NADP-specific L-glutamate dehydrogenase ghdA was unable to cause systemic infection in 
the infant rat model (Sun et al., 2000). Expression of GdhA varies across different 
meningococcal strains, and is highest in hypervirulent lineages ET-5 (serogroup B) and IV-1 
(serogroup A) (Pagliarulo et al., 2004). Further work identified a positive transcriptional regulator, 
encoded by gdhR, which controls expression of GdhA. GdhR activity was increased by the 
addition of glucose, rather than lactate, to glutamate-containing medium. Mutants lacking 
GdhR were unable to regulate carbon metabolism and exhibited a severe growth defect 
when grown in the presence of glucose (Pagliarulo et al., 2004). More recently, GdhR has been 
found to regulate additional genes encoding enzymes involved in glucose catabolism and L-
glutamate uptake. A previously unknown ABC-type transporter, GltT, was identified as an L-
glutamate importer, operating in low sodium conditions such as in the intracellular 
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environment. Accordingly, a mutant lacking GltT was unable to survive within in HeLa cells 
(Monaco et al., 2006). This importer has since been renamed PerM, and a second transporter, 
GltS, which is active in high sodium conditions has also been identified (Unpublished). The role 
of glutamate metabolism in bacterial pathogenesis has not been widely studied. Investigation 
of the importance of glutamate to pathogenic strains of E. coli has demonstrated that 
glutamate metabolism is required for acid-resistance whereby the glutamate decarboxylase 
GadA/GadB acts as a proton acceptor and the antiporter GadC exchanges the intracellular 
product of the decarboxylation to produce glutamic acid, which is secreted by the cell (Sayed 
et al., 2007; Grant et al., 2001). A similar system also operates in gastrointestinal bacterial 
pathogen, Shigella flexneri (Bhagwat and Bhagwat, 2004). Investigation of glutamate metabolism 
in Brucella abortus has also demonstrated that highly virulent strains metabolise glutamate 
at a significantly lower rate than strains with low virulence capabilities, although the reason 
for this finding is unknown (Disinger and Wilson, 1962). 
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1.6 DNA Repair 
 
1.6.1  DNA damage 
Repair of damaged DNA is an essential activity performed by all living cells. Loss or 
alterations in bases in both the coding and non-coding regions of the genome results in 
mutations. Mutation in DNA is the driving force of evolution, leading to new phenotypic 
variants which propagate or perish according to the selective pressures of an organism’s 
environment. In bacterial pathogens, mutation is a mechanism by which microbes adapt to 
their host, enabling the emergence of new traits such as antibiotic resistance (Woodford and 
Ellington, 2007; Denamur and Matic, 2006). However, mutations are more frequently detrimental to 
the bacterium, and if unchecked, the rapid accumulation of mutations in the genome would 
be lethal. Damage may be caused as a result of endogenous metabolic reactions, error-
prone replication or exogenous mutagens such as ultraviolet (UV) light or oxidative stress. 
DNA is also subject to spontaneous degradation, causing deamination and hydrolytic loss of 
bases (Davidsen and Tonjum, 2006). Bacterial DNA is also susceptible to mutation during 
replication as a result of horizontal transfer and recombination events (Sargentini and Smith, 
1985).  
 
Oxidative damage to DNA occurs as a result of free radicals and ROS produced within 
bacteria during metabolism and following spontaneous degradation of biomolecules. Free 
radicals cause damage to DNA bases and sugars both directly and indirectly by generating 
reactive aldehydes via lipid peroxidation. The most active free radical species is the hydroxyl 
radical. Hydroxyl radicals react with purines to produce 7,8-dihydro-8-oxo-2’-
deoxyguanosine (8-oxoG) (Devasagayam et al., 1991), open-ringed structures such as 2,6-
diamino-4-hydroxy-5-formamidopyrimidine (Fapy), and cyclopurine deoxynucleosides (Dirksen 
et al., 1988). Hydroxyls also target double carbon-carbon bonds in pyrimidines to produce 
glycol and pyrimidine hydrates (Cadet et al., 1999). Furthermore, hydroxyl radicals can lead to 
double-strand DNA breaks following abstraction of hydrogen atoms from the DNA structure 
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(Henner et al., 1983). Damaged bases such as 8-oxoG result in transitions in DNA such as 
replacement of guanine with thymine, while other mutations such as glycol and hydrates 
block replication and are therefore highly cytotoxic (Laval et al., 1998) (Figure 1.3). 
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In addition to endogenous sources of ROS, N. meningitidis is exposed to high 
concentrations of external oxygen during colonisation of the human nasopharynx, and 
encounters harmful oxidative agents released by the host immune response during disease 
(Davidsen and Tonjum, 2006). Phagocytosis of the bacterium by cells such as neutrophils and 
macrophages triggers the oxidative burst, which culminates in the production of ROS 
including H2O2 and hypochlorous acid (HOCl) (Thomas et al., 1988). H2O2 reacts with transition 
metals present in the bacterial cell to produce hydroxyl radicals (Almeida et al., 1999; Imlay and 
Linn, 1988), while HOCl readily breaks down into chloramines, which attacks amino-groups 
(Dukan and Touati, 1996). In order to maintain genome integrity and survive mutagenic events, 
the meningococcus possesses a series of DNA repair pathways.  
 
1.6.2 DNA repair mechanisms 
Due to the fundamental nature of DNA repair, genes encoding DNA repair enzymes are 
largely conserved in all living organisms. DNA repair pathways have been well characterised 
in E. coli. Damage to one strand of DNA is repaired using the intact complementary strand 
as the template. This process is carried out by three repair pathways that excise and replace 
the damaged or erroneous nucleotides.  
 
The Base Excision Repair (BER) pathway is initiated by DNA glycosylases which have 
specificity for particular DNA substrates. For example, uracil DNA glycosylase (UDG) targets 
erroneous uracil residues that have been incorporated into DNA. One of the most common 
lesions occurs as a result of oxidation of guanine to 8-oxoG. In E. coli 8-oxoG lesions are 
targeted by the DNA glycosylase MutY, which acts with MutT and MutM to constitute the 8-
oxoG repair system (Michaels et al., 1992). Glycosylase activity produces an abasic site, which 
can also arise spontaneously by depurination or depyrimidination. Abasic sites are acted 
upon by apurinic/apyrimidinic endonucleases (AP endonucleases) (Lindahl, 1993). These 
highly conserved enzymes bind the abasic site, cleaving the DNA 5’ to the lesion, and 
remain bound to the resulting 3’ hydroxyl group until being displaced by DNA polymerase, 
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which replaces the lesion with the correct base (Dianov et al., 2003; Demple and Harrison, 1994) 
(Figure 1.1). Many organisms possess two fully functional AP endonucleases. For example, 
E. coli expresses ExoIII and EndoIV, Saccharomyces cerevisiae expresses Apn1p and 
Uve1p, whilst the human forms are HAP1 and HAP2 (Boiteux and Guillet, 2004; Hadi and Wilson, 
2000; Ljungquist et al., 1976). This duplication is thought to reflect the fundamental importance of 
BER to the survival of all organisms. 
 
Mismatch Repair (MMR) recognises base-pair mismatches and insertion/deletion loops 
introduced into the genome by errors during DNA replication (Schofield and Hsieh, 2003). In E. 
coli these lesions are thought to be recognised by the MMR enzyme MutS which coordinates 
with MutL in an ATP-dependent manner to activate the endonuclease MutH (Junop et al., 2003). 
The endonuclease binds the lesion and directs the strand specificity of the MutS-MutL-MutH 
repairosome (Marti et al., 2002). MutL also facilitates binding of helicase II to the lesion to 
ensure the correct region is unwound (Mechanic et al., 2000). Since the damaged region of DNA 
can be as long as 1 kb and helicase II dissociates after 40–50 bases, MutL continues to 
recruit helicase II to prevent the strands from re-annealing (Mechanic et al., 2000). Following 
degradation by polarity-specific exonucleases, the resulting gap is repaired by DNA 
polymerase and ligated by DNA ligase (Marti et al., 2002). Other replicatory errors are repaired 
by translesion synthesis, which employs low fidelity translesion polymerases instead of the 
normal DNA polymerases. These enzymes, of which E. coli possesses three, pass over 
small lesions such as AP sites, allowing replication to continue, but at the risk of introducing 
frameshift mutations (Napolitano et al., 2000). 
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The Nucleotide Excision Repair (NER) pathway acts on damaged regions of two to 30 bases 
arising following exposure to exogenous agents such as UV light. The resulting bulky lesions 
interfere with normal base-pairing and impair transcription. The most common of these 
lesions are cyclobutane pyrimidine dimers (CPDs) and 6-4 photoproducts (6-4PPs) caused 
by shortwave UV irradiation, as well as numerous chemical adducts. The lesions are highly 
diverse in structure and are thought to be recognised by the distorting effect they have on 
DNA structure (de Laat et al., 1999). In E. coli, NER is performed by the UvrABC complex 
(Seeberg, 1978). UvrB interacts with both UvrA and UvrC in an ATP-dependent manner in the 
presence of damaged DNA. The damaged site is recognised and targeted by UvrA, which 
then dissociates to allow UvrC binding and endonuclease activity (Malta et al., 2007). Incisions 
are made either side of the lesion, and polymerases and ligases are recruited to repair the 
defect. 
 
Double-stranded breaks (DSBs) in DNA arise during replication when the replication fork 
encounters a blocking lesion, such as those induced by ROS, during genome 
rearrangements, physical stress exerted during cell division or as a result of endogenous 
agents such as UV light, ROS and X-rays (Shrivastav et al., 2008; Davidsen and Tonjum, 2006). 
Failure to repair DSBs results in deletion, translocation and accumulation of cytotoxic 
genome rearrangements that may stall replication altogether. DSBs are repaired by two 
recombinational repair pathways. Non-homologous recombinational repair relies on the 
specialised DNA ligase IV to ligate the free DNA ends. Recombinational repair is achieved 
by either the RecF or RecBCD pathways which remove the target lesion, leaving a gap 
which is repaired by strand exchange using a single-stranded template (Davidsen and Tonjum, 
2006).  
 
Genes encoding DNA repair enzymes in most bacterial species possess binding sites for 
components of the SOS response. This damage-inducible system is characterised by an up-
regulation of expression of a range of components of DNA repair pathways (Michel, 2005). The 
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SOS response is regulated by two proteins, the repressor LexA, and the inducer, RecA. In 
the absence of stress, LexA binds specific SOS box sequences within the promoters of 
SOS-inducible genes, preventing their expression. RecA binds single-stranded DNA that is 
produced following DNA damage. This complex induces self-cleavage of LexA, allowing 
expression of the repressed genes (Michel, 2005). The SOS response has been well studied in 
a number of pathogenic and non-pathogenic bacterial species including E. coli, 
Staphylococcus aureus, Vibrio cholerae and Bacillus subtilis (Goerke et al., 2006; Michel, 2005; 
Wojciechowski et al., 1991; Yasbin, 1977). Interestingly, N. meningitidis does not possess an SOS 
response, and is thus thought to be unable to up-regulate expression of components of the 
repair pathway, even when under stress (Davidsen and Tonjum, 2006). 
 
There has been little work devoted to investigating the role of BER in pathogenesis despite 
its potential importance in maintaining DNA integrity in the face of the innate immune 
response. Salmonella enteric Serovar Typhimurium requires its full complement of DNA 
glycosylases in order to survive effectively within host macrophages, and a putative AP 
endonuclease in Brucella abortus is necessary to resist oxidative stress (Hornback and Roop, 
2006; Suvarnapunya and Stein, 2005). However, these studies relied upon the characterisation of 
strains lacking genes identified by sequence comparison alone and did not include any 
investigation of the biochemical activity of the gene products.  
 
1.6.3 Repair pathways in Neisseria 
Examination of the N. meningitidis genome reveals that it contains homologues of genes 
encoding characterised enzymes involved in BER, NER, MMR and recombinational repair. 
However, many of the enzymes and responses characterised in E. coli are absent in the 
meningococcus. The absence of the SOS response in Neisseria was confirmed by 
transcriptional analysis of the gonococcal genome following exposure to mutagenic agents 
including UV light and methyl methanesulphonate (Black et al., 1998). The absence of a LexA 
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homologue and of LexA binding sites within Neisserial DNA repair enzyme-encoding genes 
such as recA, uvrA and uvrB supports this finding, indicating that RecA functions purely 
within recombinational repair and not as part of a damage-inducible response (Parkhill et al., 
2000; Black et al., 1997; Black et al., 1995).  
 
A number of Neisserial DNA repair pathways have been described, primarily in the 
gonococcus. It is expected that recombinational repair plays an important role in maintaining 
genome stability due to the absence of the SOS response and other regulatory systems. 
Accordingly, recombinational repair is the best characterised DNA repair system in Neisseria 
(Kline et al., 2003). In addition to repair of replication errors, recombination is involved in DNA 
transformation and is involved in phase variation of surface structures including Tfp and Opa 
(Aho et al., 1991; Hagblom et al., 1985). RecA was identified in the gonococcal genome by 
complementation of an E. coli mutant (Koomey and Falkow, 1987). Further work indicated that 
species-specific interactions are required for DNA repair, but not for homologous 
recombination. Introduction of the E. coli gene into a gonococcal recA mutant complemented 
the strain for pilin variation and partially for DNA transformation but not for repair of DNA 
damage (Stohl et al., 2002). Further rec genes have been identified in the gonococcal genome, 
including intact, functional enzymes encoded by recB, recC and recD (Mehr and Seifert, 1998). 
Strains of the meningococcus possess an inactive recB allele, and thus is impaired in repair 
of DNA damage caused by UV light (Salvatore et al., 2002). RecN, which is known to play a 
structural role in positioning DNA during transformation, also appears to be active within 
DNA repair (Skaar et al., 2002), and homologues of other recombinational repair enzymes 
including RecG, RecR, RuvA, RuvB and RuvC, are also functional (Kline et al., 2003). All 
Neisserial genomes lack a RecF homologue, but possess the other components of the RecF 
repair pathway, indicating a RecF-like pathway in Neisseria. This pathway is constitutively 
active, and thus is thought to partially compensate for the lack of an SOS response (Kline et 
al., 2003; Mehr and Seifert, 1998).  
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MMR, NER and BER in the meningococcus have been less well characterised. Examination 
of the meningococcal genome has revealed homologues of genes encoding the MMR 
enzymes MutS and MutL, but not MutH, which is likely replaced by an alternative 
unidentified component or mechanism. It is also thought that defects in MMR are likely to 
influence the virulence of the bacterium (Richardson and Stojiljkovic, 2001). NER has been studied 
in the gonococcus, in which a system that acts on pyrimidine dimer lesions has been 
identified (Campbell and Yasbin, 1984). The gonococcus also expresses UvrA, which 
complements the respective mutant strain of E. coli, and strains lacking a UvrB homologue 
have increased sensitivity to UV light (Black et al., 1997; Black et al., 1995). Interrogation of the 
meningococcal genome has identified homologues of all components of the BER pathway, 
although the glycosylases nei and alkA and endonuclease nfo are absent. The only 
component of BER studied in the meningococcus is the DNA glycosylase MutY, which has 
been characterised at a biochemical level, though there has been no work on its importance 
in virulence and disease. A strain lacking mutY showed an increased spontaneous mutation 
rate (Davidsen et al., 2005). In E. coli, MutY acts with Fpg and MutT to repair 8-oxoG. E. coli 
strains lacking these enzymes display mutator phenotypes, with the strain lacking Fpg 
showing the highest rate of mutation (Fowler et al., 2003). In contrast, a meningococcal strain 
lacking mutY displays a far greater mutation rate than a strain lacking fpg, and a double 
mutant shows considerably higher rates of mutation than either of the single mutants, 
indicating that MutY and Fpg act in synergy, and that MutY plays an important role in 
meningococcal DNA repair (Davidsen et al., 2005).  
 
 
1.6.4 Meningococcal genome plasticity 
In addition to the absence of an SOS response, the meningococcus also possesses fewer 
regulatory response elements such as σ factors and two-component regulatory systems 
compared with E. coli (Parkhill et al., 2000). It has been suggested that this less complex gene 
regulation is compensated for by a greater genome plasticity, and that this is an adaptation 
63 
 
Chapter 1 Introduction  
 
to the more limited environments encountered by N. meningitidis in the human host in 
comparison with the broad range of environments experienced by the non-host specific E. 
coli. The higher mutation rates resulting from increased genome plasticity may allow for the 
emergence of more varied phenotypic traits allowing the meningococcus to adapt and 
survive within the human host (Davidsen and Tonjum, 2006).  
 
Meningococcal genome instability is further enhanced by additional repeat and uptake 
sequences, antigenic and phase variation mechanisms and mutator alleles. Examination of 
the meningococcal genome has revealed hundreds of repeat sequences, ranging from a few 
bases to up to 1 kb or more in length (Tettelin et al., 2000). These elements allow for frequent 
duplication, deletion and recombination events. The most common of these is the 10 bp 
Neisserial DNA uptake sequence (DUS), 5’-GCCGTCTGAA-3’, that is required for natural 
transformation of both the meningococcus and gonococcus (Smith et al., 1999; Goodman and 
Scocca, 1988). DNA fragments containing a DUS are preferentially incorporated into the 
gonococcal genome (Elkins et al., 1991). The role of DUSs is not fully established although they 
are postulated to act as transcriptional regulators, and are seen most frequently in genes 
encoding components involved in DNA repair, recombination, replication and modification 
(Davidsen et al., 2004; Goodman and Scocca, 1988). Genome plasticity also plays a crucial role in 
phase variation, which allows the bacterium to present a variety of antigenic phenotypes. 
Hypermutation in localised areas of the genome, known as contingency loci, is orchestrated 
by a number of sequence elements. Short repeat sequences such as homopolymeric tracts 
and microsatellites, or tandem repeats may affect regulation or expression of nearby 
promoter regions (Feil et al., 2001). Slipped-strand mispairing results in addition or deletion 
events, and Rec-A dependent recombination is known to control variation of virulence-
associated surface components such as Opa, Tfp, LPS and capsule via the introduction of a 
stop codon (Rytkonen et al., 2004; Berrington et al., 2002; Jennings et al., 1999; Hammerschmidt et al., 1996; 
Rudel et al., 1995; Sarkari et al., 1994; Murphy et al., 1989; Kawula et al., 1988). More recently, 
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meningococcal mutator strains have also been shown to possess a defective MMR pathway 
(Richardson et al., 2002; Richardson and Stojiljkovic, 2001). 
 
1.7 Project Aims 
The aim of this project is to characterise the non-opsonic interaction between N. meningitidis 
and human PMNs. This aspect of meningococcal disease is not well understood despite its 
potential importance to the development and progression of the disease. The project will 
also investigate the role of bacterial metabolism of lactate and glutamate to the interaction 
with PMNs. Finally, the project will investigate two DNA repair enzymes that are thought to 
act within the BER pathway, and will characterise their role in the pathogenesis of N. 
meningitidis. 
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2.1 Bacterial strains and plasmids  
 
2.1.1 Bacterial strains - N. meningitidis MC58 (ET-5, ST-32) is a serogroup B 
clinical isolate expressing immunotype L3,7,9 LPS and adhesins Opa and Opc (Exley et 
al. 2005). The isogenic mutants used in this study and their characteristics are shown in 
Table 1. For GFP expression, strains were transformed with plasmid pEGFP (kind gift 
from Myron Christodoulides (Christodoulides et al, 2000)). Bacteria were cultured on Brain-
Heart Infusion (BHI) agar with Levanthal’s supplement at 37°C in 5% CO2. Antibiotics 
were added as required at the following concentrations: tetracycline 2.5 µg/ml; 
kanamycin 50 µg/ml; erythromycin 2 µg/ml. The concentration of bacteria was 
calculated by measuring the ODA260 of a 1:50 dilution of bacterial suspension in 200 
mM NaOH/1% SDS (wt/vol). 
 
E. coli XL1-blue cells (Invitrogen, for recombinant work) and ER2566 (New England 
Biolabs, for protein expression) were propagated in Luria Bertani  (LB) media. 
Antibiotics were used at the following final concentrations: ampicillin, 100 µg/ml; 
kanamycin, 75 µg/ml; tetracycline, 2 µg/ml.  
 
2.1.2 Bacterial growth conditions - For growth in liquid media bacteria were 
grown overnight on solid media, harvested to phosphate-buffered saline (PBS) and 
used to inoculate liquid BHI media at an OD600 of 0.15. For growth in defined media, 
bacteria were inoculated to Hanks Balanced Saline Solution (HBSS; 1 mg/ml D-
glucose). Lactate (1 mM) and pyruvate (100 µM) were added as necessary. 
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Table 1 Strains used in this study 
 
 
Strain 
 
 
Description 
 
Reference 
 
MC58 
 
Clinical isolate (wild-type strain, serogroup 
B) 
 
Exley et al. (2005) 
 
H44/76 
 
 
Clinical isolate (wild-type strain, serogroup 
B) 
 
Monaco et al (2006) 
 
8013 
 
 
Clinical isolate (wild-type strain, serogroup 
C); Opa negative 
 
Pujol et al 
 (1997) 
 
MC58∆lctP 
 
Deficient in lactate permease; KanR
 
Exley et al. (2005) 
 
MC58∆siaD 
 
Deficient in polysialyl-transferase; EryR
 
Exley et al. (2005) 
 
MC58∆siaC 
 
Deficient in NANA synthetase; TetR
 
Exley et al. (2005) 
 
MC58∆lst 
 
Deficient in sialyltransferase; TetR
 
Exley et al. (2005) 
 
MC58∆lctP∆siaD 
 
Deficient in lactate permease and polysialyl-
transferase 
 
Exley et al. (2005) 
 
MC58∆lctP∆siaC 
 
Deficient in lactate permease and NANA 
synthetase 
 
Exley et al. (2005) 
 
H44/76∆perM 
 
 
Deficient in low-sodium glutamate importer 
 
Monaco et al (2006) 
 
H44/76∆gltS 
 
 
Deficient in high-sodium importer 
 
Monaco et al 
(Unpublished) 
 
H44/76∆gdhA 
 
 
Deficient in L-glutamate dehydrogenase 
 
Pagliarulo et al (2004)
 
H44/76∆gdhR 
 
 
Deficient in transcriptional regulator GdhR 
 
Pagliarulo et al (2004)
 
MC58∆nexo 
 
Deficient in NMB0399; KanR  
 
This study 
 
 
MC58∆nape 
 
Deficient in NMB2082; TetR
 
This study 
 
 
MC58∆nexo∆nape 
 
Deficient in NMB0399 and NMB2082 
 
 
This study 
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2.1.3 Assay for survival against oxidative stress - Strains were grown 
overnight, harvested into PBS and the bacterial suspensions adjusted to 1 x 108 
CFU/ml and serial dilutions of 1:10 made up to 10 CFU/ml. To optimise oxidative stress 
conditions serial dilutions were spotted to solid media containing a range of 
concentrations of hydrogen peroxide (Biochemika) or paraquat (Sigma). The optimum 
concentration was described as the concentration at which 10% killing of the wild-type 
MC58 strain occurred. Each strain (10 µl, 103 CFU/ml) was then plated to BHI agar 
containing optimised concentrations of either hydrogen peroxide (13 mM; Biochemika) 
or paraquat (0.075 mM; Sigma), or onto BHI alone. Killing as a result of oxidative stress 
in the presence of hydrogen peroxide or paraquat was calculated as a percentage of 
CFU recovered from media containing no oxidative agent. The assays were performed 
in triplicate on at least three independent occasions. 
 
2.1.4 Fixation and labelling – Strains were grown on solid media overnight, 
harvested to PBS and fixed in 3% paraformaldehyde (PFA). Bacteria were then 
incubated with 2.5 mg/ml fluorescein 5(6)-isothiocyanate (FITC; Sigma) in PBS for 30 
minutes at 37°C, then washed extensively in PBS to remove unbound label. 
 
2.1.5 Construction of bacterial strains – Upstream (700 bp) and downstream (700 bp) 
fragments flanking NMB2082 were amplified using primers shown in Table 2. The PCR 
products were ligated into pCR2.1 TOPO. The upstream fragment was excised using 
restriction endonucleases HindIII and HpaI (Invitrogen) and ligated into the vector 
containing the downstream fragment. The gene encoding tetracycline resistance was 
removed from donor vector pCMT18 and inserted between the up- and down-stream 
fragments at the unique EcoRI site to produce pAC1. N. meningitidis MC58 was 
transformed to tetracycline resistance by standard methods to produce the ∆nape 
strain. The ∆nexo strain was constructed by Tn5 transposon mutagenesis by Megan  
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 Table 2 Primers used in this study 
All primer sequences are 5' to 3'. Relevant restriction sites are  
 
 
 
Sequence (5'- 3') 
 
 
Restriction 
site 
 
Application 
 
CGGGATCCATGAAAATCACCACTTGG 
 
 
BamHI 
 
Amplification of NMB0399 
 
 
CCCAAGCTTTTACCAATCGAATTCTGC 
 
HindIII 
 
Amplification of NMB0399 
 
 
CGGGATCCATGCTTAAAATCATTTCCGCC 
 
BamHI 
 
Amplification of NMB2082 
 
 
CCCAAGCTTTTCGGCAGCATAGTCATAC 
 
HindIII 
 
Amplification of NMB2082 
 
 
GAGTTAACGACGTTGGCGGAAATGATTT 
 
HpaI 
 
Mutagenesis of NMB2082 
for N. meningitidis: 
upstream fragment 
 
GAAAGCTTTGGCTGCACAACGGCTTTAT 
 
HindIII 
 
Mutagenesis of NMB2082 
for N. meningitidis: 
upstream fragment 
 
GAGATATCATCCACATCTGATCCTCTCCG 
 
EcoRI 
 
Mutagenesis of NMB2082 
for N. meningitidis: 
downstream fragment 
 
GAGTTAACAACATCGCCCACCAAAACAT 
 
HpaI 
 
Mutagenesis of NMB2082 
for N. meningitidis: 
downstream fragment 
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Winterbotham. The double ∆nexo∆nape mutant was constructed by transformation of 
the ∆nexo strain with pAC1 by standard methods. 
 
2.2 DNA manipulation  
 
2.2.1 DNA isolation – For isolation of genomic DNA, bacteria were grown 
overnight on solid media and a half loop of bacteria was harvested and resuspended in 
560 µl TE buffer (10 mM Tris, pH 7.6, 1mM EDTA), 30µl SDS (wt/vol) and 3 µl of 20 
µg/ml proteinase K (Sigma, UK). The mixture was incubated for one hour at 37°C. 100 
µl of 5 mM NaCl and 80 µl of cetyl-trimethyl-ammonium bromide/Nacl (10% CTAB, 
Sigma; 0.7 M NaCl, BDH) were added, and the solution incubated at 65°C for 10 
minutes. The aqueous layer was then transferred to a 1.5 ml tube and one volume of 
phenol pH 7.5/chloroform/isoamyl alcohol (25:24:1) (BDH, Merck) added. The solution 
was centrifuged at 16000 xg for 20 minutes and the aqueous layer retained. DNA was 
precipitated by the addition of two volumes of 100% ethanol followed by centrifugation 
at 16000 xg for five minutes. The pellet was washed with 70% ethanol, air-dried, and 
resuspended in TE buffer containing RNAse (100 µg/ml, Sigma UK). 
 
For plasmid purification from E. coli, bacteria was grown overnight in 5 ml LB media 
and pelleted by centrifugation at 16,000 xg for ten minutes. For N. meningitidis, 
bacteria were grown overnight on solid BHI media, a half loop harvested to PBS and 
pelleted by centrifugation at 16,000 xg for five minutes. Plasmid DNA was purified 
using the QIAprep® Spin Miniprep kit according to the manufacturer’s protocol 
(Qiagen). 
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2.2.2 Polymerase Chain Reaction – Reaction mixtures contained 1 pmol/µl of 
each primer, 1.5 mM MgCl2, 200 µM dNTPs, 2 units of Taq DNA polymerase (Sigma) 
and 0.1 volume of 10 x PCR buffer (Gibco BRL) in a 25 µl final volume. Control 
reactions containing no Taq polymerase or no target DNA were also performed. 
Thermal cycling conditions were as follows: initial denaturation step at 94°C for five 
minutes, followed by 30 cycles at 94°C for 30 seconds, 55°C for 30 seconds and 72°C 
for up to three minutes, depending on the length of the fragment to be amplified (1 
kb/min), and a final extension step at 72°C for ten minutes. 
 
2.2.3 Restriction endonuclease digestion of DNA – Restriction digests were 
performed with 0.01 volumes of BSA, restriction enzyme(s) and either plasmid or 
genomic DNA, and 0.1 volume of 10 x reaction buffer. All reagents were obtained from 
New England Biolabs. Reactions were incubated at 37°C for up to six hours. 
 
2.2.4 Gel electrophoresis and purification of DNA from agarose gels – DNA 
was resuspended in loading buffer (0.25% bromophenol blue, 0.25% xylene cyanol FF, 
30% glycerol) and fractionated in Tris Acetate EDTA (TAE) buffer (Tris 0.4 M, EDTA-
Na2-salt 0.01 M, acetic acid 12.01 g/L, 0.2M) on 1% agarose (Gibco, BRL) gels 
containing a 1:100 dilution of the Cybersafe DNA gel stain. DNA was visualised using a 
UV transilluminator (UVP). For purification of DNA, gel fragments were excised using a 
scalpel and purified using the QIAquick® gel extraction kit according to the 
manufacturers protocol (Qiagen). 
 
2.2.5 Ligation of DNA – DNA fragments generated by PCR were ligated into 
the pCR2.1 TOPO vector (Invitrogen) according to the manufacturers’ protocol. All 
other ligations were performed using a 1:5 ratio of insert to vector, 4 µl 5 x T4 DNA 
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ligase buffer and 1 µl T4 DNA ligase (1 U/µl; NEB), made up to a final volume of 20 µl 
with dH2O (Sigma, UK). The mixture was incubated at 16°C overnight. 
 
2.2.6 Transformation of chemically competent E. coli – A 10 µl ligation 
reaction was added to 50 µl E. coli TOP10 competent cells and incubated on ice for 30 
minutes. The mixture was subjected to heat shock at 42°C for 30 seconds, then 250 µl 
SOC medium was added. SOC medium was prepared by dissolving 20 g bacto-
tryptone (Gibco, BRL), 5 g bacto-yeast extract (Gibco, BRL), and 0.5 g NaCl (BDH) in 
950 ml dH2O, then 10 ml 250 mM KCl was added and the volume adjusted to 1 L, 
followed by autoclaving. A sterile solution of 2 M MgCl2 (5 ml) was added to the final 
solution. Following addition of SOC medium to transformed bacteria, the solution was 
incubated at 37°C with continuous shaking (200 r.p.m) for one hour. The bacteria were 
then plated to solid media containing appropriate antibiotics. 
 
2.2.7 Southern blot – Restriction endonuclease digested genomic DNA was 
separated on 1% agarose gels overnight at 30 V. Gels were incubated in depurination 
solution (0.25 M HCl) for 12 minutes, rinsed, and equilibrated in denaturing solution 
(0.5 M NaOH, 1.5 M NaCl) for 18 minutes, followed by incubation in neutralising 
solution (1.5 M NaCl, 1 M Tris pH 8) for 18 minutes. Gels were then transferred to 
nitrocellulose membranes (Hybond N+, Amersham) by capillary action in Saline-sodium 
citrate (SSC) buffer (150 mM NaCl, 15 mM NaH2(C3H5O(COO)3) pH 7). DNA was fixed 
to the membrane by exposure to UV light for 30 seconds. Membranes were washed in 
wash solution (0.5% SDS 10%, 0.1 x SSC) for 20 minutes at 65°C. DNA probe 
preparation and alkaline phosphatase labelling was performed using the AlkPhos Direct 
Labelling and Detection System with CDP-Star (GE healthcare) according to the 
manufacturer’s protocol. Membranes were placed in an enhanced chemiluminescence 
(ECL) cassette for detection. 
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2.2.8 DNA Sequencing – DNA sequencing was performed using 1 µl primer 
(3.2 pmol / µl) and dH2O (Sigma, UK) and made up to a final volume of 10 µl. 
Automated sequencing was performed by the Department of Biochemistry, 
Hammersmith Campus, Imperial College London. 
 
2.3 Protein preparation and analysis 
 
2.3.1 Preparation of protein samples for Sodium dodecyl sulphate 
polyacrylamide gel  electrophoresis (SDS-PAGE) and Tricine sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (TSDS-PAGE) - Protein samples were prepared by 
harvesting 1 x 109 CFU of bacteria from solid media to PBS. For analysis of bacteria 
post-incubation with cells or supernatant, assays were performed as described below 
and the entire contents of a microtitre dish well were transferred to a 1.5 ml tube. 
Treatment of bacteria with 50 U neuraminidase or proteinase K was performed for one 
hour at 37°C. For analysis of adherent PMNs, cells were dislodged from the wells by 
scraping with a pipette tip and thoroughly re-suspended, followed by transfer of total 
well contents to a 1.5 ml tube. Samples were then centrifuged at 16,000 xg to pellet the 
bacteria and/or PMNs, resuspended in 50 µl dH2O, and an equal volume of 2 x SDS-
PAGE sample buffer (100 mM Tris HCl, 4% SDS, 200 µM β-mercaptoethanol (BME)), 
followed by heat treatment at 90°C for ten minutes. To prepare samples for LPS 
analysis by TSDS-PAGE, 1 µl proteinase K (Qiagen) was added to the SDS-PAGE 
sample buffer, and incubated overnight at 37°C. A further 1 µl proteinase K was then 
added and incubated at 65°C for three hours.  
 
2.3.2 Sodium dodecyl sulphate polyacrylamide gel  electrophoresis (SDS-
PAGE) – SDS-PAGE analysis of proteins was carried out as previously described 
(Sambrook et al, 1989). Polyacrylamide gels were run in SDS buffer (200 mM glycine, 248 
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mM Tris, 34 mM SDS) at 120 V for 1-2 hours. The reagents used to prepare 
polyacrylamide gels are shown in Table 3. 
 
 
Table 3 SDS-PAGE gel constituents 
  
Resolving Gel 
 
 
Stacking Gel 
 
Tris 1.5 M pH 8.8 
 
 
1 ml 
 
- 
 
Tris 0.5 M pH 6.8 
 
 
- 
 
500 µl 
 
40% Acrylamide/Bis 
(Biorad)  
 
1.2 ml 
 
250 µl 
 
 10% SDS  
 
 
40 µl 
 
20 µl 
 
dH20 
 
 
1.71 ml 
 
1.21 ml 
 
Tetramethylethylenediamine 
(TEMED) (BDH) 
 
 
1.6 µl 
 
2 µl 
 
10% APS (Sigma) 
 
 
40 µl 
 
20 µl 
 
 
2.3.3 Staining and de-staining of SDS-PAGE mini-gels – Polyacrylamide gels 
were stained by placing them into approximately 20 ml of Coomassie Blue Stain (0.2% 
Coomassie Blue R-250, 40% ethanol (v/v), 10% glacial acetic acid (v/v), 50% ddH2O) 
for 30 minutes at room temperature (RT) with shaking. To destain, the gels were placed 
in 20ml Destain I solution (40% methanol (v/v), 10% glacial acetic acid (v/v), 50% 
ddH2O) for 30 minutes at RT with shaking, then replaced with Destain II solution (10% 
glacial acetic acid (v/v), 4% glycerol (v/v) 86% ddH2O) for a further 30 minutes. 
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2.3.4 Western blot analysis – Protein samples were separated by SDS-12% PAGE 
with a pre-stained marker (10–250 kDa, BioRad) and transferred to an Immubilon-P 
polyvinylidene fluoride (PVDF) membrane (Millipore) by wet transfer. A sponge soaked 
in dH2O was placed onto the transfer apparatus, followed by a piece of Whatman® 
paper pre-wet with Transfer buffer (0.2M glycine, 0.02M Tris-HCl). The gel was then 
placed on top, and covered with the PVDF membrane, which was pre-wet with 
methanol. A further piece of Whatman® soaked in Transfer buffer, and another sponge 
soaked in dH2O were placed on top, and the apparatus secured and placed into the 
wet transfer tank. Transfer was performed in Transfer buffer, with stirring, at 70 V for 
one hour. The PVDF membranes were then blocked in 5% milk (skimmed milk power 
dissolved in PBS) at 4°C overnight with gentle shaking. All further washes and antibody 
incubations were carried out in PBSTM (PBS, 0.05% Tween 20, 0.5% milk). Following 
blocking, the membranes were washed three times in PBSTM for ten minutes each, 
then incubated with the primary antibody (Table 4) for two hours unless otherwise 
stated. This was followed by three further washes, then membranes were incubated 
with the secondary antibody conjugated to horseradish peroxidise (HRP) for one hour. 
A final three washes were performed before membranes were removed from PBSTM. 
The was used to detect antibody binding according to the manufacturer’s protocol. The 
membrane was then blotted and placed in an ECL cassette for detection. 
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Table 4 Antibodies used in this study 
 
 
Antibody 
 
 
Target 
 
Dilution
 
Source 
 
Anti-L,3,7,9 (murine) 
 
N. meningitidis serogroup 
B LPS 
 
1:2000  
 
NIBSC (01/412) 
 
ZM51mAb (murine) 
 
N. meningitidis polysialic 
acid capsule 
 
1:10 
 
Oxoid 
 
B33 mAb (murine) 
 
 
Neisserial Opacity protein 
(Opa) 
 
1:10,000
 
Lammel et al.  
(1988) 
 
3F11 IgM 
 
Unsialylated LPS 
 
 
1:10 
 
Yamasaki et al.  
(1991) 
 
Anti-CD66 (rat) 
 
Human CEACAM / 
CD66a,c,d receptor 
 
1:100 
 
Serotec 
 
Anti-CD45 (murine) 
 
 
Human leukocyte CD45 
receptor 
 
1:1000 
 
Dako 
 
Anti-CD18 (murine) 
 
 
Human leukocyte CD18 
receptor 
 
1:1000 
 
BD Pharmingen 
 
Anti-CD11b (murine) 
 
 
Human leukocyte CD11b 
receptor 
 
1:1000 
 
BD Pharmingen 
 
Anti-neutrophil elastase 
(murine) 
 
 
Neutrophil elastase 
 
1:500 
 
Dako 
 
8G10 (rabbit) 
 
Cleaved and un-cleaved 
Caspase-3 
 
1:1000 
Cell Signalling 
technology 
 
Anti-actin (rabbit) 
 
 
C-terminal actin fragment 
 
1:1000 
 
Sigma 
 
Anti-mouse (FITC / 
Rhodamine conjugate) 
 
 
Mouse IgG 
 
1:400 
 
 
Jackson 
Laboratories 
 
Anti-rat (FITC conjugate) 
 
 
Rat IgG 
 
1:400 
 
Jackson 
Laboratories 
 
Mouse IgG 
 
 
Isotype control 
 
1:1000 
 
Dako 
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2.3.5 Electrophoresis of LPS – TSDS-PAGE was performed to obtain high 
resolution separation of LPS. Two-phase gels were prepared as a 16.5% resolving gel 
containing 15% urea overlaid by a 4% stacking gel. Electrophoresis was carried out as 
described for SDS-PAGE. Acrylamide concentrations of the two phases was 49.5% T, 
6% C and 49.5% T, 3% C, respectively, where T represents the total acrylamide 
percentage (acrylamide and bisacrylamide) and C is the percentage of  the cross-
linker, bisacrylamide. This method of separation utilises two electrophoresis buffers, the 
anode buffer (0.2M Tris, pH 8.9) and cathode buffer (0.1 M Tris, 0.1 M tricine, 0.1% 
SDS, pH 8.25). Electrophoresis was performed using the BioRad Mini-Protean II gel 
apparatus (BioRad). Samples were boiled for ten minutes, loaded under cathode buffer 
and subjected to electrophoresis at 30 V until the samples entered the resolving gel. 
Voltage was then increased to 105 V for approximately 1 hour. 
 
2.3.6 Silver stain – LPS samples were prepared as described above and 
separated by TSDS-PAGE. The gel was then fixed and developed using the PlusOne 
Silver Stain kit (Amersham) according to the manufacturer’s protocol. 
 
2.3.7 Protein expression and purification – NMB0399 and NMB2082 were 
amplified using primers described in Table 3. The genes were ligated into the vector 
pROEXHtb for protein expression and purification. E. coli cultures of 3 to 6 litres were 
grown to an OD A600 of 0.4 to 0.6 in LB medium and protein expression was induced by 
the addition of isopropylthiogalactoside (IPTG) to a final concentration of 1 mM, 
followed by continued growth for 3 hours at 37ºC. Cells were harvested by 
centrifugation, re-suspended in buffer containing 25 mM Tris pH 8.0, 25 mM imidazole, 
0.5 M NaCl (buffer A) and lysed by pulse sonication. The lysate was cleared by 
centrifugation at 2907 xg for 15 minutes. His-tagged proteins were purified using a 
metal affinity HisTrap chelating HP column (GE Healthcare) pre-equilibrated with 
CoCl2. Proteins were eluted with an imidazole gradient at steps of 10% and dialysed 
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into buffer containing 50 mM Tris pH 8, 0.5 mM EDTA, 1.0 mM dithiothreitol (DTT). The 
His tag was cleaved by the addition of TEV protease (Invitrogen) and the sample was 
then dialysed against buffer A. The cleaved proteins were applied to a cobalt loaded 
HisTrap column and the protein of interest was found in the flow-through. The 
NMB2082 protein was further purified by size exclusion chromatography using HiLoad 
16/60 Superdex 200 prep grade column (GE Healthcare) pre-equilibrated in 10 mM Tris 
pH 7.0, 100 mM NaCl. Samples of the NMB0399 protein were crystallised without prior 
size exclusion chromatography.  
 
2.3.8 Biochemical assays - Double-stranded DNA substrates 25U and 50U 
were made by mixing equimolar amounts of complementary strands, heating to 90°C 
and cooling slowly to room temperature. One strand contained a uracil residue and a 5’ 
hexachlorofluorescein residue (HEX) for visualisation; the complementary strand was 
unmodified. The sequence of the double-stranded 25U oligonucleotide was 5’-HEX 
GGA TCA CTA TUA TAG GTA GTT TAT–3’; the sequence of the double-stranded 
50U oligonucleotide was 5’-HEX CGT GTA TGA CAT CTA ACT ATU ATA GCG CTC 
ATC GTC ATC GTC ATC CTC GGC ACC GT–3’. Oligonucleotides were synthesised 
and HPLC-purified by MWG Biotech (Ebersberg, Germany). The 25U and 50U 
substrates were reacted with 100 nM Herpes simplex virus Type-1 uracil DNA 
glycosylase (UDG) for 2 hours at 25°C in order to create the abasic 25AP and 50AP 
DNAs (Bellamy et al, 2001).  
 
Nuclease assays were performed in a standard reaction buffer (20 mM Tris pH 7.5, 1 
mM EDTA, 20 mM NaCl, 15 mM MgCl2) supplemented with 15 mM MgCl2 at 25°C. 
Aliquots were removed at specified time points, and quenched in formamide loading 
buffer (0.01% xylene cyanol, 0.01% bromophenol blue, 30 mM EDTA in formamide) 
prior to separation via denaturing polyacrylamide gel electrophoresis. All assays used 
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100 nM of the respective DNA substrate and an equivalent of 500 fmol of DNA 
substrate was loaded per lane onto acrylamide gels. Enzyme concentrations were as 
described in figure legends. Exonuclease assays were analysed using 15% PAGE 
whereas end-processing assays used 20% PAGE. Data were fitted using Grafit 5 
(Erithacus software). 
 
2.4 Cell culture and infection 
 
2.4.1 HL60 culture and differentiation – HL60 cells, a promyelocytic leukaemia 
cell line, were cultured in RPMI-1640 medium without L-glutamine and without phenol 
red (Gibco Invitrogen), supplemented with 20% heat-inactivated foetal calf serum (TCS 
Cellworks Ltd), 10% glutamax, penicillin (250 U/ml) and streptomycin (250 µg/ml) 
(Gibco Invitrogen). Cell viability was determined by trypan blue dye exclusion. Dead 
cells are permeable and are stained blue, while live cells remain white, allowing live 
cells to be identified and enumerated. Cells were maintained by replacement with 15 ml 
fresh medium daily, and passaged weekly to a concentration of 0.5 x 105 cells/ml. Cells 
were differentiated by the addition of 4 µM retinoic acid following passage, six days 
prior to use (Pantelic et al. 2004). 
  
2.4.2 Isolation of peripheral human PMNs – 20 ml of peripheral venous blood 
was taken from a healthy volunteer and heparinised with 0.1% heparin to prevent 
clotting. Blood was layered onto Histopaque 1119 (Sigma) in 15 ml tubes and then 
centrifuged at 800 xg for 20 minutes at RT. The buffy coat from each tube were 
retained, resuspended in Hanks Balanced Saline Solution (HBSS, Gibco Invitrogen) 
containing calcium and magnesium (CaCl2 140 mg/ml, MgCl2 100 mg/ml, MgSO4 100 
mM; 0.2% BSA) and centrifuged at 200 xg for 10 minutes. The supernatant was 
discarded and the cell pellets were resuspended in >1 ml HBSS each and combined. 
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This suspension was then layered onto an isotonic percoll gradient (GE Healthcare) of 
increasing concentration from 65% to 85% in increments of 5%, made up with HBSS 
containing 0.2% BSA. The gradient was centrifuged at 800 xg for 20 minutes and the 
PMNs harvested from the interface between the 70% and 75% layers. PMNs were 
resuspended in HBSS containing 0.2% BSA and centrifuged for a further 10 minutes at 
200 xg. The cell pellet was then resuspended in 3 ml HBSS. 10 µl cell suspension was 
added to 190 µl trypan blue solution (Sigma) and cell concentration quantified using a 
haemocytometer. The PMN concentration was adjusted to 1.11 x 106 cells / ml in HBSS 
and stored at RT until needed.  
 
2.4.3 Phagocytosis assay – For phagocytosis assays, cells were washed 
twice with HBSS without CaCl2, MgCl2 or MgSO4 containing 0.2% BSA and once with 
HBSS with CaCl2 (140 mg/ml), MgCl2 (100 mg/ml), MgSO4 (100 mg/ml) and 0.2% BSA, 
and the concentration was adjusted to 2.5 x 106 cells/ml. Pre-treatment of cells with 
cytochalasin D (10 µg/ml; Sigma), or with antibodies for blocking experiments (Table 3), 
was performed at 37°C for 30 minutes. Phagocytosis assays were performed in HBSS 
with 2 µM lactate in 96- or 24-well microtitre plates for analysis by flow cytometry and 
microscopy respectively. Bacteria were added at an multiplicity of infection (MOI) of 
12.5 bacteria:cells for experiments with fixed bacteria, and an MOI of 100 for 
experiments with live bacteria. For opsonisation, bacteria were incubated with heat-
killed human serum (1:40 dilution in PBS) for 30 minutes at 37°C, followed by 
incubation with baby rabbit complement (Pelfreeze) for a further 15 minutes before 
addition to cells. Plates were incubated at 37°C for 25 minutes at 140 rpm on a shaker. 
The contents of wells with assays including live bacteria were fixed in 3% PFA before 
analysis. 
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2.4.4 Preparation and treatment of HL60 cell supernatants – The 
phagocytosis assay was performed as described in a 24-well plate. Following 
incubation, well contents were transferred to a 1.5 ml tube and pulse-spun to 6000 xg. 
The supernatant was removed and filtered using a 0.2 µm filter (VWR). For treatment 
with trypsin, supernatants were incubated with 0.1% trypsin (Sigma) for 20 minutes at 
RT, followed by addition of 0.1% trypsin-specific inhibitor (Sigma) for 15 minutes at RT. 
Size fractionation of supernatants was performed by centrifugation using filters that 
allow passage of proteins of 100 kDa, 50 kDa or 30 kDa. Centrifugation was performed 
at 2000 xg for 30 minutes at RT. 
 
2.4.5 Assay for bacterial survival in PMNs – 500 µl PMNs were seeded to 48-
well flat-bottomed plates at a concentration of 1.11 x 106 cells/ml and centrifuged at 
350 xg for five minutes, then allowed to rest for fifteen minutes prior to use. Treatment 
with inhibitors cytochalasin D (5 µM) and resveratrol (100 µM) was performed for 
twenty minutes at 37°C when needed. Bacterial suspensions were prepared at a 
concentration of 2.8 x 107 in HBSS with CaCl2 (140 mg/ml), MgCl2 (100 mg/ml) and 
MgSO4 (100 mg/ml). Medium was then removed from the adherent resting PMNs and 
replaced with 200 µl of the inoculum to give an MOI of 100. For each bacterial strain or 
species used, a control well was included without PMNs. Plates were sealed with 
parafilm, centrifuged at 800 xg for five minutes and incubated at 37°C in 5% CO2. After 
one hour, saponin was added to a final concentration of 0.1% to each well and 
incubated for a further ten minutes to lyse PMNs. The base of each well was then 
scraped with a pipette tip, and thoroughly resuspended. Serial dilutions of each well 
were spotted in triplicate to solid media and incubated overnight. For each assay, 
counts were measured at time zero. Survival was quantified by counting the CFU for 
each condition at time zero and after the one-hour incubation. Percentage survival was 
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calculated by comparing each condition with the number of bacteria recovered at time 
zero. 
 
2.4.6 Lactate dehydrogenase quantification – At zero, one, two and three 
hours post-inoculation, supernatants from cells were removed from the adherent 
PMNs, spun briefly three times at 6000 xg and passed through a low volume 0.2 µM 
filter. A positive control was also prepared by lysing 5.5 x 105 adherent PMNs with a 
final concentration of 0.1% saponin, then preparing the supernatant in the same way. 
The supernatants were then tested for lactate dehydrogenase (LDH) activity using the 
LDH Cytotoxicity Detection Kit (Roche) according to the manufacturers protocol. 
Percentage cytotoxicity was calculated using the following equation: 
 
  
  
% Cytotoxicity   = 
(Lysed PMNs) – PMNs alone 
[(Infected PMNs) = (Bacteria alone)] – PMNs alone 
 
 
2.5 Flow cytometry 
 
Analysis of the association of FITC-labelled or GFP-expressing bacteria PMNs was 
performed using the FACS Calibur (Becton Dickinson) gated to the PMN population. At 
least 10,000 events were counted. Association was quantified by multiplying the 
geometric mean fluorescence by the percentage total positive gated population to 
calculate the Mean Fluorescence Index (MFI).  
 
Analysis of the expression of bacterial surface structures or cell receptors was 
performed by incubating bacteria (1 x 108 cells/ml) or cells (2.5 x 106 cells/ml) with a 
primary antibody (Table 3), followed by washes with PBS WITH 0.2% Tween. The cells 
were incubated with a secondary antibody conjugated to a fluorescent marker (Table 
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3). Samples were analysed using the FACS Calibur gating to the bacterial or HL60 
population as appropriate, and at least 20,000 events were counted. Expression was 
quantified by the percentage total positive population. All assays were performed in 
triplicate on at least three independent occasions. 
 
2.6 Microscopy 
 
2.6.1 Immunofluorescence – For microscopy, phagocytosis assays were 
performed as described in 24-well plates with coverslips. Following incubation, plates 
were centrifuged at 35 xg for 3 minutes, the cells fixed with 3% PFA and washed. 
Staining of cellular components was performed using antibodies shown in Table 2. To 
visualise internalised and associated bacteria coverslips were stained differentially pre- 
and post-permeabilisation with 0.2% saponin (Sigma). Phagocytosis was scored by 
counting the number of intracellular (green) and extracellular (red) bacteria per cell. 
The total number of intracellular bacteria is the Phagocytic Index; the total number of 
cell-associated bacteria is the Association Index. For this scoring system 50 cells were 
counted for each coverslip. For all other parameters, at least 100 cells were scored. 
Each assay was analysed in triplicate on three independent occasions. 
 
2.6.2 Light microscopy – For analysis of PMN morphology and nuclear 
condensation, PMNs were seeded to coverslips in 24-well plates and/or infected and 
incubated as described. PMNs were then fixed with 3% PFA overnight and  then 
washed in PBS. Prior to staining coverslips were air-dried. To stain, coverslips were 
held feather-side down without shaking in Giemsa-Wright stain (Sigma) for thirty 
seconds, followed by five minutes in dH2O, air-dried, then mounted feather-side up on 
slides for visualisation by light microscopy. 
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2.7 In vivo analysis of virulence 
Mixed litters of 5-day-old rats (Wistar) received 75 µl  containing 1 x 107 CFU/ml N. 
meningitidis in PBS. The virulence of mutants was compared directly with MC58 in 
individual animals given a 1:1 ratio of wild-type to mutant bacteria. The number of 
mutant and wild-type bacteria recovered from the blood of animals 8 hours later was 
established by plating to media with or without antibiotics. The Competitive Index (C.I.) 
was calculated using the following equation: 
 
 (number of mutant / wild-type bacteria recovered from animals) 
C.I . = 
(number of mutant / wild-type bacteria in the inoculum)  
 
 
2.8 Statistics 
Statistics were calculated using Microsoft Office Excel. Statistical significance was 
analysed by the Student’s t-test. P values of less than 0.01 were accepted to be 
significant. Unless otherwise stated, figures represent assays performed in triplicate. 
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N. meningitidis preferentially utilises lactate during growth in the CSF. Previous work has 
shown that a mutant strain lacking the lactate permease enzyme, encoded by lctP, is 
attenuated in the infant rat model of infection (Exley et al., 2005). A mutant lacking LctP had a 
defect in LPS sialylation (Exley et al., 2005). This was thought to be due to a reduction in 
available PEP, generated via pyruvate, entering the sialic acid synthesis pathway. Loss of 
LctP may therefore also affect expression of the polysialic acid capsule on the bacterial 
surface. 
 
The meningococcus is thought to utilise glutamate during bloodstream infection. Imported 
glutamate contributes to the TCA cycle, and thus it is possible that reduced availability of this 
carbon/nitrogen source will also affect sialic acid biosynthesis. Recent work has identified 
the genes involved in glutamate import by N. meningitidis. GdhR is a transcriptional regulator 
that regulates expression of ghdA, which encodes an L-glutamate dehydrogenase, and is 
essential for growth, in low sodium concentrations (Pagliarulo et al., 2004). GdhR also regulates 
transcription of an operon encoding an ABC transporter involved in glutamate import. 
Inactivation of genes encoding the putative substrate-binding protein (NMB1963) and 
permease (NMB1965) within this operon resulted in reduced intracellular survival in epithelial 
cells (Monaco et al., 2006). Further examination of the Neisserial MC58 genome has revealed 
two glutamate uptake enzymes encoded by perM and gltS, which are involved in glutamate 
import in environments presenting low and high sodium concentrations, respectively. The 
relevance of these genes in expression of outer membrane polysaccharides and on the 
survival of the meningococcus in vivo is unknown.  
 
Meningococcal surface structures such as LPS and capsule are known to play a role in 
phagocytosis. However, the role of metabolism during interactions between N. meningitidis 
and phagocytic cells has not been previously examined. 
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The work described in this chapter was performed with the closely related N. meningitidis 
serogroup B, ST-32, ET-5 strains, MC58 and H44/76, and the human cell line, HL60.  
Previous studies have characterised this cell line according to its morphology and receptor 
expression (Pantelic et al., 2004). Therefore, this cell line was used in initial studies instead of 
primary isolated human cells to reduce host-to-host variation. 
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3.1 PerM is required for survival in vivo 
The importance of the two previously identified glutamate transporters, PerM and GltS, for 
survival of the meningococcus in vivo had not yet been elucidated. A mutant  strain lacking 
perM was constructed in the wild-type H44/76 strain. The mutant was reconstructed by 
transforming the wild-type strain with genomic DNA from the mutant. Loss of perM in the 
strains was confirmed by PCR analysis (not shown). Both strains were analysed for their 
ability to cause bacteraemia in the infant rat model. Twenty hours after inoculation with a 1:1 
ratio of mutant and wild-type strain, blood was recovered and bacteraemia assessed by 
plating to solid media. The Competitive Index (C.I.) of each mutant was calculated by 
comparing the recovery of the mutants with the wild-type strain. The mutant lacking perM 
showed significant attenuation in vivo, indicating that the PerM glutamate transporter plays a 
role in survival of the wild-type strain (Figure 3.1). However, gltS expression was not 
necessary to cause bacteraemia as the mutant lacking this gene showed no significant 
attenuation (data not shown). This work was performed by Caterina Monaco and Christoph 
Tang.  
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3.2 LPS sialylation is not affected in the absence of glutamate 
The inability to utilise lactate has previously been shown to result in a reduction in sialylation 
of the LPS. Therefore, the effect of the loss of enzymes involved in glutamate import on 
sialylation was also investigated. Mutant strains lacking genes encoding the L-glutamate 
dehydrogenase GdhA and transcriptional regulator GdhR were constructed by Caterina 
Monaco (Monaco et al., 2006) (Unpublished). Bacteria were grown overnight on solid media and 
harvested to PBS prior to fixation in PFA. The extent of LPS sialylation was investigated in 
strains H44/76∆gdhR, H44/76∆gdhA, H44/76∆perM and H44/76∆gltS. Western blot analysis 
was performed with a mAb, 3F11, which recognises unsialylated LPS (Apicella et al., 1981). The 
amount of sample loaded was adjusted according to Coomassie staining and Western 
blotting with the anti-L,3,7,9 LPS immunotype mAb (Figure 3.2 A & B). There was no 
significant difference in sialylation between the wild-type H44/76 strain and the glutamate 
import-deficient mutants (Figure 3.2 B). The extent of sialylation was also examined by flow 
cytometry using the 3F11 mAb, with the unsialylated MC58∆lst mutant as a positive control 
(Figure 3.2 C). The data obtained from flow cytometry was consistent with the Western blot 
analysis. There was no significant difference in binding of the 3F11 mAb to any of the strains 
tested. 
 
 
 
 
 
 
 
 
 
 
 
 
90 
 
Chapter 3 The role of bacterial metabolism in association with PMNs  
 
 
 
Unsialylated LPS (3F11)
H4
4/
76
∆g
ltS
∆
pe
rM
∆g
dh
R
Total protein
LPS (L,3,7,9)
 (A)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
10
20
30
40
50
60
70
80
90
100
MC58 ∆lst H44/76 ∆gltS∆perM∆gdhR
%
 p
os
iti
ve
 p
op
ul
at
io
n
%
 p
os
iti
ve
 p
op
ul
at
io
n
(B)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 3.2 LPS sialylation is unaffected in strains lacking components of 
glutamate import systems 
(A) Whole cell lysates of bacteria were separated by SDS-PAGE and the proteins 
stained with Coomassie Blue. Lysates were also transferred to a nitrocellulose 
membrane and incubated with mAbs against L3,7,9 LPS immunotype (L3,7,9) or 
unsialylated LPS (3F11) to determine the extent of LPS sialylation. (B) Fixed 
bacteria were incubated with a mAb against unsialylated LPS (3F11) followed by 
incubation with a FITC-conjugated secondary antibody. The LPS sialylation-
deficient strain MC58∆lst was included as a positive control for 3F11 binding, 
which was quantified by flow cytometry. There was no difference in sialylation 
between strains. Error bars represent the standard error of the mean % positive 
population. 
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3.3 Capsule expression is reduced in the MC58∆lctP strain but is unaffected in 
mutants affected for glutamate uptake  
The first step in the biosynthesis of polysialic acid capsule is the addition of N-acetyl 
mannosamine to PEP to produce sialic acid. PEP can be produced from glucose via the 
Entner Doudoroff pathway, or from imported lactate via pyruvate. The effect of the ∆lctP 
mutation on polysialic acid capsule production was therefore analysed by flow cytometry 
using mAb ZM51 against the serogroup B polysaccharide capsule. This assay was carried 
out with wild-type, MC58∆lctP and MC58∆siaD strains. The MC58∆siaD strain lacks the 
capsule-specific polysialyltransferase and is therefore unencapsulated. FACS analysis 
confirmed the absence of the capsule in the MC58∆siaD strain (Figure 3.3 A). A significant 
reduction in capsule expression was seen in the MC58∆lctP strain when compared to the 
wild-type MC58 (Figure 3.3 A). 
 
The effect on capsule expression of loss of components of the glutamate import systems, 
PerM and GltS, and the transcriptional regulator GhdR was also examined. Mutants lacking 
the genes gdhR, gltS and perM were tested against the wild-type strain H44/76. There was 
no significant reduction in capsule expression in any of these strains (Figure 3.3 B). The 
MC58 wild-type strain and MC58∆siaD mutant were included as controls.  
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 Figure 3.3  Capsule expression is reduced in the MC58∆lctP strain but 
is unaffected in mutants lacking components of glutamate import 
systems 
Fixed bacteria were incubated with a mAb against the serogroup B capsule, 
followed by a FITC-conjugated secondary antibody. Binding to all strains was 
quantified by flow cytometry. The capsule-negative MC58∆siaD strain was 
included as a negative control. (A) Capsule expression was reduced in the 
MC58∆lctP strain. (B) The ability to utilise glutamate has no effect on expression of 
capsule. Error bars represent the standard error of the mean % positive population. 
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3.4 Serogroup B N. meningitidis associates with HL60 cells with or without 
opsonisation 
Due to their anti-phagocytic properties, the changes observed in the capsule and LPS 
sialylation state of the MC58∆lctP mutant might be expected to influence its interactions with 
phagocytic cells. Furthermore, it would therefore be expected that the strains lacking the 
glutamate import system would behave as the wild-type strain during interactions with 
phagocytes since they had no detectable change in capsule or LPS expression. These 
hypotheses were tested with human neutrophils since they are one of the first forms of 
cellular immune defence encountered by pathogens, and it is known that the meningococcus 
comes into contact with these phagocytes during infection (Guarner et al., 2004).  
 
To investigate the interaction between N. meningitidis and human neutrophils, initial assays 
were performed to confirm the association between the neutrophil cell line, HL60, and N. 
meningitidis MC58. Assays were performed in HBSS, which contains 1 mg/ml glucose, with 
PFA-fixed FITC-labelled bacteria. HL60 cells were differentiated with 4 µM retinoic acid for 
six days prior to use. Bacteria were incubated in the presence or absence of heat-inactivated 
human serum (10%) and rabbit complement (1:50), then added to differentiated HL60 cells. 
The association of labelled bacteria with HL60 cells was analysed by flow cytometry. Due to 
the fragile nature of the HL60 cells, care was taken to gate the intact HL60 population during 
data analysis. This was done by selecting cells of the appropriate size according to the 
forward- and side-scatter data produced during analysis. Association of labelled bacteria to 
cells was measured as the mean fluorescence index (MFI), which was calculated by 
multiplying the total percentage positive population with the geometric mean fluorescence 
intensity. Preliminary assays verified that fixed FITC-labelled MC58 strain associated with 
HL60 cells in the presence of serum and complement (Figure 3.4 A). Association was 
observed as a shift in the fluorescence of the gated population to the right. Association was 
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also observed in the absence of serum and complement, albeit at a lower level than for 
opsonised bacteria, but at a significantly higher level than background (Figure 3.4 A & B).  
 
FACS analysis does not differentiate internalised from adherent bacteria. Phagocytosis 
relies on reorganisation and polymerisation of actin within the host cell (Stossel, 1976). This 
process can be inhibited by cytochalasin D, which prevents actin filament polymerisation by 
binding to high-affinity binding sites, disrupting the cytoskeletal network depolymerising the 
actin fibres. By binding to the termini of the resulting fragments, the drug prevents re-
elongation of the actin fibre (Schliwa, 1982). Therefore, in order to determine whether 
phagocytosis was occurring, the assay was performed in the presence of cytochalasin D. 
Incubation with this inhibitor significantly reduced association detected by FACS (Figure 3.4 
C). This trend was also confirmed by microscopy, which showed that bacteria associated to 
HL60 cells incubated with cytochalasin D to a lesser extent, and that treatment with the 
inhibitor prevented any bacteria from being internalised (data not shown). 
 
All further assays were carried out with bacteria and cells alone to investigate the non-
opsonic interaction between N. meningitidis and neutrophils. This process is of potential 
importance to the clearance of the meningococcus by the innate immune system. It is also of 
significance during colonisation and early stages of the disease. Activated neutrophils 
infiltrate infected tissues where they would encounter the meningococcus in the absence of 
opsonins. Since neutrophils employ cytokine release as a mechanism of activating the 
immune system and priming further cellular responses, this initial interaction may impact on 
immune response events and their outcomes later in disease development. 
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 Figure 3.4 Serogroup B N. meningitidis associates with HL60 
cells in the presence and absence of opsonisation 
Fixed FITC-labelled bacteria were incubated with HL60 cells in the presence 
and absence of heat-inactivated human serum or complement, and 
association with cells analysed by flow cytometry, and MFI was calculated by 
multiplying the mean fluorescence with the percentage positive cell 
population. Traces show cells alone (red), and cells with bacteria (green). (A) 
Wild-type N. meningitidis associates with HL60 cells in the presence and 
absence of opsonisation by human serum. (B) Association is independent of 
complement. (C) Assays were performed in the presence of cytochalasin D, 
demonstrating that association is dependent on actin polymerisation. Error 
bars represent standard error of the mean. 
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3.5 The polysialic acid capsule reduces phagocytosis 
Previous studies have demonstrated that the polysialic acid capsule is an important bacterial 
structure for avoidance of phagocytosis (Kolb-Maurer et al., 2001; Read et al., 1996; McNeil et al., 1994). 
Thus, association assays were performed with MC58∆siaD. This capsule-negative strain 
associated to a significantly higher degree than the wild-type strain, confirming the anti-
phagocytic nature of the capsule, and validating the assay (Figure 3.5).  
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 Figure 3.5 The polysialic acid capsule reduces phagocytosis of N. 
meningitidis 
Fixed FITC-labelled bacteria were incubated with HL60 cells, and the 
association of the wild-type strain was compared with the capsule-negative 
strain, MC58∆siaD. MFI was calculated by multiplying the mean fluorescence 
with the percentage positive cell population. The increased association of 
MC58∆siaD confirmed the anti-phagocytic nature of the capsule. Error bars 
represent the standard error of the mean.  
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3.6 Non-opsonic association of bacteria with HL60 cells is mediated in part by 
CD66a,c,d  
It has been shown previously that non-opsonic interactions between N. meningitidis and 
PMNs are mediated by the CD66 receptor (Virji et al., 1996). CD66 expression by HL60 cells 
was therefore examined by flow cytometry (Figure 3.6 A), and the association of fixed 
bacteria following incubation with an anti-CD66 mAb was analysed to determine whether this 
receptor mediates the interaction. Preliminary assays were performed to determine 
saturation of binding of the anti-CD66 mAb to the cell population (data not shown). 
Incubation of HL60 cells with a 1:50 dilution of the anti-CD66 mAb significantly reduced, but 
did not entirely abolish, the association of N. meningitidis with HL60 cells, indicating that this 
interaction is mediated in part by the CD66 receptor (Figure 3.6 B).  
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Figure 3.6 Association of N. meningitidis to HL60 cells is mediated 
in part by CD66 
 (A) Expression of CD66a,c,d receptors by HL60 cells was analysed by 
incubating cells with a mAb against the receptor followed by a FITC-conjugated 
secondary antibody. Binding was quantified by flow cytometry and the MFI was 
calculated by multiplying the mean fluorescence with the percentage positive 
cell population. Cells incubated with an isotype matched control are shown in 
magenta, while cells with the anti-CD66 mAb are in green. (B) Live bacteria 
were incubated with HL60 cells following pre-incubation with the mAb against 
CD66a,c,d. The decrease in association indicates that association with HL60 
cells is mediated in part by CD66. Error bars represent the standard error of the 
mean.  
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3.7  The inability to utilise lactate, but not glutamate, affects association to HL60 
cells  
Next, the effect of the ∆lctP mutation on association with HL60 cells was investigated. HL60 
cells were incubated with fixed, FITC-labelled bacteria, and association analysed by flow 
cytometry. Results indicate that the MC58∆lctP strain associated with cells at a significantly 
higher level compared with the wild-type strain. This was observed on five different 
occasions with bacteria prepared at three separate times. Uptake of the mutant reverted to 
wild-type levels following complementation of the mutant with a single intact copy of lctP in 
trans (Exley et al., 2005), confirming that the loss of lctP was responsible for the enhanced 
uptake of the mutant (Figure 3.7 A). The influence of glutamate metabolism on association 
with HL60 cells was also investigated. As expected, there was no significant difference in 
association to the HL60 cells of any of mutants lacking glutamate import components, except 
for an apparent decrease in association of the H44/76∆ghdR mutant (Figure 3.7 B) 
 
The association of the MC58 and MC58∆lctP strains with HL60 was also determined by 
microscopy. The number of bacteria associated per 100 HL60 cells was scored. There was a 
significant increase in the number of MC58∆lctP bacteria associated with HL60 cells 
compared with the wild-type strain, demonstrating an increased density of infection with the 
mutant strain (data not shown).  
 
It has been shown previously that CD66 receptors interact with Opa expressed on the 
bacterial surface (Virji et al., 1996). Expression of Opa in the wild-type and MC58∆lctP strains 
was examined by Western blot analysis to determine whether the ∆lctP mutation affects Opa 
expression. The serogroup C Opa-negative 8013 strain was used as a negative control. 
Binding of the anti-Opa mAb B33 was not altered in the MC58∆lctP strain, showing that the 
difference in association was not due to changes in Opa expression (Figure 3.7 C). 
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Figure 3.7 The inability to utilise lactate, but not glutamate, 
results in increased association of bacteria to HL60 cells 
(A;B) Fixed FITC-labelled bacteria were incubated with HL60 cells and the 
MFI was calculated by multiplying the mean fluorescence with the percentage 
positive cell population. The MC58∆lctP strain showed higher association to 
cells than the wild-type (n = 5). Wild-type levels of association were restored 
by complementation of the ∆lctP mutation (A). Mutant strains lacking enzymes 
involved in glutamate metabolism showed no significant difference in the 
association when compared with the wild-type strain (B). Error bars represent 
the standard error of the mean. (C) Whole cell lysates of MC58, MC58∆lctP 
and 8013 (Opa-negative, serogroup C strain) were analysed for Opa 
expression. Samples were separated by SDS-PAGE then transferred to nylon 
membranes which were incubated with anti-Opa antibody B33 (1:10000). No 
differences in Opa expression were observed. 
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3.8  Increased association of MC58∆lctP is not only due to changes in capsule 
expression 
To determine whether the enhanced association of MC58∆lctP was due to a reduction in 
capsule production alone, phagocytosis assays were repeated to include the 
MC58∆siaD∆lctP, MC58∆siaC and MC58∆siaC∆lctP mutants. While MC58∆siaD lacks the 
polysialic capsule, MC58∆siaC is unable to synthesise sialic acid and therefore lacks both 
capsule and LPS sialylation in the absence of exogenous CMP-NANA. Flow cytometry and 
microscopic analyses of association of these strains showed that the MC58∆siaD∆lctP strain 
associated more than MC58∆siaD, but that MC58∆siaC and MC58∆siaC∆lctP associated to 
the same degree (Figure 3.8). This indicates that the difference in MC58∆lctP association 
with HL60 cells is due to changes downstream of SiaC, and is not due to changes in capsule 
production alone. 
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Figure 3.8 The increased association of MC58∆lctP  is not only due to changes 
in capsule expression 
Fixed FITC-labelled bacteria were incubated with HL60 cells and association analysed by 
flow cytometry. The MFI was calculated by multiplying the mean fluorescence with the 
percent positive cell population (n = 5). Analysis of mutants lacking capsule (MC58∆siaD; 
MC58∆siaD∆lctP) or unable to produce sialic acid (MC58∆siaC; MC58∆siaC∆lctP) indicate 
that the increase in association of strains lacking LctP is due to changes downstream of SiaC 
and is not due to changes in capsule alone. Error bars represent standard error of MFI. 
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3.9   Live MC58∆lctP associates to HL60 cells to the same extent as wild-type  
To determine whether the trends seen with fixed bacteria are also seen with live bacteria, 
phagocytosis assays were performed using live bacteria expressing GFP. The plasmid 
pEGFP (Christodoulides et al., 2000) was introduced into the strains by transformation and prior to 
use, expression of GFP was checked by flow cytometry (data not shown). Analysis of 
phagocytosis by flow cytometry showed that in contrast with the pattern seen for fixed 
bacteria, live MC58∆lctP associated with, and were internalised by, HL60 cells to the same 
extent as the wild-type strain (Figure 3.9 A).  To confirm this result, phagocytosis assays 
were also performed in the presence of the actin polymerisation inhibitor cytochalasin D, 
which successfully blocked phagocytosis and significantly reduced association (Figure 3.9 
B).  
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Figure 3.9 Live MC58∆lctP associates with HL60 cells to the same extent as 
the wild-type strain 
(A) Live GFP-expressing bacteria were incubated with HL60 cells and the association 
quantified by flow cytometry. MC58∆lctP shows the same level of association as the wild-
type strain. (B) Live bacteria were incubated with cells following pre-incubation with the 
actin inhibitor cytochalasin D. (C) To confirm this result, GFP-expressing live and fixed 
bacteria were incubated with HL60 cells and association analysed by flow cytometry. Error 
bars represent standard error of the mean. 
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3.10 Live N. meningitidis is internalised by HL60 cells 
To verify data obtained by flow cytometry, HL60 cells were incubated with live bacteria and 
analysed by fluorescence microscopy. Inside:outside staining was performed by labelling 
bacteria with the anti-LPS mAb before and after permeabilisation with 0.2% saponin. (Figure 
3.10 A). A total of 100 HL60 cells were scored by counting the total number of bacteria, both 
adherent and internalised, associated wtih each cell. This figure is the Association Index 
(AI). HL60 cells were also scored for the total number of internalised bacteria, to give the 
Phagocytic Index (PI). Microscopy confirmed that all strains were internalised by HL60 cells. 
The capsule-negative MC58∆siaD strain showed significantly higher levels of association 
and internalisation compared with the wild-type strain. However, MC58∆lctP associated with 
HL60 cells to the same extent as the wild-type, and with the same level of phagocytosis 
(Figure 3.10 B), thus confirming the results observed by flow cytometry. 
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Figure 3.10 Live N. meningitidis is internalised by HL60 cells 
(A) Live MC58, MC58∆lctP and MC58∆siaD strains were incubated with HL60 cells and 
stained for microscopic analysis. To differentiate between extra- and intracellular bacteria, 
samples were stained pre- and post-permeabilisation with 0.2% saponin. Extracellular bacteria 
are red, while intracellular bacteria are green. (B) Association Index (AI; total associated 
bacteria; black bars) and Phagocytic Index (PI; total intracellular bacteria; grey bars) were 
calculated for 100 cells. Error bars represent standard error of the mean. 
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3.11 Summary 
The work described in this chapter characterised non-opsonic interactions between 
serogroup B N. meningitidis and the human neutrophil cell line, HL60. It is known that the 
meningococcus interacts with neutrophils during disease, and that the non-opsonic 
interaction can occur via the CD66 receptor expressed by neutrophils (Virji et al., 1996). We 
have confirmed this interaction, and the role of CD66, which mediates association. Complete 
blocking of CD66 by incubation with the anti-CD66 mAb cannot be assumed but association 
was not fully eliminated following incubation with this mAb, indicating that another receptor 
may also be involved. Analysis by microscopy also demonstrated that the bacterium is 
internalised, confirming that phagocytosis as well as adherence of bacteria to the outer 
surface of the HL60 cells occurs. The role of lactate metabolism in expression of the 
polysialic acid capsule, in addition to its previously described effect on sialylation of the LPS, 
has also been demonstrated. The reduction in both these surface components are likely to 
be the cause of the increased association MC58∆lctP to HL60 cells compared to the wild-
type. In addition, mutants lacking components of a glutamate import system showed no 
change in either capsule expression or LPS sialylation. As expected, these strains also 
showed no difference in association with HL60 cells when compared to the wild-type strain 
H44/76.  
 
Interestingly, the difference in association with HL60 cells seen with fixed MC58∆lctP is not 
observed with live bacteria. In addition, levels of association, as calculated by flow cytometry 
and microscopy, were significantly lower for all strains when infections were performed with 
live bacteria. A similar pattern was observed in previous work with dendritic cells (Jones et al., 
2007) and this was attributed to a bacterial activity that resulted in an alteration in DC 
function.  
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The next chapter will investigate the processes behind the disparity in results with live and 
killed bacteria and the possible reasons for the lower level of association of all strains during 
infection with live bacteria.  
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The previous chapter demonstrated that serogroup B N. meningitidis associates with 
differentiated HL60 cells. MC58∆lctP associated more than the wild-type strain when 
phagocytosis assays were performed with fixed bacteria. However, when the assays were 
repeated with live bacteria, this difference in association was not detected. In addition, the 
degree of association of all strains with the HL60 cells was greatly reduced with live bacteria 
compared to fixed strains.  
Previous work on the phagocytosis of N. meningitidis by DCs has also described enhanced 
phagocytosis of fixed meningococci compared to live bacteria (Jones et al., 2007). This effect is 
independent of bacterial replication. It could be mediated either by the response of the 
bacteria to cells or by the production of a bacterial component that inhibits phagocytosis. 
Activated PMN release a variety of cytokines and antimicrobial compounds as a response to 
infection, and the meningococcus may be able to detect and respond to them. Both the 
polysialic acid capsule and sialylation of the LPS are anti-phagocytic (Estabrook et al., 1998; 
Read et al., 1996). Levels of capsule expression are regulated during interactions with host 
cells, displaying a largely unencapsulated phenotype during colonisation, but switching to a 
capsulated state during bloodstream infection (Vogel et al., 1997; Read et al., 1996; Hammerschmidt 
et al., 1994; Stephens et al., 1993; Virji et al., 1993).  
 
Work in this chapter was aimed at determining the cause for the reduced level of association 
of live meningococci to HL60 cells through analysis of both the polysaccharide capsule and 
the LPS following exposure of bacteria to HL60 cells. 
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4.1 The presence of live bacteria does not affect association of fixed bacteria to 
HL60 cells 
To determine whether the reduced association of live meningococci to HL60 cells was due to 
a cellular response to the live bacteria, mixed infections were performed. HL60 cells were 
infected with a 1:1 mixture of live and FITC-labelled fixed MC58, and incubated for thirty 
minutes. The contents of the wells were then fixed in PFA and association was analysed by 
flow cytometry. No significant reduction in association of fixed bacteria was seen in the 
presence of live meningococci (Figure 4.1). This indicates that the reduced association of 
live meningococci with HL60 cells is the result of a bacterial response to infection rather than 
an effect on the HL60 cells elicited by the presence of live bacteria. 
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 Figure 4.1 The presence of live bacteria does not affect association of 
fixed bacteria with HL60 cells 
L60 cells were inoculated with a 1:1 mixture of live and FITC-labelled dead MC58 at 
 MOI of 100 and incubated for thirty minutes. The contents of the wells were then 
ed in PFA and association analysed by flow cytometry. The MFI was calculated as the
 positive HL60 population multiplied by the geometric mean fluorescence. The 
esence of live bacteria did not affect the association of fixed MC58 with HL60 cells. 
rror bars represent standard error of the mean. 111 
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4.2 Capsule expression increases in the wild-type and MC58∆lctP strains in the 
presence of HL60 and epithelial cells and cell supernatants 
The meningococcal polysialic acid capsule is anti-phagocytic and its expression is known to 
be regulated according to the host environment encountered by the bacterium (Deghmane et 
al., 2002; Read et al., 1996). Therefore, capsule expression was analysed in bacteria incubated in 
the presence of HL60 cells. Infection of HL60 cells with live MC58 and ∆lctP strains was 
carried out at an MOI of 100 followed by a thirty minute incubation. MC58∆siaD was 
included as a control. Binding of a mAb against the serogroup B capsule to bacteria was 
analysed by flow cytometry. Both the MC58 and MC58∆lctP strains showed significant 
increase in capsule expression following incubation with HL60 cells when compared to 
bacteria incubated in media alone (Figure 4.2 A). In bacteria recovered from media alone, 
(which does not contain lactate), capsule expression in MC58∆lctP was the same as the 
wild-type.  
To determine whether the increase in capsule in the presence of HL60 cells was contact 
dependent, bacteria were incubated with supernatants from infected HL60 cells in the 
presence and absence of cells. HL60 cells were challenged with MC58 at an MOI of 100, 
and incubated as previously described. Following incubation, the contents of wells were 
spun to 6000 xg to pellet the cells, and then filtered with 2 µm filters to remove bacteria. 
Absence of bacteria in the filtrate was confirmed by plating to solid media (data not shown). 
Live MC58, MC58∆lctP and MC58∆siaD strains were then incubated in the recovered 
supernatant and incubated for thirty minutes at 37°C. Capsule expression was then 
analysed by flow cytometry. Both MC58 and MC58∆lctP strains both showed a significant 
increase in capsule expression following incubation with HL60 cell supernatants when 
compared to bacteria incubated in naive media (Figure 4.2 B). This increase in capsule 
production was also observed when bacteria were incubated with supernatants prepared 
from uninfected HL60 cells (data not shown). These results indicate that N. meningitidis 
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responds to a compound(s) secreted by the HL60 cells, regardless of whether they have 
been infected.  
Since an increase in capsule expression was observed in both the wild-type and mutant 
strains, subsequent work to investigate this change in capsule production was performed 
with the wild-type strain. 
To investigate the effect of epithelial cells and their supernatants on capsule expression, 
Calu-3 human airway epithelial cells were grown to confluency in 24-well plates (provided by 
Dr Rachel Exley) and infected with MC58 at an MOI of 100. Infected Calu-3 cell 
supernatants were also prepared as described and these were examined for their effect on 
capsule expression by MC58. Binding of a mAb against the serogroup B capsule was 
analysed by flow cytometry. Capsule expression was significantly increased in bacteria 
incubated in the presence of Calu-3 cells and in cell supernatants compared with bacteria 
incubated in media alone (Figure 4.2 C). This result indicates that the increase in capsule 
expression in the presence of HL60 cells is not exclusive to this cell line. 
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 Figure 4.2 Capsule expression increases following exposure to HL60 and 
Calu-3 cells and supernatants 
(A) Bacteria were fixed following incubation with HL60 cells and analysed for capsule 
expression by FACS analysis with a mAb against serogroup B capsule. The mean 
fluorescence index (MFI) was calculated by multiplying the total positive population with 
the geometric mean fluorescence. Both wild-type and MC58∆lctP showed a significant 
increase in capsule expression following exposure to HL60 cells (P < 0.05). (B) HL60 
cells were inoculated with wild-type MC58. Following incubation, cells were removed by 
centrifugation and the supernatant filtered to remove remaining bacteria. Strains were 
then incubated with the filtered supernatant, and fixed, then analysed for capsule 
expression by FACS. Both MC58 and the MC58∆lctP strain show an increase in 
capsule expression following incubation with cell supernatants (P < 0.015; P < 0.001). 
(C) Calu-3 cells and cell supernatants were infected with MC58 followed by fixation of 
bacteria and analysis of capsule expression by FACS using a mAb against serogroup B 
capsule. Capsule expression increases in the presence of both Calu-3 cells and their 
supernatant (P < 0.01; P < 0.001). Error bars represent standard error of the mean 
fluorescence index. 
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4.3 Capsule expression is not influenced by carbon source alone 
The meningococcus is able to acquire a limited repertoire of carbon energy sources, 
predominantly glucose, lactate and pyruvate, from the immediate environment (Exley et al., 
2005b; Smith et al., 2001). Work in the previous chapter demonstrated that lactate availability 
affects capsule expression as well as LPS sialylation (Exley et al., 2005a). The medium used to 
carry out infection of HL60 cells contained 1 mg/ml glucose but no lactate or pyruvate. 
Acquisition of these two compounds is closely linked to sialic acid biosynthesis and central 
intermediary metabolism. Therefore, to determine the carbon sources available to the 
meningococcus during incubation with HL60 cells, cell supernatants were analysed by NMR. 
HL60 cells were infected with MC58 and the were supernatants harvested after five, ten, 30, 
60 and 120 minutes. The supernatants were analysed by NMR by Dr Jake Bundy at the 
Department of Biomolecular Medicine at Imperial College London. The NMR spectrum 
shows that glucose is the most abundant molecule present in the supernatant. Glucose is 
present in the HBSS medium and therefore was used as the standard. The spectrum also 
indicates the presence of lactate and pyruvate, in addition to acetate and a number of amino 
acids, including alanine (Figure 4.3 A & B). Concentrations of both lactate and pyruvate 
increased over time in media containing HL60 cells, indicating production of these 
metabolites by HL60 cells (Figure 4.3 C).  
 
To investigate whether lactate and pyruvate alone could elicit an increase in capsule 
expression, MC58 was incubated in media containing glucose with or without lactate (1 mM) 
and pyruvate (100 µM), reflecting the concentrations of these compounds in blood. Analysis 
of capsule expression was then performed by flow cytometry using a mAb against the 
serogroup B capsule. No change in capsule was seen in any of the conditions, indicating 
that the carbon source cannot be the sole reason for the increase in capsule expression 
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following incubation with cell supernatants (Figure 4.3 D). Capsule expression was also 
tested in media containing a range of lactate and pyruvate concentrations, and no effect was 
seen (data not shown). It is interesting that no effect on capsule was observed in the 
presence of lactate since the MC58∆lctP strain shows reduced capsule expression. It is 
likely that this is due to harvesting bacteria directly from rich solid media prior to the assay so 
capsule expression would be constitutively high. This assay was designed to detect any 
change in capsule beyond the level of expression expected after growth on rich media. 
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Figure 4.3 Capsule expression is not influenced by carbon source 
Bacteria were incubated with HL60 cells, and the supernatants filter-sterilised then 
analysed by NMR. (A) NMR spectrum of supernatant. (B) Spectral region outlined in red in 
(A) is magnified and known molecules of significant concentration are labelled. (C) NMR 
spectra of lactate and pyruvate in infected HL60 supernatants over time. Both compounds 
increase in concentration over time. (D) Bacteria were incubated in HBSS with additional 
pyruvate (200 µM) and/or lactate (20 mM). Fixed bacteria were then analysed for capsule 
expression by FACS with a mAb against serogroup B capsule. Mean fluorescence index 
(MFI) was calculated by multiplying the total positive population with the geometric mean 
fluorescence. No significant change in capsule was seen in the presence of any 
combination of carbon source. Error bars represent standard error of the mean 
fluorescence index. 
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4.4 A proteinaceous compound in HL60 supernatants elicits an increase in capsule 
expression 
To determine whether a proteinaceous component of the supernatant was responsible for 
the observed increase in bacterial capsule expression, supernatants were treated with the 
serine protease trypsin (0.1%) for 30 minutes followed by a specific trypsin inhibitor (From 
bovine pancreas; Sigma; 0.1%) for 20 minutes. Untreated supernatants and inhibitor-only 
controls were also included. Bacterial capsule expression was analysed by flow cytometry 
using a mAb against the serogroup B capsule. Supernatants treated with trypsin elicited a 
greatly reduced effect on capsule expression compared to untreated supernatants or those 
with only the added protease inhibitor, indicating that the increase in capsule observed in the 
presence of cellular supernatant is dependent on a proteinaceous component  (Figure 4.4). 
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Figure 4.4 Protein analysis of assay supernatant 
Infected, filtered HL60 cell supernatant was treated with trypsin, which was then 
inactivated with a specific inhibitor. Treated and untreated supernatants were then 
infected with MC58 strain. Capsule expression was analysed by flow cytometry using 
a mAb against the serogroup B capsule. Mean fluorescence index (MFI) was 
calculated by multiplying the total positive population with the geometric mean 
fluorescence. Trypsin treatment of the supernatants reduced their ability to cause an 
increase in capsule expression (P < 0.01). Error bars represent standard error of the 
mean fluorescence index. 
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4.5 CAMPs LL-37 and HNP-1 elicit an increase in capsule expression in the 
meningococcus 
During infection CAMPs are released into the surrounding medium by PMNs. Both LL-37 
and Human neutrophil peptide-1 (HNP-1) are common PMN CAMPs, which are susceptible 
to degradation by serine proteases and therefore could be potential candidates for the 
proteinaceous effector of increased capsule expression present in the HL60 supernatant. 
Recent work revealed that unencapsulated meningococci are more susceptible to killing by 
CAMPs compared to capsulated bacteria, and that genes involved in the capsule 
biosynthesis pathway are upregulated in intracellular meningococci, and in bacteria exposed 
to CAMPs in growth media (Spinosa et al., 2007). Therefore, MC58 was incubated in medium 
containing LL-37 (10 µg/ml; 100 µg/ml) or HNP-1 (1 µg/ml; 5 µg/ml) for 30 minutes then fixed 
in PFA. Capsule expression was assessed by flow cytometry using a mAb against the 
serogroup B capsule. Bacterial survival was also analysed by plating aliquots to solid media. 
Incubation with both LL-37 and HNP-1 resulted in an increase in capsule expression in a 
concentration-dependent manner (Figure 4.5 A & C). Killing of bacteria also occurred in the 
presence of both CAMPs, and was dependent on concentration. Both concentrations of LL-
37 were cytotoxic, while HNP-1 was only lethal at a concentration of 5 µg/ml (Figure 4.5 B & 
D). To confirm that the increase in capsule was the result of the CAMPs and not due to 
changes in antibody binding as the result of bacterial death, capsule expression was 
analysed in bacteria killed by heat-treatment prior to fixation. Capsule expression following 
heat-killing was not affected in comparison bacteria fixed in PFA alone (data not shown). 
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 Figure 4.5 CAMPs LL-37 and HNP-1 induce an increase in capsule 
expression 
 B) MC58 was incubated in the presence and absence of CAMPs LL-37 (10 µg/ml
d 100 µg/ml) or HNP-1 (1 µg/ml and 5 µg/ml) for thirty minutes, and capsule
ression analysed by flow cytometry using a mAb against the serogroup B capsule.
an fluorescence index (MFI) was calculated by multiplying the total positive
pulation with the geometric mean fluorescence. Bacterial survival was also
lysed by plating to BHI agar. Incubation with both LL-37 and HNP-1 result in an
rease in capsule expression and in bacterial killing, both in a dose-dependent
nner. Error bars represent standard error of the mean survival or fluorescence
ex. 
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4.6 The protein effector present in the HL60 supernatants has a molecular mass of 
50 -100 kDa 
Since addition of both LL-37 and HNP-1 effected an increase in capsule expression in the 
meningococcus, the HL60 supernatants were fractionated to determine the molecular mass 
of the active fraction. Supernatants were prepared as previously, and subjected to 
fractionation by centrifugation with filters that allow passage of proteins with the molecular 
mass of 100 kDa, 50 kDa and 10 kDa. Samples were examined by SDS-PAGE and 
Coomassie blue staining to confirm fractionation (data not shown). Live MC58 was added to 
each filtrate for thirty minutes and then examined for capsule expression. Analysis of capsule 
expression by flow cytometry showed that only the 100 kDa filter fraction retained activity, 
indicating a protein smaller than 100 kDa and larger than 50 kDa was responsible for the 
increase in capsule expression (Figure 4.6 A). Since CAMPs are less than 10 kDa in size, 
this data excludes them from being an effector candidate unless they were present in the 
form of a complex with another, larger protein.  
The protein constituents of HL60 cellular supernatants were analysed. TCA-precipitated 
proteins from HL60 and Calu-3 cell supernatants, whole-cell lysates of MC58 incubated in 
HL60 supernatant, and naive medium were separated by SDS-PAGE and stained with 
Coomassie blue (Figure 4.6 B). Protein bands of a range of sizes are present in all lanes. An 
abundant 70 kDa protein seen in the whole cell lysate of bacteria incubated in supernatant 
and in the precipitated proteins of supernatant. This was identified as BSA carried over from 
the cell culture medium by mass spectrometry. The was performed by Professor Jun 
Wheeler at the National Institute of Biological Standards and Control (NIBSC). To confirm 
that the increase in capsule expression was not caused by BSA, MC58 was incubated in 
media containing 0.1% BSA for thirty minutes, followed by fixation. Analysis of capsule 
expression by flow cytometry showed that bacteria incubated with BSA do not show any 
change in capsule expression compared with bacteria in media alone (data not shown). 
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Figure 4.6 Fractionation and protein content of HL60 cell supernatant  
(A) Infected HL60 cell supernatants were filter-sterilised and then subjected to size 
fractionation by centrifugation  with filters allowing passage of molecules of less than 
100, 50 and 30 kDa. MC58 was then incubated with the fractions for thirty minutes 
and analysed for capsule expression by flow cytometry using a mAb against the 
serogroup B capsule. Mean fluorescence index (MFI) was calculated by multiplying 
the total positive population with the geometric mean fluorescence. Only the 100kDa 
fraction retained activity, indicating that a protein of between 100 and 50 kDa elicits 
the increase in capsule seen with the whole supernatant. Error bars represent the 
standard error of the mean fluorescence index. (B) SDS-PAGE analysis of proteins 
present in TCA-precipitated supernatants of infected HL60 and Calu-3 cells (pS), 
MC58 incubated in the presence of HL60 supernatants (MC58 – S) or in media alone 
(MC58 – H). 
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4.7 Incubation with HL60 cells results in a change in meningococcal LPS 
Apart from the polysialic acid capsule, sialylated LPS is also an anti-phagocytic surface 
component of N. meningitidis (Estabrook et al., 1998). Thus, changes in LPS sialylation could 
contribute to the reduced association of live MC58 to HL60 cells. LPS sialylation was 
therefore analysed in bacteria in the presence and absence of cells. HL60 cells were 
infected with MC58 and MC58∆lctP strains at an MOI of 100, and incubated for thirty 
minutes. The unsialylated MC58∆lst mutant was included as a control. LPS sialylation was 
analysed by flow cytometry using a mAb (3F11) which recognises unsialylated LPS. The 
MC58∆lctP strain showed a decrease in 3F11 binding following incubation with HL60 cells, 
indicating an apparent increase in sialylation (Figure 4.7 A). However, the MC58∆lst strain 
also showed reduced binding. Since this strain is unable to sialylate LPS, this suggests that 
a mechanism other than sialylation may be affecting the binding of the 3F11 mAb. 
 
To determine whether there were any other changes in the LPS, Western blot analysis was 
performed on bacterial strains MC58, MC58∆lctP and MC58∆lst incubated in the presence 
and absence of HL60 cells. Binding of a mAb against immunotype L3,7,9 LPS showed a 
change in the binding pattern, with detection of a higher molecular weight LPS in the 
presence of cells (Figure 4.7 B).  
 
LPS was also analysed by silver staining of Proteinase K-treated lysates of bacteria 
separated by SDS-PAGE on a 15% urea gel, followed by staining. A subtle shift to a higher 
molecular weight LPS was consistently visible for each strain after incubation with cells 
(Figure 4.7 B). 
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Figure 4.7 Incubation with HL60 cells results in a change in bacterial LPS  
(A) Bacterial LPS was analysed in bacteria following incubation in the presence and 
absence of HL60 cells. Reduced binding of mAb 3F11 (which recognises unsialylated 
LPS) was analysed by flow cytometry, indicates an increase in sialylation in MC58∆lctP 
and the unsialylated strain ∆lst. Extent of sialylation was quantified according to the 
percentage of the bacterial population that was positive for antibody binding. Error bars 
represent the standard error of the mean % positive population. (B) LPS was examined 
by Western blot analysis with an immunotype specific mAb against neisserial LPS. 
Incubation with cells resulted in an alteration in the pattern of LPS in all strains. 
Sialylation was also analysed by silver staining. The shift towards a higher molecular 
weight LPS was seen in all strains.  
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4.8 The change in meningococcal LPS on incubation with HL60 cells is caused by 
interaction with a protein  
To determine whether the change in LPS was the result of alterations in LPS sialylation, the 
binding of the anti-L3,7,9 mAb was analysed by Western blotting following incubation of 
bacteria with neuraminidase. Neuraminidase is a glycoside hydrolase which specifically 
cleaves sialic acid residues from substrates such as glycolipids and glycoproteins. MC58, 
MC58∆lctP and MC58∆lst strains were incubated in the presence or absence of  50 U 
neuraminidase at 37°C for one hour. Initially the binding of mAb 3F11 was analysed to verify 
the activity of the neuraminidase. mAb 3F11 binding was entirely absent in samples of MC58 
and MC58∆lctP not treated with neuraminidase. However, following treatment with this 
enzyme, mAb 3F11 bound at equal levels with all strains including MC58∆lst, thus 
confirming that incubation with neuraminidase removes all sialic acid from the LPS (Figure 
4.8 A). Furthermore, there was no change in binding of the mAb against L3,7,9 LPS in the 
presence or absence of neuraminidase, indicating that the shift in binding seen in the 
presence of HL60 cells is not due to LPS sialylation (Figure 4.8 A). Since the shift in LPS 
was observed in both the wild-type and mutant strains, all further work to investigate the 
nature of this change was performed with the wild-type strain. 
 
To investigate whether the shift in LPS was mediated by a proteinaceous compound, whole-
cell lysates of MC58 strain incubated in the presence and absence of HL60 cells were 
treated with the serine protease proteinase K. Binding of the mAb against L3,7,9 LPS was 
analysed by Western blot. The shift in binding that occurs in the presence of HL60 cells was 
lost in bacterial lysates treated with proteinase K, indicating that the shift was caused by 
interaction with a protein (Figure 4.8 B). Control bacterial lysates prepared in the absence of 
HL60 cells showed no change in binding following incubation with proteinase K.  
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Figure 4.8 The change in LPS is due to a protein interaction  
(A) Bacteria were incubated with neuraminidase to remove sialic acid from the LPS. 
Bacterial lysates were then analysed by Western analysis incubating with mAbs against 
against unsialylated LPS (3F11) and against L3,7,9 immunotype LPS. Following 
treatment of MC58 and MC58∆lctP with neuraminidase, binding of mAb 3F11 to 
samples of LPS was indistinguishable from MC58∆lst, confirming the activity of 
neuraminidase. There was no change in binding of the anti-LPS mAb, indicating that the 
change in LPS on incubation with HL60 cells is not due to sialylation. (B) Bacterial 
lysates were prepared from bacteria incubated in the presence and absence of HL60 
cells. The lysates were then incubated in the presence or absence of proteinase K and 
the LPS analysed by Western blot with an antibody against the Neisserial LPS. The shift 
in binding seen in the presence of HL60 cells is partially removed by incubation with 
proteinase K, indicating an interaction with a protein. 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4 Changes in bacterial surface components during interactions with PMNs  
 
127 
4.9 Incubation with CAMP LL-37 also causes a change in meningococcal LPS 
CAMPs are released by PMN during infection, and are also known to bind bacterial LPS 
(Golec, 2007; Rosenfeld et al., 2006). Therefore, the effect of two CAMPs, and lysozyme, a 
common PMN secretin, on meningococcal LPS was analysed. MC58 was incubated with LL-
37 (100 µg/ml), HNP-1 (5 µg/ml) and lysozyme (100 µg/ml) and bacteria lysates analysed by 
Western blot. Binding of the mAb against L3,7,9 immunotype LPS was unaffected in the 
presence of HNP-1 and lysozyme, but showed a significant shift in binding following 
incubation with LL-37 (Figure 4.9 A). 
 
The effect of LL-37 on meningococcal LPS was analysed further. To determine whether the 
effect was the result of an active bacterial function, both live and fixed bacteria were 
incubated with LL-37 (100 µg/ml). Analysis by Western blot showed that incubation with LL-
37 results in a shift in binding, regardless of whether the meningococcus is live or dead, 
indicating that this shift cannot be responsible for the difference in association of live and 
dead bacteria to HL60 cells (Figure 4.8 B). To confirm that the CAMP LL-37 was binding the 
LPS, bacteria lysates were treated with proteinase-K before analysis by western blot. The 
shift in binding of the mAb against L3,7,9 LPS was partially reduced following proteinase-K 
treatment of bacteria incubated with LL-37, indicating that the LL-37 binds to LPS directly 
(Figure 4.9 C). 
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  Figure 4.9 CAMP LL-37 causes a change in LPS  
LPS in bacterial lysates was analysed by Western blotting with the L-3,7,9 mAb. (A) 
Bacteria were incubated with CAMPs LL-37 (100 µg/ml) and HNP-1 (5 mg/ml) and 
lysozyme (100 µg/ml). Incubation with LL-37, but not HNP-1 or lysozyme, elicits a 
change in binding of the α-LPS antibody. (B) Live or PFA-fixed bacteria were incubated 
in the presence and absence of LL-37. (C) Bacteria were incubated in the presence and 
absence of LL-37. Lysates were then incubated in the presence or absence of 
proteinase K. The change in LPS occurs when the incubation is performed with both live 
and dead bacteria. The change is partially removed following proteinase K treatment, 
indicating an interaction with a protein. 
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4.10 Summary 
The work presented in this chapter demonstrates that changes occur in capsule expression 
and LPS structure following exposure of the meningococcus to HL60 cells. Incubation with 
cells and cellular supernatants leads to an increase in capsule expression. It is possible that 
this trend is the mechanism behind the reduced association of live bacteria with HL60 cells 
compared with dead bacteria. It might also be the reason for the loss of the difference in 
association between the wild-type and MC58∆lctP strains when performed with live bacteria 
since the strain lacking LctP also showed a significant increase in capsule expression to 
wild-type levels. However, there is no direct evidence for this. Interestingly, the change in 
capsule expression was also observed in bacteria incubated with epithelial cell line, Calu-3, 
and with supernatants prepared with these cells. Previous studies have shown a down-
regulation of capsule expression on contact with epithelial cells (Deghmane et al., 2002), and this 
also suggests that the increase in capsule is due to a component in the supernatant rather 
than the result of direct contact with the cells themselves. Analysis of the supernatant 
indicated that the increase in capsule expression was due to a protein component of 
between 50–100 kDa. This excludes all known CAMPs released by PMNs, including LL-37, 
which also elicits an increase in capsule, because they are significantly smaller molecules. 
However, it is possible that the supernatant protein represents a complex that includes a 
CAMP such as LL-37. Alternative candidate proteins may include the LPS binding proteins 
LBP and BPI (Tobias et al., 1997). 
 
Analysis of LPS following incubation with HL60 cells shows a change in LPS structure 
resulting in binding of an anti-L3,7,9 immunotype antibody to a higher molecular weight LPS. 
This does not occur in the presence of cell supernatants alone, indicating either a contact-
dependent mechanism, or that the effect relies on the microenvironment that occurs in close 
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proximity to the HL60 cells. Proteinase treatment indicated that the change in LPS is the 
result of binding with a protein, and that the CAMP LL-37 also elicits the same change in 
LPS structure. However, no direct link between the two could be established as attempts to 
detect LL-37 by Western blot analysis were unsuccessful (data not shown). The nature of 
the change in LPS structure has not yet been elucidated and would require detailed analysis 
by mass spectrometry. Attempts to prepare samples for this analysis were also unsuccessful 
due to technical difficulties and were abandoned due to time constraints. 
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The Base Excision Repair (BER) pathway is responsible for the repair of DNA lesions 
induced by oxidative damage. Bacterial pathogens are likely to encounter damage of this 
nature during disease development, particularly during interactions with phagocytic cells 
which generate an oxidative burst in response to phagocytosis of microbes (Babior et al., 1976). 
Despite this, the importance of BER in bacterial virulence is not well understood. Previous 
studies have identified homologues of known BER enzymes in bacterial species such as 
Brucella abortus and Salmonella typhimurium (Hornback and Roop, 2006; Suvarnapunya and Stein, 
2005).  A B. abortus mutant strain lacking an Exonuclease III homologue is sensitive to 
oxidative stress, whilst S. typhimurium strains lacking a range of BER enzyme homologues, 
including a putative AP endonuclease, are significantly attenuated for intracellular survival in 
macrophages and the murine model of typhoid (Hornback and Roop, 2006; Suvarnapunya and Stein, 
2005). The crystal structure of some BER components has been determined, including the 
human and E. coli AP endonucleases, HAP1 and ExoIII respectively (Mol et al., 2000; Gorman, 
1997; Mol et al., 1995). Work has also characterised the biochemical activity of some bacterial 
BER enzymes, predominantly from E. coli, such as ExoIII, MutY and Fpg (Francis and David, 
2003; Mol et al., 1995). However, there have been no studies on the impact of biochemically 
characterised BER enzymes on virulence. 
 
The trEMBL database was examined for homologues of the E. coli AP endonuclease, ExoIII, 
in the genome of N. meningitidis gene strain MC58. This revealed NMB0399, whose 
predicted product shared 37% amino acid identity with ExoIII (Carpenter et al., 2007). 
Recombinant NMB0399 has similar activities to other known AP endonucleases, exhibiting 
3’-5’ exonuclease and 3’phosphodiesterase (3dRp) activity, the process of removing 
phospoglycolates from the 3’ terminus of the DNA strand (Carpenter et al., 2007). However, the 
protein did not exhibit AP endonuclease activity and was therefore named NExo. Resolution 
of the crystal structure of NExo showed that a histidine at position 167 within the DNA 
binding site could prevent binding of the abasic site, and thus inhibit AP endonuclease 
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activity (Figure 5.1). Substitution of His167 with serine or glycine conferred AP endonuclease 
activity on NExo. This work was performed by Julien Bergeron and Elisabeth Carpenter at 
the Centre of Structural Biology at Imperial College London. Biochemical analysis was 
carried out by Hellen Thompson in the Biochemistry Department of the Faculty of Life 
Sciences. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 His167 is a structural determinant for the lack of AP endonuclease 
activity in NExo 
The abasic ribose binding site of HAP1 with a 15mer DNA complex is shown with the 
electrostatic potential surface of the HAP1 protein (blue and red representing positive and 
negative charge respectively) and the superimposed NExo protein (yellow), showing the 
presence of His167 of NExo in the proposed abasic ribose binding site. Atoms in the DNA 
structure are coloured cyan for carbons, red for oxygen, blue for nitrogen and orange for 
phosphate. Residues Arg177 and Met270 were removed from the HAP1 structure to reveal 
the binding site beneath. This work was performed by Elisabeth Carpenter, and this image 
is reproduced with her kind permission. 
 
This chapter describes the subsequent search for an active Neisserial AP endonuclease, 
and the investigation into its role in the pathogenesis of meningococcal infections. 
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5.1 Identification and purification of NMB2082, a Neisserial AP endonuclease 
paralogue 
The N. meningitidis serogroup B MC58 genome was interrogated on the trEMBL database 
(Boeckmann et al., 2003) using the program BLAST (Altschul et al., 1997), at the European 
Bioinformatics Institute (www.ebi.ac.uk), for further AP endonuclease paralogues using the 
sequence of the human AP endonuclease HAP1. This search  identified NMB2082, which 
shares 34% amino acid identity with HAP1, 27% identity with ExoIII and 25% identity with 
NExo (Figure 5.2 A & B). NMB2082 was amplified and ligated into the expression vector 
pROEXHtb. The recombinant protein was expressed in E. coli strain ER2566, followed by 
lysis of the cells by pulse sonication. The His-tagged proteins were then separated using a 
metal affinity column, followed by elutions with imidazole. The His tag was cleaved from the 
recombinant protein which was further purified by dialysis and size exclusion 
chromatography. The resulting fractions were separated by SDS-PAGE to verify purity 
(Figure 5.2 C). 
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endonuclease homologue 
 Orientation of NMB2082, a putative AP endonuclease in the MC58 genome. Size bar
icates 1 kb. (B) Structure-based multiple sequence alignment of the complete
uences of NExo (NMB0399), ExoIII (E. coli endonuclease), HAP1 (human
onuclease) and NApe (NMB2082).  Positions in the alignment are colour coded in
ker blue according to the number of identical residues at that position. Residues
olved in metal binding, catalysis and abasic ribose binding are coloured pink, green
 yellow respectively. The amino acid sequence numbers of NExo are indicated under
 sequence. The predicted secondary structure is indicated in red for α-helices and
en for β-strands. (C) Protein fractions from the final purification step of NMB2082 were
lysed by SDS-PAGE to verify protein size and purity. The predicted size of NMB2082
0 kDa.  
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5.2 Structural and biochemical analysis of NMB2082  
Crystallisation of NMB2082 was achieved by hanging-drop experiments with 20 mg / ml 
protein in a well solution made up from 20% PEG 20000, 0.1M bicine pH 9.0, 2% dioxane. 
The crystal structure of NMB2082 was solved at a 1.5 Å resolution under the conditions 
outlined in Figure 5.2 A and showed a high degree of structural similarity with NExo, HAP1 
and ExoIII, including the conservation of key catalytic residues (Figure 5.3 B). Notably, 
NMB2082 possessed glycine (Gly170) at the equivalent position to NExo His167, suggesting 
that NMB2082 could be a functional AP endonuclease (Figure 5.3 B). Determination of the 
crystal structure was performed by Dr Elisabeth Carpenter.  
 
To analyse the AP endonuclease activity of NMB2082, the purified protein was incubated 
with an abasic DNA substrate. The substrate was produced from a double-stranded DNA 
template, 25U, which was made by mixing equimolar amounts of complementary 25 bp 
strands, one of which contained a uracil residue at position 11, and a 5’-
hexachlorofluorescein label (HEX) for visualisation. The resulting double-stranded DNA 
substrate was incubated with Herpes simplex virus type-1 uracil DNA glycosylase (UDG, a 
gift from Dr Geoff Baldwin) to excise the uracil residue, producing the abasic DNA substrate 
25AP, containing an AP lesion at the 11 bp position. The NMB2082 protein was incubated 
with both the 25AP and 25U substrates. Concurrent control reactions were peformed in the 
absence of the NMB2082 protein, and with the E. coli AP endonuclease ExoIII as a positive 
control. Aliquots were then separated by denaturing polyacrylamide gel electrophoresis. AP 
endonuclease activity was detected by the appearance of a 10 bp product resulting from 
cleavage of the AP site at position 11 on the DNA strand (data not shown). Like other active 
AP endonucleases, NMB2082 displayed 3’-5’exonuclease activity when incubated with the 
25U substrate (Figure 5.3 C). NMB2082 also showed 3’dRp diesterase activity (data not 
shown; work performed by Hellen Thompson). The NMB2082 protein also displayed 
significant specific AP endonuclease activity (Figure 5.3 C). Kinetic constants were 
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generated by fitting the data from the gel-based assay to the Michaelis-Menten steady-state 
equation to give a turnover rate, kAP of 0.651 ± 0.085 s-1 and KM of 15.71 ± 17.17 nM (Figure 
5.2D). The rate of AP endonuclease activity exhibited by ExoIII did not vary and thus the 
data from assays with this enzyme could not be fitted to the same equation for comparison. 
However, the ExoIII kAP was approximated as 0.083 ± 0.013 s-1 from the average rate, 
indicating that NApe has a faster turnover of AP sites than E. coli equivalent ExoIII.  N. 
meningitidis NMB2082 was therefore designated NApe (Neisserial Apurinic / apyrimidinc 
endonuclease).  
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Parameter  
Beamline ESRF, id14.2 
Space Group P21
Unit cell parameters   
a, b, c (Å) 
38.16, 79.5, 
41.0 
β (°) 107.2 
Resolution (Å) 30.0 – 1.50 (1.55-1.50) 
Completeness (%)* 94.6 (86.3) 
Redundancy* 3.5 
<I>/<σI>* 18.3 (4.5) 
Unique reflections 35560 
Rsym (%)*† 5.6 (26.9) 
Refinement 
resolution range (Å) 20.0 - 1.5 
No reflections 
working/test 33629/1774 
Rcryst§ / Rfree¶  (%) 16.6 / 13.7 
Rmsd  bonds (Å) 0.011 
Rmsd on angles (°) 1.384 
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Figure 5.3 NMB2082 is the Neisserial AP endonuclease (NApe) 
(A) Crystallographic statistics for NMB2082. (B) The crystal structure of NMB2082 (green) 
was resolved and compared with HAP1 (red), ExoIII (magenta) and NExo (yellow). (C) 
Substrates 25AP (100 nM) and 25U (100 nM) were incubated with NApe (NMB2082; 
concentrations indicated) for the time periods shown and separated by denaturing PAGE. 
Control lanes show the unreacted 25AP and 25U substrates. NApe shows both 3’-5’ 
exonuclease (with the 25U substrate) and AP endonuclease activity (with the 25AP 
substrate). AP endonuclease activity was confirmed by the appearance of the 10 bp 
product following cleavage at the AP site at position 11 in the 25AP DNA substrate. (D) 
The rate of AP endonuclease activity for NApe was measured by the appearance of the 
10 bp product band over time. Data are shown with the best fit to the Michaelis Menten 
equation with a kAP of 0.651 ± 0.085 s-1 and KM of 15.71 ± 17.17 nM. 
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5.3 Construction and characterisation of MC58∆nexo, MC58∆nape and 
MC58∆nexo∆nape in N. meningitidis 
To insertionally inactivate NMB2082, a tetracycline resistance cassette was inserted into the 
target gene to produce MC58∆nape (Figure 5.4 A). 700 bp fragments up- and downstream 
of the NMB2082 gene were amplified and a gene encoding tetracycline resistance from 
plasmid pCMT18 was inserted between them. The resulting plasmid was used to transform 
wild-type N. meningitidis strain MC58 to antibiotic resistance. An insertional inactivation  of 
the gene encoding NExo was also performed by Tn5 mutagenesis to produce the 
MC58∆nexo strain. This strain was constructed by Megan Winterbotham (Figure 5.4 A). A 
double mutant strain, MC58∆nexo∆nape was also constructed. The identity of strains was 
confirmed by Southern analysis (data not shown). To determine whether NExo and Nape are 
expressed by wild-type strain MC58, and to verify the loss of expression in the mutant 
strains, whole-cell lysates of the wild-type and mutant strains grown overnight on solid 
medium were separated by SDS-PAGE and analysed by Western blot using antibodies 
raised in mice immunised with recombinant NExo and NApe (Figure 5.4 B). Immunisation of 
mice was performed by Yanwen Li. To confirm the absence of any growth defect as a result 
of the mutations liquid BHI medium was inoculated with each strain taken from solid 
medium, to give an initial O.D. A600 of 0.15. The O.D. A600 was measured every hour over a 
period of 8 hours to produce a growth curve. None of the mutant strains exhibited a 
significant growth defect (Figure 5.4 C). 
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Figure 5.4 Construction of mutants MC58∆nexo, MC58∆nape and 
MC58∆nexo∆nape in N. meningitidis  
(A) Construction of mutant strains. 700 bp regions up- and down-stream of NMB2082 
were amplified, ligated into a plasmid vector and a tetracycline resistance cassette 
inserted between them to produce plasmid pAC2. NMB0399 was amplified, inserted 
into a vector and subjected to mutagenesis with Tn5 to produce plasmid pMW1. 
These constructs were then used to transform MC58. (B) Whole cell lysates of MC58, 
MC58∆nexo, MC58∆nape and MC58∆nexo∆nape were analysed for expression of 
NExo and NApe. Samples were separated by SDS-PAGE following transfer to nylon 
membranes and incubated with sera against NExo or NApe (at a dilution of 1:1000). 
Expression of both proteins is seen in the wild-type strain but not in the corresponding 
mutants. (C) Liquid BHI media was inoculated with MC58, MC58∆nexo, MC58∆nape 
and MC58∆nexo∆nape, and OD600 measured hourly. None of the mutant strains 
display a growth defect in liquid media. 
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5.4 Both NExo and Nape are required for resistance against oxidative stress 
Oxidative stress is an important aspect of innate immunity against bacterial pathogens, and 
AP endonucleases are critical for repairing DNA lesions induced by oxidative stress. 
Therefore the role of NApe and NExo in bacterial survival under conditions of oxidative 
stress was examined.  
 
To analyse the importance of NExo and NApe in resistance to oxidative stress, mutants 
lacking these enzymes were compared with the wild-type strain for survival in media 
containing oxidising agents hydrogen peroxide (H2O2) and paraquat, which generate free 
radicals in the periplasm and cytoplasm, respectively (Pacello et al., 2008; Turner et al., 2003). H2O2 
is produced naturally as a by-product of oxygen metabolism and is catabolised by 
peroxidases to produce water and oxygen. However, at higher concentrations it is readily 
converted into highly reactive hydroxyl radicals which lead to extensive DNA damage 
(Balasubramanian et al., 1998). Paraquat reacts with cellular NADPH to produce superoxide 
radicals, disrupting cellular biochemistry, particularly pathways that rely on NADPH. 
Superoxide radicals promote hydroxyl radical production, and thus contribute to damage to 
cellular DNA (Keyer and Imlay, 1996). Known numbers of bacteria were plated onto media with 
or without these oxidising agents. The percentage survival was calculated by comparison 
with the number of CFU after overnight growth. The mutants lacking NExo or NApe were 
significantly more sensitive to oxidative stress compared with the wild-type strain. Both 
MC58∆nexo and MC58∆nape were recovered at 70% of the wild-type in the presence of 
paraquat, and at 60% and 80% of the wild-type respectively when incubated with H2O2 
(Figure 5.5). Furthermore, the survival of the double mutant under conditions of oxidative 
stress was significantly impaired (40% of wild-type in paraquat and 30% in H2O2) compared 
with both the single mutants (Figure 5.5)  
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Figure 5.5 Both NExo and NApe are necessary for resistance to oxidative 
stress 
(A) Bacterial strains were grown on solid media in the presence and absence of the 
oxidising agents H2O2 (13 mM) or Paraquat (0.075 mM). The image shown is 
representative of strains grown on media containing H2O2. (B) Killing was calculated 
as a percentage of CFU recovered of strain on media without these agents. Strains 
lacking NExo and NApe were more sensitive to H2O2 and Paraquat; the strain lacking 
both enzymes is significantly more sensitive than the single mutants alone. Error bars 
represent Standard error of the Mean. 
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5.5 NExo and NApe are necessary for virulence 
The generation of oxidative stress is an important aspect of defence against microbial 
infection in vivo. Therefore the physiological relevance of the sensitivity to oxidative stress of 
the NExo and NApe mutant strains was evaluated by assessing their ability to cause 
bacteraemia. Five-day old infant rats were challenged with a 1:1 ratio of mutant and wild-
type strain, and 24 hours later the relative survival of the strains was determined by plating 
venous blood to media with and without antibiotics. The Competitive Index was calculated by 
comparing the recovery of the mutants with the wild-type strain. Both MC58∆nexo and 
MC58∆nape were recovered from the bloodstream of infected infant rats at significantly 
lower levels than the wild-type strain (Figure 5.6). The double mutant displayed significantly 
higher attenuation than either of the single mutant strains, indicating an additive effect of the 
loss of both NExo and NApe.   
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Figure 5.6 NExo and NApe are required for virulence in the infant rat 
model 
Infant rats were challenged with a 1:1 ratio of wild-type to mutant bacteria. 
Following bleeding 24 hours later, serial dilutions were plated to solid media and 
incubated overnight. Competitive Index (C.I) was calculated following quantification 
of CFU recovered. Attenuation is shown as a negative log.CI value. The single 
mutants were significantly attenuated, while the double mutant was more 
attenuated than either of the single mutants. 
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5.6 Summary 
 
The data presented in this chapter constitute the first study to combine structural and 
biochemical analysis of predicted DNA repair enzymes with analysis of their role in survival 
and pathogenesis (Carpenter et al., 2007). NExo is the meningococcal protein that is most 
closely related to the E. coli AP endonuclease and has exonuclease activity. However, this 
enzyme is not an AP endonuclease due to the His167 blocking the DNA binding site The His 
residue is present in the genome so did not arise due to a point mutation during cloning or 
expression of the NMB0399 gene. This work highlights the importance of characterising the 
gene product rather than relying on the known activity of homologues in other genomes. 
Instead, NApe, which is more closely related to a human than the E. coli AP endonuclease, 
was demonstrated to be a functional AP endonuclease. Assays to determine the role of 
these two enzymes demonstrated that NExo and NApe are expressed by N. meningitidis 
and play independent roles in the survival and pathogenesis of the bacterium.  
 
Both NExo and NApe are required for resistance against oxidative stress, and for survival in 
vivo. The additive effect seen in assays with the double mutant strain indicates that each 
enzyme acts independently and in separate pathways. The meningococcus is known to 
interact with phagocytic cells during development of disease, and thus is exposed to the 
oxidative burst. It is likely that NExo and NApe play a role in ameliorating the effects of the 
oxidative burst by repairing the resulting lesions in the bacterial DNA. Their differing range of 
substrate specificities means that both enzymes would be necessary for efficient DNA repair 
function. 
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The next chapter examines the interaction of the meningococcus with human neutrophils. 
The double mutant MC58∆nexo∆nape is included in this work to further analyse the role of 
these two DNA repair enzymes in meningococcal disease. 
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Chapter 3 described work in which non-opsonic phagocytosis of N. meningitidis by the 
human neutrophil cell line HL60 was investigated. Live meningococci associated with and 
were internalised by HL60 cells in a manner that is independent of lactate acquisition by the 
bacterium. Previous work has also described phagocytosis of N. meningitidis by PMNs and 
macrophages, identifying the anti-phagocytic role of the polysialic acid capsule (Read et al., 
1996) and some host cell receptors involved in internalisation (Virji et al., 1996). However, 
nothing is known about the fate of the meningococcus following uptake by PMNs. It has 
been shown that the gonococcus survives and replicates within PMNs, and that it utilises 
lactate generated by the cells. It has been suggested that lactate utilisation is a mechanism 
by which N. gonorrhoeae reduces the efficacy of the oxidative burst. Recent work has 
confirmed that the gonococcus does inhibit the oxidative burst elicited by PMNs (Criss et al., 
2008). Other mechanisms of reducing the effect of the oxidative burst have also been 
identified. The meningococcus expresses functional catalase, peroxidase and cytoplasmic 
superoxide dismutases (Seib et al., 2005; Wilks et al., 1998; Archibald and Duong, 1986). Genes 
encoding a manganese import transporter MntABC, which is involved in protection of the 
gonococcus against ROS, and SodB are also present in the meningococcal genome (Tettelin 
et al., 2000). Expression of the gonococcal porin PorB has also been shown to reduce the 
efficacy of oxidative burst (Lorenzen et al., 2000).  
 
The gonococcus also delays apoptosis of neutrophils following phagocytosis (Simons et al., 
2006). It has been suggested that this process enables the bacterium to replicate 
intracellularly and thus aid in the propogation of disease. This process has not yet been 
investigated in the meningococcus. Neutrophils containing multiple intracellular 
meningococci have been recovered from the bloodstream of patients (Guarner et al., 2004). It is 
possible that the bacterium may survive within neutrophils to aid dissemination within the 
host, but as yet there is no direct evidence for this. To survive within a phagocytic cell, the 
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meningococcus would require the means to both withstand or manipulate PMN killing 
mechanisms, and/or to repair the resulting damage. 
 
Work in this chapter investigates the fate of N. meningitidis and human PMNs following 
phagocytosis. Furthermore the role of the bacterial lactate permease LctP, glutamate uptake 
enzyme PerM, and BER enzymes NExo and NApe is examined. Since work with the 
gonococcus suggests that survival of the wild-type strain in PMNs relies on its ability to 
scavenge intracellular lactate from the host cell (Simons et al., 2006; Britigan et al., 1988), the 
survival of the MC58∆lctP strain was analysed. PerM is a component of an ABC-type 
glutamate transporter that operates at low sodium conditions such as those that may be 
experienced by the meningococcus within PMNs. Bacterial glutamate is predicted to be 
converted to glutathione, a low molecular weight, water-soluble antioxidant. In its reduced 
state, glutathione acts as a scavenger of free radicals and as an electron donor to restore 
oxidised macromolecules (Carmel-Harel and Storz, 2000). High concentrations of glutathione have 
been identified in the gonococcus and it is thought to be an important first-line defence 
against oxidative stress (Archibald and Duong, 1986). For this reason, the H44/76∆perM strain 
was also analysed in PMNs. BER is the primary pathway by which organisms repair DNA 
damage caused by oxidative stress (Wilson et al., 2003). NExo and NApe are required for 
resistance to oxidation by H2O2 and paraquat, and for survival in vivo (Carpenter et al., 2007) & 
(Chapter 5). Thus, the influence of these enzymes in survival in PMNs was also examined. 
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6.1 Characterisation of isolated primary PMNs 
Venous blood was obtained from healthy volunteers, and PMNs were purified by histopaque 
separation. PMNs were separated on a dextran gradient, and the concentration of cells was 
adjusted to 1 x 106 cells/ml in HBSS. The viability of PMNs was assessed using trypan blue 
exclusion, and was calculated to be >99% (not shown). The homogeneity of PMNs was 
confirmed by microscopy and flow cytometry. For microscopy, 5.5 x 105 PMNs were stained 
on coverslips with Giemsa-Wright stain and scored for the presence of a multi-lobed 
nucleus; purity was calculated as >95% by this method (Figure 6.1 A).  PMN receptor 
expression was also examined by flow cytometry. Following activation with 100 ng/ml PMA, 
5.5 x 105 PMNs were incubated with antibodies against CD45, CD18 or CD11b. CD45 is 
also termed leukocyte common antigen (Thomas, 1989). The CD18 integrin forms a 
heterodimer with CD11b, generating CR3, which is expressed by activated PMNs (Mazzone 
and Ricevuti, 1995). Binding of antibodies against CD45, CD18 and CD11b was analysed by 
flow cytometry. All activated PMNs were recognised by antibodies against these cell markers 
but not by an isotype control (Figure 6.1 B).  
 
Expression of CEACAM-1 (CD66) was analysed by both fluorescence microscopy and flow 
cytometry using an antibody against the a,c,d isoforms of CD66. This receptor mediates 
non-opsonic interactions with N. meningitidis via the meningococcal Opa proteins (Virji et al., 
1996) (Figure 6.1 C). Expression of the granular protein, neutrophil elastase, was also 
analysed by fluorescence microscopy. Cells were scored (n = 100), of which >95% were 
positive for neutrophil elastase (Figure 6.1 D & data not shown). Collectively, these data 
demonstrate that the procedure for isolating PMNs from peripheral blood was successful. 
 
 
Chapter 6 The non‐opsonic interaction with primary human PMNs  
 
 
CD45 CD18 CD11b
α-CD66a,c,d
α-Neutrophil 
elastase
 
(A) 
 
 
 
 
 
(B) 
 
 
 
 
 
(C) 
 
 
 
 
(D) 
 
 
 
PMNs were
analysis by
stain and s
Magnificatio
by flow cyto
binding (gre
trace) and 
was analys
isoforms. (D
against this
 
 
 
 
 
 
 
 Figure 6.1 Characterisation of isolated primary PMNs 
 isolated from the venous blood of healthy volunteers and prepared for 
 microscopy and flow cytometry. (A) PMNs were stained with Giemsa-Wright 
cored for the presence of multi-lobed nuclei. Purity was confirmed as >95% 
n is shown above each image. (B) PMN receptor expression was analysed 
metry using mAbs against CD45, CD18 and CD11b (as indicated). Antibody 
en trace) was compared with cells incubated with an isotype control (purple 
confirmed expression of each receptor. (C) Expression of the CD66 receptor 
ed by microscopy and flow cytometry using a mAb against the CD66a,c,d 
) Neutrophil elastase expression was analysed by microscopy using a mAb 
 granule protein. Scale bars represent 20 µm. 149 
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6.2 Primary PMNs associate with N. meningitidis strains in the absence of 
opsonins 
Prior to investigating the survival of bacteria during and after phagocytosis, it was necessary 
to determine whether phagocytosis of N. meningitidis by primary PMNs occurred in a similar 
manner as observed with HL60 cells (Chapter 3). PMNs were challenged with live GFP-
expressing MC58, MC58∆lctP and MC58∆siaD at an MOI of 100 in the absence of 
opsonins, and incubated for thirty minutes. Following fixation, the association of bacteria with 
PMN was analysed by flow cytometry. All strains associated to similar levels to those seen 
with HL60 cells. MC58 and MC58∆lctP strains associated with primary PMNs to the same 
extent, whilst the unencapsulated MC58∆siaD strain showed significantly increased 
association (Figure 6.2). Microscopic analysis was also performed to verify internalisation of 
bacteria (data not shown). These assays were performed on at least three independent 
occasions with PMNs isolated from different donors. 
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Figure 6.2 Primary PMNs phagocytose N. meningitidis in the absence of 
opsonins 
(A) Primary PMNs were incubated with live GFP-expressing MC58, MC58∆lctP and 
MC58∆siaD strains and association analysed by flow cytometry. MFI was calculated by 
multiplying the mean fluorescence with the percentage positive cell population. All strains 
associated with PMNs. MC58∆siaD associated to a significantly higher degree than either 
wild-type or MC58∆lctP strains. The MC58∆lctP strain associated to PMNs to the same 
level as the wild-type. Error bars represent standard error of the mean fluorescence index. 
(B) Primary PMNs were incubated with live GFP-expressing MC58. FACS trace shows the 
uninfected PMN population (purple trace) and confirms association of the wild-type strain 
with PMNs (green trace). 
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6.3 Wild-type N. meningitidis MC58 survives in the presence of human PMNs 
To determine the fate of bacteria following interaction with PMNs, assays were established 
to examine bacterial survival using adherent PMNs. Optimisation of this assay included 
verifying that a confluent layer of PMNs was produced by centrifugation of 5.5 x 105 PMN 
onto flat-bottomed 48-well plates, where they adhered. This was necessary to ensure 
maximum contact between PMNs and bacteria. Further optimisation was performed to 
analyse the influence of altering the MOI (data not shown). Assays were performed by 
inoculating the adherent PMNs with bacteria at an MOI of 100 in the absence of opsonins, 
and incubating for one hour. Bacterial survival in the presence and absence of PMNs was 
analysed by plating serial dilutions of the contents of the wells to solid media following lysis 
of PMNs with 0.1% saponin which does not kill N. meningitidis. Survival was calculated as 
the percentage of bacteria recovered after incubation with PMNs compared with the number 
of bacteria in the input. E. coli DH5α was used as a control. If DH5α was not killed in the 
presence of PMNs, results were not examined. Wild-type MC58 strain was not killed in the 
presence of PMN (Figure 6.3). This was confirmed with PMNs from at least three different 
donors, on at least three independent occasions with each donor. 
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Figure 6.3 Wild-type N. meningitidis MC58 strain survives within PMNs 
Adherent primary human PMNs were challenged with bacteria at an MOI of 100. 
Survival of E. coli DH5α was compared with MC58 by recovery of bacteria from PMNs 
following lysis with saponin. The percentage survival was calculated after a one-hour 
incubation by comparing the number of bacteria recovered with the number in the input. 
E. coli DH5α was killed by PMNs (P < 0.005), while MC58 was not. Error bars represent 
the standard error of the mean. This figure is a representative dataset from an assay 
performed on PMNs isolated from one donor on three independent occasions. 
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6.4 Infection with N. meningitidis delays PMN apoptosis 
To investigate the effect of N. meningitidis on PMN viability, markers of cell death and 
apoptosis were analysed in PMNs in the presence and absence of bacteria. Lactate 
dehydrogenase (LDH) is a membrane-bound enzyme located on the cytoplasmic face of the 
plasma membrane that converts lactate to pyruvate (Holten and Jyssum, 1974). Due to its 
location on the plasma membrane of eukaryotic cells, LDH is found in the surrounding 
medium following loss of membrane integrity during early stages of apoptosis and cell death. 
LDH release into the medium is therefore a commonly used marker of apoptosis. Adherent 
PMNs were infected with live or dead MC58 at an MOI of 100, and incubated for up to three 
hours. Supernatants of both infected and non-infected cells were harvested and analysed for 
LDH activity. Percentage cytotoxicity was calculated by comparing results with wells in which 
all cells had been lysed by the addition of saponin as described in Material and Methods 
(Chapter 2). Uninfected cells showed a baseline level of between ten to 14% cytotoxicity 
over three hours (Figure 6.4 A). This indicates that in all assays involving infection of PMNs, 
>85% are viable on infection with N. meningitidis as described in this chapter. PMNs infected 
with both live and dead MC58 strain show reduced cell death compared to uninfected cells. 
This trend was most marked in PMNs infected with the live meningococcus (Figure 6.4 B).  
 
Apoptosis was also analysed by examining the activation of caspase-3. Caspases are a 
family of cysteine proteases that include both initiators and effectors that coordinate the 
cellular destruction and disassembly that occurs during apoptosis (Slee et al., 1999). Caspase-
3, also known as apopain or CPP32, is a key effector of apoptosis in mammalian cells 
(Fernandes-Alnemri et al., 1994). It is present in an inactive form as a 37 kDa pro-caspase that is 
cleaved to produce the active 15 kDa and 17 kDa fragments. Adherent PMNs were 
inoculated with non-opsonised MC58, or with the Saccharomyces cerevisiae particle 
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zymosan, with or without 10% human serum. The total contents of the wells were harvested 
following a 4-hour incubation, and the proteins separated by SDS-PAGE. Equal protein 
loading was verified by Western blot analysis with a mAb against actin. Caspase-3 activation 
was then analysed by Western blot analysis using mAb 8G10 that recognises both the 
cleaved and uncleaved forms of caspase-3. Caspase-3 was detected in both its active and 
inactive forms under all conditions. PMNs inoculated with opsonised and non-opsonised 
zymosan showed significantly higher activation of caspase-3 compared with uninfected 
PMNs, indicating that phagocytosis of these particles initiated apoptosis. In contrast, PMNs 
infected with MC58 showed less caspase-3 activation than those infected with zymosan, or 
than uninfected cells, indicating that live N. meningitidis appears to down-regulate apoptosis 
of PMNs (Figure 6.4 C).  
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Figure 6.4 Infection with N. meningitidis leads to a delay in PMN apoptosis 
(A; B) Supernatants from non-infected (A) and infected (B) PMNs were harvested at 
one, two and three hours post-challenge and analysed for lactate dehydrogenase (LDH) 
activity. The percentage cytotoxicity was calculated by comparison with uninfected cells 
and results obtained after all cells had been lysed with saponin. Cytotoxicity is reduced 
in cells infected with both live (white bars) or dead (black bars) bacteria, although this 
trend is more marked in cells infected with live MC58. Error bars represent the standard 
error of the mean. (C) Adherent PMNs were inoculated with MC58, and with opsonised 
and non-opsonised zymosan. The contents of the wells were harvested four hours post-
challenge. Proteins were separated by SDS-PAGE and PMN caspase activation 
analysed by Western blot with a mAb that recognises both cleaved (active) and 
uncleaved (inactive) Caspase-3. A mAb that recognises actin was used as a loading 
control. Cells inoculated with MC58 show lower caspase activation than those with 
zymosan, indicating an inhibition of this apoptotic pathway. 
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6.5 Infection with N. meningitidis leads to a delay in nuclear condensation 
A feature of apoptosis in PMNs is a change in morphology of nuclei from the characteristic 
multi-lobed form to a more condensed, rounded shape. To investigate whether infection with 
N. meningitidis also affects this marker of apoptosis, adherent PMN were infected with MC58 
or non-opsonised zymosan on coverslips and incubated for three hours. Cells were fixed 
with PFA, and the coverslips were stained with the Giemsa-Wright stain. Qualitative 
assessment of the appearance of PMN nuclei indicate that PMNs infected with MC58 show 
less condensation of the nucleus when compared with cells infected with zymosan (Figure 
6.5). This result provides further independent evidence indicating that wild-type N. 
meningitidis delays the apoptosis of PMNs. 
 
Figure 6.5 Infection with N. meningitidis leads to a delay in PMN nuclear 
condensation 
Adherent PMNs were challenged with non-opsonised zymosan or N. meningitidis MC58 
and incubated for three hours. Coverslips were prepared for analysis of nuclear 
condensation by microscopy. PMNs were stained with Giemsa-Wright stain and nuclear 
morphology compared with uninfected PMNs. Cells stained at time zero show normal 
multi-lobed nuclear morphology. Three hours post-challenge, uninfected and zymosan-
infected cells show clear nuclear condensation. Cells infected with MC58 show a lesser 
degree of condensation. Scale bars represent 30 µM. 
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6.6 N. meningitidis requires the lactate permease LctP, glutamate transporter PerM 
and BER enzymes, NExo and NApe, for survival in PMNs 
Due to the potential biological roles of LctP, PerM and NExo and NApe in resistance against 
the oxidative burst, mutant strains MC58∆lctP, MC58∆nexo∆nape and H44/76∆perM were 
assessed for survival in the presence of PMNs. Adherent PMNs were inoculated with 
bacteria at an MOI of 100 and incubated for one hour. Wild-type strains MC58 and H44/76 
were included, along with E. coli DH5α. Following lysis of PMNs with 0.1% saponin, the 
survival of each strain was assessed by plating to solid media. Percentage survival was 
calculated as the ratio of bacteria recovered compared with the input at time zero. This 
assay was performed with at least three different PMN donors, on at least three independent 
occasions for each donor. E. coli DH5α was significantly killed by PMNs in every assay. Both 
wild-type MC58 and H44/76 strains survived in the presence of PMNs. However, 
MC58∆lctP, MC58∆nexo∆nape and H44/76∆perM strains were all significantly killed by 
PMNs even in the absence of opsonins (Figure 6.6). This indicates that LctP, PerM and a 
combination of NExo and NApe are required for survival in the presence of PMNs. 
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Figure 6.6 N. meningitidis requires the lactate permease LctP, glutamate 
transporter PerM, and BER enzymes NExo and NApe for survival in PMNs 
Adherent primary human PMNs were challenged with bacteria at an MOI of 100. E. coli 
DH5α was included as a control. The survival of strains was analysed by plating serial 
dilutions of the total contents of wells after lysing cells with saponin. The percentage 
survival was calculated after a one-hour incubation by comparing the number of 
recovered bacteria with the input. Neither wild-type strain was killed by PMNs. All three 
mutant strains were sensitive to PMNs. The figure shows representative results from 
assays performed with PMNs from one donor on three independent occasions. Error 
bars represent the standard error of the mean. 
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6.7 MC58∆lctP, MC58∆nexo∆nape and H44/76∆perM are killed by PMN in an actin- 
and ROS-dependent manner 
MC58∆lctP, MC58∆nexo∆nape and H44/76∆perM were attenuated in the presence of PMNs 
unlike the corresponding wild-type parental strains. To elucidate the mechanism of sensitivity 
of each strain, PMNs were treated with cytochalasin D or resveratrol. Cytochalasin D inhibits 
actin polymerisation, and thus prevents phagocytosis of bacteria (Schliwa, 1982). Resveratrol is 
a phytoalexin produced by plants in response to infection with bacteria and fungi. It has anti-
oxidant, anti-inflammatory and immunomodulatory activities, and has been shown to reduce 
the oxidative burst of PMNs, monocytes and T-cells by inhibiting myeloperoxidase activity 
and interfering with phosphatidylinositol 3-kinase (PI3-K) signalling to NADPH oxidase (Castro 
et al., 2008; Deby-Dupont et al., 2005; Poolman et al., 2005). Prior to use of these inhibitors with PMNs, 
their potential antibacterial activity was determined. MC58 strain was incubated with 
cytochalasin D (5 µM) and resveratrol (100 µM) for one hour, and survival was calculated as 
the number of bacteria recovered as a percentage of the input. Neither cytochalasin nor 
resveratrol inhibited bacterial growth at these concentrations (data not shown). This assay 
was also attempted with the standard ROS inhibitor, Diphenyleneiodonium chloride (DPI), 
however this agent was bactericidal and therefore could not be used (data not shown). 
Therefore, assays were performed with adherent PMNs in the presence of cytochalasin (5 
µM) or resveratrol (100 µM). PMNs were pre-treated with each inhibitor for 20 minutes prior 
to challenge with E. coli DH5α, MC58, MC58∆lctP, MC58∆nexo∆nape, H44/76 and 
H44/76∆perM. Inhibitor- and PMN-free controls were included for each strain. Following a 
one-hour incubation, PMNs were lysed with 0.1% saponin, and surviving bacteria recovered 
by plating. This assay was performed with at least three different PMN donors, on at least 
three independent occasions for each donor. In the absence of cytochalasin D or resveratrol, 
neither MC58 or H44/76 were killed, whilst E. coli, MC58∆lctP, MC58∆nexo∆nape and 
H44/76∆perM had reproducible significant defects for survival in PMNs. However, in the 
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presence of both cytochalasin D and resveratrol, survival of MC58∆lctP, MC58∆nexo∆nape 
and H44/76∆perM was restored to wild-type levels (Figure 6.7 A & B). E. coli DH5α also 
survived in the presence of the actin and ROS inhibitors. The effect of cytochalasin D on 
survival indicates that the attenuation of strains relies on actin polymerisation. The effect of 
resveratrol in restoring wild-type levels of survival indicate that killing of MC58∆lctP, 
MC58∆nexo∆nape and H44/76∆perM was the result of ROS-dependent killing mechanisms. 
Therefore the wild-type MC58 and H44/76 strains rely on the activity of LctP, PerM and BER 
enzymes NExo and NApe to survive ROS-mediated killing by PMNs.  
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Figure 6.7 N. meningitidis mutants are killed in an actin- and ROS-
dependent manner 
Adherent primary human PMNs were pre-treated with either 5 µM cytochalasin (A) or 
100 µM resveratrol (B) for twenty minutes prior to challenge with bacteria at an MOI of 
100. Bacteria were recovered after a one-hour incubation by plating to solid media after 
lysing PMNs. The percentage survival was calculated after a one-hour incubation by 
comparing the number of recovered bacteria with the input. Both cytochalasin D and 
resveratrol restored the survival of MC58∆lctP, MC58∆nexp∆nape and H44/76∆perM to 
wild-type levels, indicating that sensitivity of these mutant to PMNs is dependent on 
actin polymerisation and ROS production. The figure shows a representative dataset 
from assays performed with PMNs from one donor on three independent occasions. 
Error bars represent the standard error of the mean. 
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6.8 Summary 
The work described in this chapter investigated the fate of both the bacterium and host cells 
when primary human PMNs were infected with N. meningitidis. Following validation of the 
procedure to isolate primary PMNs, assays demonstrated that wild-type N. meningitidis 
MC58 is able to survive in the presence of human PMNs, and to delay apoptosis of the host 
cells. The same observation has been made previously in work with the gonococcus (Simons 
et al., 2006). The ability to survive intracellularly in PMNs is likely to be important for 
development of meningococcal disease since intracellular bacteria are not exposed to 
complement-mediated killing in the bloodstream. It is possible that delayed PMN apoptosis 
may influence cytokine signalling by PMNs, thus affecting the innate immune response to 
the infection, and prolonging the protection afforded to the bacteria by the live PMN. It is also 
possible that meningococci residing within circulating PMNs may contribute directly to 
development of meningitis since PMNs are able to cross the BBB via cell adhesion 
molecules (CAMs) expressed by activated endothelial cells as a result of the inflammatory 
response to infection (Wong et al., 2007). Manipulation of phagocyte function is well described 
in bacterial pathogenesis. For example, work with dendritic cells (DC) has shown that 
infection with live meningococci results in a different outcome than infection with dead 
bacteria. Live meningococci were phagocytosed to a lesser extent and despite eliciting 
cytokine release, they impeded DC maturation more than fixed bacteria (Jones et al., 2007). It is 
suggested that the resulting lower density of maturation marker receptors expressed by DCs 
may influence the subsequent T-cell response, and thus progression of the inflammatory 
response (Jones et al., 2007).  
 
The role of LctP, PerM and NExo and NApe in survival within PMNs was also investigated in 
this chapter. Mutant strains lacking the genes encoding these enzymes were attenuated for 
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survival in the presence of PMNs. Treatment with cytochalasin D restored survival of all 
three strains to wild-type levels, indicating that the attenuation of these mutants relied on 
actin polymerisation. It may therefore be extrapolated that killing therefore relies upon 
phagocytosis, but the effects of cytochalasin D on NADPH oxidase signalling pathways and 
extracellular release of anti-microbial peptides is not known and therefore care should be 
taken when making this assumption. Treatment with resveratrol to inhibit ROS production 
also restored survival of mutant strains to wild-type levels, indicating that the attenuation 
seen with each mutant relied on the oxidative burst. Work with the gonococcus has 
demonstrated that the bacterium utilises lactate produced by PMNs (Goldner et al., 1979), and it 
has been suggested that this process depletes the intracellular lactate reserves, thus 
potentially reducing the extent of the oxidative burst. The gonococcus is known to inhibit the 
oxidative burst of PMNs and it is possible that the same activity is performed by the 
meningococcus. Attempts were made to quantify the production of ROS by infected PMNs. 
However, the detection methods used did not allow the use of resveratrol as a negative 
control due to cross-reaction between resveratrol and the detection agent, and therefore this 
analysis was not possible. The mechanism of inhibition of ROS production by the 
gonococcus has not yet been eludicated but it may be that the ability to utilise lactate is 
necessary for this activity. Previous work has also shown that lactate is required for 
sialylation of the LPS and production of the polysialic acid capsule (Exley et al., 2005) & (Chapter 
4). The role of these surface components for survival within phagocytes is not well 
understood, although work has demonstrated a role for the capsule in survival within both 
phagocytic and non-phagocytic cells (Spinosa et al., 2007). It is possible that the inability to 
acquire lactate results in a reduction of the defence of this mutant strain to the oxygen-
dependent killing mechanisms employed by the PMNs. Glutamate uptake is mediated by 
PerM in low sodium conditions such as in the intracellular environment. Glutamate is 
required for the production of the antioxidant molecule glutathione (Unpublished). Thus it is 
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likely that the H44/76∆perM mutant lacks intracellular glutathione and is less efficient at 
ameliorating the effects of free radicals, making it more susceptible to the oxidative burst 
(Unpublished). 
 
Attenuation of the mutant lacking BER enzymes NExo and NApe highlights the importance 
of the BER pathway in repairing damage inflicted on the bacterial genome by ROS. 
Accumulation of mutations will occur rapidly during exposure to high concentrations of ROS 
and in the absence of a functional repair pathway, represented by these two enzymes, the 
mutations are cytotoxic. 
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7.1 Overview 
PMNs are voracious killers of bacterial pathogens and a critical part of the innate immune 
system. They are activated by cytokines in their environment, or by certain pathogen-
associated molecule patterns (PAMPs), most notably LPS (Saluk-Juszczak and Wachowicz, 2005; 
Harada et al., 1994). N. meningitidis encounters PMNs in the host, and has been recovered 
from within the phagocytic cells of patients with meningococcal disease (Guarner et al., 2004; 
Peters et al., 2003). PMNs are recruited to sites of infection and are able to migrate through 
cellular layers to gain access to invading pathogens (Spanaus et al., 1997). It is therefore likely 
that the first point of contact of N. meningitidis with these cells occurs during colonisation of 
the nasopharyngeal epithelium. PMNs also circulate in the bloodstream, the route by which 
the meningococcus disseminates within the host (Exley et al., 2005a). PMNs express a wide 
range of receptors, some of which (including CR3 and Fcγ receptors) recognise opsonised 
particles (Fijen et al., 2000). Other receptors exhibit specificity for structures expressed on the 
surface of the meningococcus, such as CD66 and CD14, which recognise Opa and LPS 
respectively (Ahren et al., 2001; Virji et al., 1996). Following engagement by these receptors, the 
pathogen can be internalised regardless of opsonisation. Expression of surface antigens 
such as the polysialic acid capsule and sialylation of LPS play an important role in mediating 
interactions with phagocytic cells (Estabrook et al., 1998; McNeil and Virji, 1997; Read et al., 1996). 
Production of these structures is closely linked to bacterial carbon metabolism and it is 
known that lactate is required for wild-type levels of LPS sialylation (Exley et al., 2005b; Smith et 
al., 2001). The role of the metabolism of the carbon sources lactate and glutamate was 
therefore investigated during interactions with PMNs. 
 
In meningitis and meningococcal septicaemia, killing of the bacterium primarily occurs via 
complement-mediated lysis. Initiation of the classical (CP), alternative (AP) or lectin 
pathways of the complement cascade leads to deposition of C3b on the bacterium, and 
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subsequent insertion of the membrane attack complex (MAC) in the bacterial outer 
membrane, and bacterial lysis (Schneider et al., 2007). The complement component C3bi also 
acts as an opsonin through recognition by CR3 on phagocytic cells (Messner and Jelinek, 1970). 
For these reasons, individuals who possess defects in the complement system are 
particularly susceptible to meningococcal disease (Rosa et al., 2004; Figueroa et al., 1993; Fine et al., 
1983). In the absence of this important killing mechanism, hosts must rely on other defensive 
immune mechanisms. One such mechanism is non-opsonic uptake and killing by PMNs. It 
has been shown that serogroup C N. meningitidis is taken up by PMNs in a non-opsonic 
manner (Estabrook et al., 1998). Work with N. gonorrhoeae has shown that the gonococcus 
survives and replicates within PMNs, and results in a delay in PMN apoptosis (Simons et al., 
2005; Parsons et al., 1982) but this interaction has not previously been studied with the 
meningococcus.  
 
PMNs also play an important role in the inflammatory response, releasing pro-inflammatory 
cytokines and anti-microbial compounds, and producing ROS in response to engagement 
and phagocytosis of bacterial pathogens. ROS cause oxidative damage to the bacterial cell, 
including the formation of lesions in DNA. The BER pathway is dedicated to ameliorating the 
effects of oxidative damage (Wilson et al., 2003). A robust repair system would be required for 
the bacterial genome to withstand attack by the ROS produced by PMNs. Therefore, two 
putative meningococcal AP endonuclease homologues were identified and their role in 
pathogenesis and survival in the presence of PMNs was investigated. 
 
The aim of this thesis was to characterise the non-opsonic interaction of N. meningitidis with 
human PMNs. This included investigation of the role of lactate and glutamate metabolism, 
and the importance of the BER DNA repair pathway in the meningococcus. 
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7.2 Outcome of interaction between wild-type N. meningitidis and PMNs 
The interaction between serogroup C N. meningitidis and PMNs has been studied 
previously. Both opsonised and non-opsonised meningococci associate with, and are 
internalised by PMNs (Fijen et al., 2000; Estabrook et al., 1998). In this study, the association of 
fixed serogroup B MC58 strain to HL60 cells was shown by flow cytometry, and 
phagocytosis confirmed by microscopy.  It is known that the neisserial Opa proteins interact 
with the CD66 receptor (de Jonge et al., 2003; Popp et al., 1999; Chen et al., 1997). Analysis of 
differentiated HL60 cells confirmed expression of this receptor and pre-incubation of the cells 
with an anti-CD66 antibody significantly reduced the association with bacteria. This indicates 
that the CD66 receptor mediates non-opsonic interaction between Opa-expressing 
meningococci, although additional receptors may also be involved. No alternative receptors 
have yet been identified although candidates include sialic acid-specific receptors that could 
mediate lectinophagocytosis, such as sialic acid-binding Ig-like lectins (siglecs), which are 
expressed by all leukocytes (Monteiro et al., 2004; Zhang et al., 2000). Phagocytosis of 
meningococci is also affected by anti-phagocytic components expressed on the surface of 
the bacterium. Expression of the polysialic acid capsule and sialylation of LPS are known to 
reduce association and internalisation by phagocytes (Read et al., 1996; Estabrook et al., 1992). An 
unencapsulated mutant lacking the polysialyl-transferase SiaD associated with HL60 cells 
significantly more than the wild-type strain, confirming the previously described anti-
phagocytic role of the capsule, and validating this flow cytometric method for analysis of the 
interaction between HL60 cells and N. meningitidis.  
 
When phagocytosis assays with HL60 cells were repeated with live bacteria, association and 
phagocytosis were greatly reduced in comparison with fixed bacteria. This effect has been 
observed previously in work with DCs where it was attributed to manipulation of the cell by 
the bacteria, thus inhibiting uptake (Jones et al., 2007). Here, a mixed infection of HL60 cells 
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with live and FITC-labelled fixed bacteria was performed to investigate whether the reduced 
uptake was due to a cellular response to the live bacteria. However, the presence of live 
bacteria did not significantly affect the uptake of fixed bacteria by HL60 cells. This data 
indicates that the reduced association of live bacteria is due to a bacterial response to host 
cells. Examination of bacteria following exposure to HL60 cells showed that capsule 
expression in live, but not fixed, N. meningitidis increased significantly. This pattern was also 
observed in bacteria incubated in supernatants taken from HL60 cells infected with N. 
meningitidis, indicating that the increase in capsule expression occurs as a result of a 
contact-independent mechanism. The same response was seen in bacteria exposed to the 
epithelial cell line Calu-3 and to supernatants from infected Calu-3 cells. 
 
Previous work has demonstrated a down-regulation in capsule expression on contact with 
epithelial cells (Deghmane et al., 2002). This is in keeping with the increase in capsule in the 
presence of epithelial cells or neutrophils being dependent on a mechanism that does not 
involve contact with the cells themselves. Supernatants from infected HL60 cells were 
analysed by NMR to determine potential candidates that may induce this increase in capsule 
expression. The NMR spectra indicated the presence of both lactate and pyruvate, in 
addition to alanine, acetate and some unidentified organic acids. Sialic acid production by N. 
meningitidis is closely linked to the metabolism of lactate and pyruvate and further 
investigation of the availability of these carbon sources in cell supernatants showed an 
increase in concentration of both over time, indicating that they are secreted by HL60 cells. 
However, there was no change in capsule expression in bacteria incubated with lactate 
and/or pyruvate in addition to glucose. This does not exclude their potential importance in 
the bacterial response to HL60 cells since it remains possible that the source of PEP for the 
production of sialic acid originates from the lactate and/or pyruvate present in the media. 
However, this result indicates that the increase in capsule expression is not due to carbon 
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source availability alone. Furthermore, NMR may be insufficiently sensitive to detect 
significant changes in alternative candidate compounds in the cellular supernatants. 
 
Supernatants were analysed further to determine whether a protein was responsible. 
Treatment with a protease resulted in a significant reduction in the response of bacteria to 
HL60 supernatants, indicating a role for a proteinaceous component. PMNs release CAMPs 
such as LL-37 and HNP-1 in response to bacterial pathogens (Borregaard, 1984). Epithelial 
cells also secrete a range of CAMPs including LL-37 (Weinberg et al., 1998). Previous work has 
demonstrated that capsule expression increases resistance to killing by CAMPs and that 
expression is increased in intracellular bacteria within epithelial cells (Spinosa et al., 2007). 
Incubation of MC58 with LL-37 or HNP-1 elicited an increase in capsule expression in a 
dose-dependent manner. However, the potential role of CAMPs in the response to HL60 and 
Calu-3 cells is dubious since size fractionation of supernatants showed that the fraction 
containing proteins of 50-100 kDa was active rather than lower molecular weight fractions. 
LL-37 and HNP-1 are both <10 kDa in size, and therefore could not be the effector of the 
observed capsule expression response unless they were present in complex with a larger 
protein. LL-37 is known to bind LPS, which in turn forms complexes with LPS-binding protein 
(LBP), a 55 kDa protein secreted by PMNs. However, there is no evidence that this potential 
complex might be present in the supernatants, nor that it would induce the effects seen in 
capsule expression. Further investigation into the active component of HL60 cell 
supernatants might include analysis of the effect of LBP on capsule expression in the 
presence and absence of LL-37, and work to detect this protein in cell supernatants. Also, 
detailed dissection of the protein components of cell supernatants could be performed by 
HPLC to identify candidates that could then be tested for their effect on capsule expression. 
N. meningitidis expresses a number of two-component regulatory systems such as PhoPQ, 
which is known to be linked to alterations in genes encoding components of the bacterial cell 
surface in response to detection of endogenous proteins, such as CAMPs (Newcombe et al., 
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2005). It is possible that the protein effector responsible for the change in capsule expression 
is detected via one such regulatory system, leading to transcriptional or structural alterations 
in capsule biosynthesis or in utilisation of available carbon sources. Therefore, further work 
might involve investigation of the importance of known two-component regulatory systems in 
the response to cells and cell supernatants (Tzeng et al., 2008; Newcombe et al., 2005). 
Identification of candidate genes involved in the response might also be achieved using 
microarray analysis of bacteria exposed to cells (Claus et al., 2007). In addition, mass 
spectrometric analysis of the capsule following exposure to cells and supernatants may 
provide an indication of the nature of the change in capsule. Since the increase in 
expression was measured by antibody binding it is not clear whether the response observed 
is due to an increase in the amount of capsule produced or as a result of a change in 
capsule structure that would affect binding of the mAb against the serogroup B capsule.  
 
LPS sialylation is known to influence the outcome of interactions with phagocytic cells and 
was also analysed in bacteria following incubation with cells. Both antibody binding assays 
and silver staining indicated an increase in sialylation following exposure to cells, but not to 
cellular supernatants. However, the mutant lacking the LPS sialyltransferase Lst also 
showed this trend. Since this strain is unable to sialylate its LPS, this result was unexpected. 
Interestingly, analysis of the LPS of strains exposed to HL60 cells indicated a change in the 
LPS itself following exposure to cells. The nature of the change has not been elucidated and 
requires detailed analysis of the LPS by mass spectrometry. Preparation of LPS samples for 
mass spectrometric analysis was attempted but was unsuccessful. Sialic acid is bound to the 
terminal Gal of the lacto-N-neotetraose (Galß1-4GlcNAcß1-3Galß1-4Glc) on the LPS α 
chain. It is possible that alteration of the LPS on incubation with cells could influence the 
level of this sialylatable LPS substrate. However, my results indicate that there may be a 
fundamental modification in the structure of the LPS that may modify the interaction with the 
HL60 cells. It is unlikely, however, that this change in LPS is responsible for the difference in 
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association of live and dead bacteria with HL60 cells since the change was observed in LPS 
analysed from both live and dead bacteria. Alternatively, the change in LPS may be due to 
protein binding. Treatment of LPS samples taken from bacteria exposed to HL60 cells with a 
protease resulted in a loss of the shift in binding of the anti-L3,7,9 LPS mAb, indicating that a 
protein interaction plays a role. Incubation of bacteria with CAMPs was also performed and a 
clear shift in LPS was seen following incubation with LL-37. This shift was reduced following 
incubation with a protease. LL-37 has previously been shown to bind bacterial LPS (Golec, 
2007; Rosenfeld et al., 2006), and it is possible that this interaction is responsible for the shift in 
LPS observed in the presence of HL60 cells. It may not be significant that the shift is not 
seen with cellular supernatants since it is likely that such an interaction could be dependent 
on higher concentrations of CAMPs that might only arise in the micro-environment in close 
proximity to PMNs. However, there is no direct evidence for this. Attempts were made to 
detect LL-37 in HL60 cells and cell supernatants. However, the sensitivity of a commercially 
available mAb against LL-37 was too low to enable this analysis to be performed 
successfully. Western blot analysis was performed with a positive control lane containing 10 
µg LL-37, a far higher concentration than could be expected in a normal preparation of 2.5 x 
105 PMNs. The mAb used for this analysis was sensitive enough to detect this control, but 
only to a low degree. Thus when lysates of PMNs were tested using the same method, no 
detection of LL-37 was seen. It is unknown whether this was due to the absence of the 
CAMP or the low sensitivity of the mAb. Identification of additional candidates responsible for 
the change in LPS might also be achieved by microarray analysis and investigation of the 
potential role of known meningococcal two-component systems. 
 
The events following phagocytosis of N. meningitidis by PMNs were studied using primary 
human PMNs from a number of donors instead of HL60 cells to ensure the data were as 
physiologically relevant as possible. The intracellular fate of the meningococcus following 
non-opsonic uptake by PMNs has not previously been studied, although work with the 
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gonococcus has shown that the bacterium survives and replicates within PMNs, and result in 
a delay in PMN apoptosis. Association of meningococci with primary PMNs was confirmed 
prior to any further work with these cells to ensure that phagocytosis of bacteria occurred in 
the absence of opsonins as described with HL60 cells (Chapter 3). Bacterial survival assays 
were then performed and showed that wild-type MC58 and H44/76 strains were able to 
survive in the presence of adherent PMNs whilst E. coli DH5α did not.  
 
A number of meningococcal enzymes have been previously characterised that are likely to 
contribute to survival in PMNs. These are predominantly enzymes that act to ameliorate the 
effects of oxidative stress on the bacterium, and include superoxide dismutase, glutathione 
peroxidise and catalase (Soler-Garcia and Jerse, 2004; Dunn et al., 2003; Moore and Sparling, 1996). 
Intracellular survival of the meningococcus in PMNs has potential importance in the 
progression of disease. The host utilises PMNs to eradicate bacterial infection and to 
prevent dissemination and systemic disease. The ability to survive PMN killing may be one 
explanation for the rapid progression of meningococcal disease and septicaemia. Also, since 
PMNs circulate within the bloodstream and are known to cross damaged regions of the BBB 
(Wong et al., 2007), it is possible that bacteria could hijack PMNs and use them as a route into 
the CSF, and a mechanism to avoid bactericidal components within the bloodstream, most 
crucially the complement pathway. However, as yet there is no direct evidence for this.  
 
The fate of PMNs infected with N. meningitidis was also investigated. Analysis of apoptosis 
by LDH release, caspase-3 activation and cell morphology demonstrated that PMNs infected 
with wild-type meningococcus showed delayed apoptosis. This trend has also been 
observed in PMNs infected with the gonococcus (Simons et al., 2005). Inhibition of apoptosis in 
PMNs may have a dual effect on infection. Firstly, increased survival of the host cell may 
provide the bacteria with more protection from the hostile environment of the plasma, thus 
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improving bacterial survival and aiding in progression of the disease. Second, manipulation 
of the natural apoptotic pathways of PMNs, which are usually very short-lived, is likely to 
affect the profile of cytokine and chemokines, with a larger number of viable PMNs available 
to respond to infection. This could lead to a more rapid and intense inflammatory response.  
 
Previous studies have also shown that nitric oxide-regulated expression of cytokines by 
macrophages is affected by metabolism of nitric oxide by the meningococcus, thus 
influencing the cytokine release profile and potentially modulating the immune response as a 
result (Stevanin et al., 2005; Dunn et al., 2003). It is possible that a similar effect occurs in PMNs, 
and this may also play a role in the uncontrolled inflammatory response that occurs on 
infection with this bacterium. Further investigation into this effect on PMN viability would 
include analysis of the cytokine release profiles of PMNs in the presence and absence of the 
meningococcus and the potential effects on the subsequent inflammatory response. This 
could include work with additional phagocytic cells such as DCs and lymphocytes such as T- 
and B-cells. A comparison of the effect of live and dead bacteria in these systems would also 
be an interesting addition to the trend of reduced uptake of live bacteria by phagocytes 
described here (Chapter 3) and previously (Jones et al., 2007) and might help explain the 
difference in response of phagocytes to live and dead bacteria. Further work with mutant 
strains deficient in genes known to encode key virulence factors and surface components 
such as capsule, different LPS structures and OMPs would also aim to identify which 
bacterial components are required to prolong PMN viability. Finally, it would be interesting to 
analyse bacterial survival and PMN activity in the context of the upper airway organ culture 
model (Exley et al., 2005a) or in combination with a polarised layer of epithelial cells to mimic 
the conditions present in the nasopharynx. This work would allow a greater understanding of 
the role of PMNs and their interactions with host cells during colonisation and the early 
stages of meningococcal disease. 
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7.3 Role of lactate   
The role of metabolism in interactions of N. meningitidis with phagocytic cells has not 
previously been examined. It has been shown that the ability to utilise lactate via the lactate 
permease is necessary for a wild-type level of LPS sialylation (Exley et al., 2005a). Analysis of 
the lactate permease mutant showed that it produces less polysialic acid capsule, indicating 
that the importance of lactate to the meningococcus is also extended to this critical surface 
structure. Due to its anti-phagocytic properties, the reduction in capsule may have resulted in 
the increased association of the MC58∆lctP strain to HL60 cells compared with the wild-type 
strain. To verify that the increased association of this mutant was not the result of changes in 
Opa expression that might affect the interaction with the CD66 receptor, Opa expression 
was analysed in MC58∆lctP. However, no effect was seen. It can therefore be postulated 
that the increased association of the MC58∆lctP mutant occurs in part as a result of the 
reduced capsule expression in this strain. As has been previously hypothesised, it is 
possible that the capsule reduces recognition of the Opa proteins by the phagocytic 
receptors. The reduced capsule expression in MC58∆lctP would result in increased 
exposure of the antigens and thus increased association and internalisation of the bacteria. 
This hypothesis could be tested by performing phagocytosis assays with strains lacking LctP 
in an Opa negative background. The phagocytosis assays were performed with fixed strains 
containing mutations in a range of genes within the sialic acid synthesis pathway. Results 
indicated that although capsule is involved in preventing phagocytosis by neutrophils, that 
mutations affecting biosynthesis of sialic acid had a more profound effect than those leading 
to loss of capsule alone. Additionally, the effect of the lactate permease mutation was not 
entirely masked by the loss of polysialyl-transferase SiaD. Mutants lacking the sialic acid 
synthase SiaC associated with HL60 cells to a greater extent than those lacking capsule 
alone. SiaC is necessary for sialic acid synthesis which is then incorporated either in the 
capsule or in LPS. 
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The differential uptake between live and dead bacteria, and the increase in capsule 
expression as described above for the wild-type strain was also observed with MC58∆lctP. 
This suggests that the meningococcus is capable of producing capsular components in 
response to cells in both the presence and absence of lactate. Interrogation of carbon 
metabolism of the meningococcus presents two possible carbon sources that may be 
recruited as alternatives to lactate. Glucose is readily utilised by the bacterium during 
aerobic respiration whilst pyruvate is also available in the blood and CSF (Siesjo et al., 1968), 
albeit in far lower concentrations. It is possible that either of these carbon sources may be 
re-directed in the wild-type and MC58∆lctP strains, via PEP, to produce sialic acid in the 
absence of lactate. It is also of note that the reduction in capsule expression in MC58∆lctP is 
only seen in bacteria grown on nutrient-rich medium. Analysis of capsule expression 
following incubation in minimal media such as HBSS showed that there was no difference in 
expression between the wild-type strain and MC58∆lctP. It is likely that this is due to reduced 
capsule expression by the wild-type strain since the only carbon source provided by minimal 
media is glucose so the inability to utilise lactate in the mutant strain has no effect. This 
might also explain the loss of the difference in association of the MC58∆lctP strain with HL60 
cells when analysed with live bacteria.  
 
Despite associating with PMNs to the same degree as the wild-type, the MC58∆lctP strain 
was significantly attenuated for intracellular survival in primary PMNs. Inhibition of actin 
polymerisation and ROS production restored survival of the mutant strain to wild-type levels, 
indicating that the killing mechanism is likely to rely predominantly on the oxidative burst 
following phagocytosis of the bacteria. There are a number of potential explanations for the 
attenuation of this strain. It may be the result of a growth defect within PMNs caused by the 
inability to utilise lactate. N. gonorrhoeae is known to utilise cellular lactate for growth so the 
attenuation may partly be the result of reduced growth rate (Goldner et al., 1979). Also, the 
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scavenging of lactate from PMNs might be the mechanism by which the gonococcus might 
reduce the oxidative burst since PMNs require lactate to generate ROS (Topley et al., 1996; 
Britigan et al., 1988). The same may be true of the meningococcus and this is a possible 
explanation for the attenuation of this mutant since it would be unable to reduce the oxidative 
burst by depriving the PMNs of their lactate supply. Unfortunately this could not be 
demonstrated here as assays to quantify ROS production were unsuccessful due to 
technical difficulties. Both available ROS production inhibitors, DPI and resveratrol, cross-
reacted with the detection agent used to quantify ROS. A variable decrease in ROS 
detection was observed in the presence of MC58∆lctP compared to the wild-type, but this 
could not be validated in the absence of control samples. Finally, the enhanced killing of the 
MC58∆lctP strain by PMNs may be due to its reduced ability to express capsule and 
sialylate LPS. Available intracellular lactate would provide wild-type strains with a substrate 
for sialic acid production in a similar way to growth in rich medium. Capsule expression and 
LPS sialylation are thought to be important for intracellular survival and capsule also 
promotes resistance to CAMPs (Spinosa et al., 2007; Nikulin et al., 2006). However, it is unlikely 
that this is the reason for attenuation since MC58∆lctP bacteria recovered from HL60 cells 
show wild-type levels of capsule expression.  
 
The importance of lactate acquisition to the meningococcus is clearly multi-faceted. Previous 
studies have shown its importance in resistance against complement-mediated killing and 
virulence (Exley et al., 2005a) and the work described here has indicated the role of lactate in 
survival within PMNs. However, it appears that the contribution of lactate in these distinct 
locations is likely to be different. Since lactate is an important carbon source for the 
meningococcus, and is present in blood, CSF and intracellularly, metabolism of this carbon 
source is clearly crucial to survival of the meningococcus and plays a role in more than one 
aspect of virulence. The work described here may also be relevant to the interaction of the 
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meningococcus with other phagocytic cells such as macrophages and DCs, demonstrating 
the wide-reaching effects of metabolism to this bacterial pathogen. 
 
7.4 Role of Glutamate 
The importance of glutamate metabolism in interactions of N. meningitidis with phagocytic 
cells has not been previously studied. Production of sialic acid for capsule expression and 
LPS sialylation, which are key components in the interaction between the meningococcus 
and host cells, relies on carbon metabolism. A clear link between lactate metabolism and 
sialic acid production has been demonstrated and this was also investigated in strains 
deficient in four components of glutamate metabolism. The mutant strains were lacking 
either one of the two glutamate import enzymes, PerM or GltS (which operate in low sodium 
and high sodium concentrations respectively) GdhA, the glutamate dehydrogenase, and 
GhdR, the transcriptional regulator of GhdA. Analysis of capsule expression and LPS 
sialylation in each of these mutants demonstrated no change in either of these surface 
components. When analysed for association with the HL60 cell line, there was also no 
difference in association of any of the mutants compared with the wild-type H44/76 strain, 
with the possible exception of the H44/76∆gdhR strain, although the variation observed with 
this strain means it is difficult to draw conclusions about this result.  
The absence of an effect of glutamate metabolism on capsule expression and LPS 
sialylation, and on association with HL60 cells is not surprising. During metabolism, some 
glutamate is redirected to produce 2-oxoglutarate, a component of the citrate cycle, which 
indirectly provides oxaloacetate for the production of PEP (www.genome.ad.jp/kegg/pathway). 
However, metabolism of glutamate is not closely linked to sialic acid production in the same 
way as lactate, which does play a role in capsule biosynthesis and LPS sialylation. It is 
therefore likely that even if glutamate does contribute to the PEP required for normal sialic 
acid production, that in the absence of glutamate import or production, this loss could be 
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compensated for by a more immediate carbon sources, such as lactate, pyruvate or glucose. 
Since there was no effect on capsule or LPS, it would therefore be expected that association 
of bacteria with HL60 cells would not be affected in the absence of an intact glutamate 
metabolism pathway. 
 
The ability of the H44/76∆perM strain to cause bacteraemia in the infant rat model was 
analysed. Despite the absence of an effect on capsule and LPS sialylation in this strain, it 
was significantly attenuated in vivo compared to the wild-type strain, indicating an effect of 
the mutation somewhere other than in the bacterial surface components. Interrogation of the 
metabolic pathway associated with glutamate metabolism revealed a potential link between 
glutamate and glutathione production (Archibald and Duong, 1986). In its reduced state, 
glutathione is known to act as a scavenger of free radicals and as an electron donor to 
restore oxidised macromolecules (Carmel-Harel and Storz, 2000), and in the gonococcus 
glutathione is thought to play an important role in defence against oxidative stress. Thus it 
was suggested that the attenuation of H44/76∆perM may be due to an inability to resist 
oxidative damage due to low cellular content of glutathione resulting from the mutation in the 
glutamate transporter PerM. Subsequent analysis of resistance of the H44/76∆perM strain to 
oxidative agents H2O2 and paraquat performed by Caterina Monaco at The University of 
Lecce revealed that this strain is significantly more sensitive to oxidative stress than the wild-
type strain. The oxidative burst elicited by PMNs relies on production of ROS that exert 
oxidative stress on bacterial pathogens. Therefore, the strain deficient in PerM was analysed 
for intracellular survival in PMNs, where it showed a significant defect in survival compared 
to the wild-type strain. Inhibition of actin polymerisation and ROS production in PMNs 
restored survival of the mutant to wild-type levels, indicating that the susceptibility of the 
mutant relied upon internalisation and subsequent ROS production by PMNs. This result 
therefore indicates that the attenuation of H44/76∆perM in vivo is likely to be due to its 
inability to withstand the oxidative burst of phagocytic cells such as PMNs and 
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macrophages. This represents in interesting link between carbon/nitrogen metabolism and 
oxidation resistance mechanisms. Analysis of glutathione production in the H44/76∆perM 
strain has been performed at The University of Lecce. This work has shown that the strain 
lacking PerM has significantly reduced levels of intracellular glutathione compared to the 
wild-type strain, indicating that this is a likely cause of the attenuation of this mutant in the 
face of oxidative stress (Unpublished). Glutathione was also analysed in mutants lacking the 
glutathione synthetase Gsh. In this background, a deficiency in PerM had no additional effect 
on glutathione concentrations, indicating that these enzymes act in the same pathway 
(Unpublished). Additional work has also been completed by Christoph Tang, with the 
assistance of the Max Plank Institute in Berlin, to analyse the survival of the H44/76∆perM 
strain in mice lacking the gp91 phox subunit of the NADPH oxidase. The PMNs of these 
animals are unable to elicit an oxidative burst. This work has shown that survival of the 
mutant strain is restored to wild-type levels during infection of these knockout animals, 
confirming the role of the oxidative burst in the attenuation of this mutant (Unpublished). Further 
investigation into the importance of glutamate metabolism would require complementation of 
the mutants described here, and quantification of ROS production during assays with PMNs 
and in vivo. 
 
7.5 Role of DNA repair 
Investigation into the interaction between N. meningitidis and PMNs indicates that the 
bacterium is capable of responding to the presence of PMNs by altering certain surface 
structure components in order to evade phagocytosis. However, analysis by microscopy 
shows that a significant number of bacteria are still internalised. Initiation of phagocytosis 
triggers the signalling pathways involved in the PMN oxidative burst that culminates in the 
release of potent bactericidal compounds into the phagosome (Babior et al., 1976). Even if the 
bacterium was to survive this assault, the resulting damage to the bacterial DNA would likely 
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be cytotoxic. AP endonucleases act within the BER pathway to ameliorate the effects of 
oxidative damage to cellular DNA (Wilson et al., 2003). Therefore the neisserial AP 
endonuclease would be predicted to play a role in protecting the bacterial genome from this 
attack. Searches of the serogroup B MC58 genome revealed two putative AP 
endonucleases, NExo (NMB0399) and NApe (NMB2082). Despite possessing the closest 
identity with the E. coli enzyme ExoIII, NExo does not display AP endonuclease activity. 
Instead NExo appears to be specialised for exonuclease and efficient 3’dRp activity 
(Carpenter et al., 2007). Surprisingly, the human HAP1 paralogue, NApe, is actually the 
functional AP endonuclease. Interrogation of the structures of NExo and NApe revealed that 
their differing activities can be attributed to an amino acid change in the DNA binding site. 
Substitution of His167 in NExo with glycine or serine, the residues found in ExoIII and HAP1 
respectively, conferred AP endonuclease activity (Carpenter et al., 2007). This work highlights 
the importance of combining biochemical and structural characterisation of hypothetical 
proteins with investigation of their function. Most previous studies have relied on 
identification of proteins purely by sequence homology, followed by characterisation of 
mutants lacking the genes encoding those proteins. The work described here has 
demonstrated that although NExo is the closest bacterial AP endonuclease homologue, it is 
NApe that fulfils this role and therefore care should be taken in assuming that the closest 
homologues of known proteins will perform an identical function in vivo.  
 
NApe is an AP endonuclease and it is therefore thought to act within the BER pathway. 
However, since NExo acts independently, despite its homology to ExoIII, its role in DNA 
repair is more ambiguous. Exonuclease activity has previously been ascribed to AP 
endonucleases and DNA polymerases while 3’dRp activity is restricted to AP 
endonucleases. NExo is therefore a novel enzyme. It is possible that it may act within BER, 
within a pathway distinct from NApe. Alternatively, NExo may act in a different pathway 
altogether, or may potentially act alone to clear blocked ends and cleave terminal 
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mismatched bases. Both NExo and NApe are required for resistance to oxidative stress and 
for virulence. A mutant lacking both enzymes is significantly more attenuated under oxidative 
stress and in vivo, indicating that despite NApe possessing the same activities, that NExo 
has a specific role independent of NApe. The double mutant was also significantly 
attenuated for intracellular survival in PMNs. Survival was restored to wild-type levels when 
ROS production and actin polymerisation was inhibited in PMNs, indicating that attenuation 
of the mutant lacking NExo and NApe was due to killing by the oxidative burst following 
phagocytosis. This supports the hypothesis that NApe plays a role in BER since BER acts 
on damage caused by oxidative stress, such as that elicited by the oxidative burst. This work 
also suggests that NExo is linked with BER since a single mutant deficient in NExo is 
sensitive to oxidative stress.  
 
The roles of each enzyme cannot be extrapolated individually to their importance in survival 
in PMNs since survival of only the double mutant strain, MC58∆nexo∆nape was investigated 
and further work would require characterisation of the MC58∆nexo and MC58∆nape to 
identify the role each enzyme plays in survival in the presence of PMNs. Complementation 
of these mutations would also be required for further work, and it would be interesting to 
analyse the survival of these strains in mice lacking the gp91 phox subunit of the NADPH 
oxidase to confirm their role in ameliorating the effects of the oxidative burst. However, the 
data obtained from analysis of survival in the presence of oxidative agents and in vivo would 
suggest that both NExo and NApe are likely to be involved in resistance to the oxidative 
burst. Attenuation of mutants lacking NExo and NApe in the presence of oxidative stress is 
likely to be the result of an inability to repair damage to DNA that would usually be repaired 
by BER. Accumulation of lesions such as 8-oxoG, Fapy, pyrimidine dimers and glycols, and 
AP sites would result in cytotoxic mutations. Bacteria deficient in NApe would lack an AP 
endonuclease, and thus would be unable to excise AP lesions resulting either directly from 
oxidation or from the activity of glycosylases. The strain lacking NExo could have severely 
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impaired ability to repair blocked ends and terminal mismatched bases. This process may 
still be carried out by NApe, although the rate of exonuclease activity of NExo is far higher. 
Further analysis of the role of NExo within DNA repair would involve the analysis of a range 
of bacterial mutants lacking different enzymes known to act within BER and other DNA 
repair pathways. These include MutT, MutY, Fpg, RecA, UvrA and UvrB (Davidsen et al., 2005; 
Black et al., 1997; Black et al., 1995). It would also be interesting to analyse the extent and nature 
of DNA damage occurring within the genomes of the wild-type and mutant strains following 
exposure to oxidative stress to determine the lesions that NExo and NApe act on.  
 
The pairing of NExo- and NApe-like enzymes is not unique to the meningococcus. A search 
of the genomes of 297 bacterial species performed by Elisabeth Carpenter at the Centre for 
Structural Biology at Imperial College revealed the NExo-NApe pairing in widely divergent 
species (Figure 7.1). These include other strains of N. meningitidis, N. gonorrhoeae and 
other pathogenic species such as Pseudomonas aeruginosa and Bordetella pertussis. The 
pairing also extends into non-pathogenic species. There are three main hypotheses to 
explain the occurrence of this pairing. First, it is possible that one of the genes was acquired 
by horizontal transfer from a different species or from a eukaryotic host. However, analysis 
of the GC content of nexo and nape (data not shown) show that there is no significant 
difference between them and the remainder of the genome, providing no evidence that they 
originated by horizontal transfer. A second possible explanation is that one of the genes 
could have arisen by duplication. As shown by the NExo substitution mutants, a single 
change in the amino acid sequence of the DNA binding site alters the binding specificity, and 
therefore the activity, of the enzyme. Such a mutation may have become established in the 
genome if it confers an evolutionary advantage and would therefore have been selected for 
and established within the population by genetic drift. However, this hypothesis is also 
unlikely since nexo and nape are more similar to their E. coli and human counterparts than 
they are to each other. The most likely explanation is that the NExo-NApe pairing has arisen 
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as a result of convergent evolution. The diversity of species in which the pairing is found 
suggests it is likely that it arose numerous times, supporting the importance of both enzymes 
to survival. It has been conserved within these species as it confers an evolutionary 
advantage. In the case of the meningococcus this advantage is translated as the ability to 
resist killing by oxidising agents. This could also be the case for the other pathogenic 
species with the enzyme pairing, and may protect species that are not in contact with 
eukaryotic hosts from alternative forms of oxidative stress. 
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 Figure 7.1 The NExo / NApe pairing is found in divergent bacterial species 
logenetic analysis of 297 sequenced bacterial genomes was performed to determine the 
uency of the NExo / NApe pairing. The difference between NExo and ExoIII paralogues was 
ned by the presence of a small or large sidechain in the position equivalent to NExo His167. 
 number of species with both NExo and NApe paralogues is given after the phylum name, 
 the number of genomes searched is in brackets. Phyla with pairs of these enzymes are 
wn in red. The NExo/NApe pairing found in three bacterial phyla, the actinobacteria, 
maproteobacteria and betaproteobacteria. This phylogenetic analysis was performed by 
abeth Carpenter at the Centre for Structural Biology at Imperial College London, and this 
ge is reproduced with her kind permission. 185 
Chapter 7 Discussion  
 
Interestingly, a conflicting clue towards the origin of the NExo-NApe pairing in the 
meningococcus exists within the gene encoding NExo. Interrogation of the NExo gene 
sequence reveals the DNA Uptake Sequence, 5’-GGCGGCGGCG-3’ within the coding 
region. Despite the similarity in GC content between nexo and nape, it is possible that NExo 
was acquired from an external source, most likely of bacterial origin due to its homology with 
ExoIII. The novel activity of NExo endows the meningococcus with efficient exonuclease and 
3’dRp activity in addition to that performed by NApe. The work described here has 
demonstrated the importance of BER and its related enzymes to survival of oxidative stress 
and the addition of NExo to the meningococcal enzyme profile may have aided in the ability 
of the bacterium to survive in the hostile intracellular environment encountered within 
phagocytic cells, thus contributing to its virulence. The meningococcal genome, like many 
other bacterial pathogens, shows a high degree of plasticity, allowing high mutation rates 
leading to rapid evolution and adaptation to the human host. However, in circumstances 
such as those encountered within the intracellular compartment, the bacterium would require 
strict control of DNA damage to prevent build-up of cytotoxic mutations. It is likely that this 
role is fulfilled by NExo and NApe, and that this was the reason for the evolution of the 
NExo-NApe pairing in the meningococcus. 
 
7.6 Summary 
The aim of this project was to characterise the non-opsonic interaction between N. 
meningitidis and PMNs. This was performed using the human PMN cell line HL60 to 
investigate the events involved in initial contact and phagocytosis of the meningococcus, and 
primary human PMNs to investigate the fate of the bacteria and PMNs during the interaction. 
This work has demonstrated that although the meningococcus is internalised by PMNs, and 
that live bacteria actively respond to the presence of the cells, resulting in increased 
expression of the anti-phagocytic polysialic acid capsule and a change in LPS structure. It is 
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possible that these responses result in reduced uptake of bacteria by PMNs. Intracellular 
meningococci are able to survive within PMNs. This ability relies on the ability to utilise 
lactate, to import glutamate in low sodium conditions, and to perform DNA repair via the 
newly identified NExo-NApe enzyme pairing. The presence of the meningococcus also 
results in a delay in apoptosis of PMNs.  
 
The implications of this work for the human host are that since PMNs are unable to eradicate 
the meningococcus, their primary role in defence against disease is compromised. The 
additional manipulation of the life span of PMNs through delaying apoptosis suggests that 
this may be a mechanism behind the uncontrolled inflammatory response that is a hallmark 
of infection with N. meningitidis. PMNs may therefore represent a safe haven for bacteria in 
the bloodstream, allowing them to avoid complement-mediated killing, and potentially 
providing an alternative route into the CSF. The absence of an efficient cell-mediated 
immune response combined with this manipulation of PMN function may partly explain the 
rapid progression of meningococcal disease in many cases, particularly in individuals lacking 
components of the complement pathway. 
 
Carbon metabolism has been previously shown to play a crucial factor in the pathogenesis 
and phenotypic traits of the meningococcus, particularly in growth and expression of surface 
structures. The work described here has demonstrated additional roles for the metabolism of 
both lactate and glutamate in the progression of disease by identifying the link between 
carbon metabolism and resistance to killing by intracellular ROS. Clearly the role of bacterial 
metabolism in disease is multi-faceted and closely linked to the immediate environment 
within the host.  
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DNA repair has not been extensively studied in the meningococcus and the identification of 
the NExo-NApe pairing raises important questions about the validity of work where the 
function of enzymes is assumed from the activity of the closest genetic homologue. This 
work has also shown that despite the extensive plasticity of the meningococcal genome and 
frequency of mutator phenotypes in highly virulent strains, that DNA repair is also crucial to 
the survival of the bacterium. The meningococcus expresses an additional enzyme, NExo, 
that appears to work in parallel to BER to allow for survival in the hostile intracellular 
environment. The frequency of the pairing fo NExo and NApe homologues in diverse 
bacterial strains indicates that this is an important and valuable acquisition. 
It is unlikely that this work will contribute to efforts to develop or improve current vaccine 
design. Although enzymes involved in metabolic pathways have previously been suggested 
as vaccine candidates, LctP and PerM are located in the membrane and therefore are not 
exposed in the bacterial surface (Exley et al., 2005a; Pagliarulo et al., 2004). NExo and NApe are 
also unlikely candidates due to their intracellular location and close homology to the human 
AP endonuclease. However, this work does contribute towards a better understanding of the 
mechanisms behind the pathogenesis of N. meningitidis and the ways in which 
meningococcal disease develops. Such knowledge aids in the development of more 
effective treatment regimes and may help in more accurate planning of vaccination strategy. 
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